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To people worldwide suffering from various neurodegenerative dis-
eases.
Abstract
Clinical deep brain stimulation (DBS) is a tool used to mitigate pharmacologically
intractable neurodegenerative diseases such as Parkinson’s disease (PD), tremor and
dystonia. Present implementations of DBS use continuous, high frequency voltage or
current pulses so as to mitigate PD. This results in some limitations, among which there
is stimulation induced side effects and shortening of pacemaker battery life. Adaptive
DBS (aDBS) can be used to overcome a number of these limitations. Adaptive DBS is
intended to deliver stimulation precisely only when needed. This thesis presents work
undertaken to investigate, propose and develop novel algorithms and implementations
of systems for adapting DBS. This thesis proposes four system implementations that
could facilitate DBS adaptation either in the form of closed-loop DBS or spatial adap-
tation. The first method involved the use of dynamic detection to track changes in
local field potentials (LFP) which can be indicative of PD symptoms. The work on
dynamic detection included the synthesis of validation dataset using mainly autore-
gressive moving average (ARMA) models to enable the evaluation of a subset of PD
detection algorithms for accuracy and complexity trade-offs. The subset of algorithms
consisted of feature extraction (FE), dimensionality reduction (DR) and dynamic pat-
tern classification stages. The combination with the best trade-off in terms of accuracy
and complexity consisted of discrete wavelet transform (DWT) for FE, maximum ratio
method (MRM) for DR and k-nearest neighbours (k-NN) for classification. The MRM
is a novel DR method inspired by Fisher’s separability criterion. The best combination
achieved accuracy measures: F1-score of 97.9%, choice probability of 99.86% and classi-
fication accuracy of 99.29%. Regarding complexity, it had an estimated microchip area
of 0.84 mm2 for estimates in 90 nm CMOS process. The second implementation devel-
oped the first known PD detection and monitoring processor. This was achieved using
complementary detection, which presents a hardware-efficient method of implementing
a PD detection processor for monitoring PD progression in Parkinsonian patients. Com-
plementary detection is achieved by using a combination of weak classifiers to produce
a classifier with a higher consistency and confidence level than the individual classifiers
in the configuration. The PD detection processor using the same processing stages as
the first implementation was validated on an FPGA platform. By mapping the imple-
mented design on a 45 nm CMOS process, the most optimal implementation achieved
a dynamic power per channel of 2.26 µW and an area per channel of 0.2384 mm2.
It also achieved mean accuracy measures: Mathews correlation coefficient (MCC) of
0.6162, an F1-score of 91.38%, and mean classification accuracy of 91.91%. The third
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implementation proposed a framework for adapting DBS based on a critic-actor con-
trol approach. This models the relationship between a trained clinician (critic) and
a neuro-modulation system (actor) for modulating DBS. The critic was implemented
and validated using machine learning models, and the actor was implemented using a
fuzzy controller. Therapy is modulated based on state estimates obtained through the
machine learning models. PD suppression was achieved in seven out of nine test cases.
The final implementation introduces spatial adaptation for aDBS. Spatial adaptation
adjusts to variation in lead position and/or stimulation focus, as poor stimulation focus
has been reported to affect therapeutic benefits of DBS. The implementation proposes
dynamic current steering systems as a power-efficient implementation for multi-polar
multisite current steering, with a particular focus on the output stage of the dynamic
current steering system. The output stage uses dynamic current sources in implement-
ing push-pull current sources that are interfaced to 16 electrodes so as to enable current
steering. The performance of the output stage was demonstrated using a supply of 3.3 V
to drive biphasic current pulses of up to 0.5 mA through its electrodes. The preliminary
design of the circuit was implemented in 0.18 µm CMOS technology.
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The field of neurostimulation dates back to the 18th century when the Italian physician
and physicist Luigi Galvani discovered what he called “animal electricity” when he
activated skeletal muscle contraction with an electric current. Since that time there
have been significant advances in the understanding of basic anatomy and physiology of
body tissue when in contact with electricity. Cortical stimulation dates back to the 19th
century when the first direct electrical stimulation of the cortex was recorded [1]. Even
though cortical stimulation has existed from the 19th century, therapeutic Deep brain
stimulation (DBS) was discovered by Benabid et al. [11]. DBS is the conventional
therapy for treating various neurological disorders such as Parkinsons disease (PD),
essential tremor (ET) and dystonia. From then on, research in DBS has witnessed
a remarkable surge in interest. A particularly significant milestone was the approval
of DBS as a therapy for PD in 1997 by the Food and Drug Administration (FDA).
At present, there is a growing interest in using DBS as a therapy for neuropsychiatric
disorders like medication resistant cases of depression, obsessive-compulsive disorder
(OCD) and Tourette’s syndrome (TS) [12]. Essentially, this chapter provides a context
for clinical DBS for PD and some of its challenges that motivated this work. The
sections of this chapter are organised as follows: Section 1.1 provides a brief introduction
on therapeutic interventions for mitigating PD notably, clinical DBS and its limitations.
Section 1.2 provides the objectives of the work as well as the research gaps targeted by
this work. Section 1.3 lists the publications that have so far resulted from this work.
And finally, Section 1.4 summarises the major points addressed in subsequent chapters
of the thesis.
1.1 Clinical DBS
In the UK, based on figures from the National Health Service (NHS), it is estimated
that 127,000 people are suffering from PD [13], these numbers are on the rise. PD
is one of the most common neurodegenerative diseases leading to impairment of both
motor and non-motor functions [14]. It manifests mostly in elderly persons but can
occasionally be found in younger patients. Pathologically, PD is caused by degenera-
tion of the dopamine-producing neurons in the substantia nigra (SN), this starves the
brain of dopamine [15]. Thus, affecting basic tasks in patients since dopamine is a neu-
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rotransmitter in the brain that assists in functions like movement, memory, cognition
among others. Symptoms manifest by the presence of rest tremor, postural instability,
rigidity and bradykinesia [16].
At its advanced stage, therapeutic interventions like ablative surgery and clinical DBS
are administered. The surgical sites for these interventions are the ventral intermediate
nucleus (VIM) of the thalamus, the globus pallidus pars internus (GPi), or the sub-
thalamic nucleus (STN), to restore motor functions. The STN has been identified as
the most effective site for mitigating PD symptoms [17]. PD treatment using ablative
surgery results in serious side effects by exacerbating speech, gait, and cognitive disor-
ders; and may even cause hemiballismus [18]. This makes it less advantageous compared
to DBS, which has reversible effects. For clinical DBS, the choice of stimulation site
depends on the dominant symptom of each patient. Tremor dominant PD is mitigated
by stimulating the VIM, while bradykinesia and rigidity dominant PD can be reduced
by stimulating the GPi or STN. Furthermore, DBS is most effective when used in a
bilateral configuration. Figure 1.1 illustrates DBS being unilaterally administered at
the STN. Currently, PD is the neurological condition most widely treated by DBS [1].
Though the underlying mechanism of DBS therapy is still unclear [1,19,20]. Nonethe-
less, it improves the quality of life of patients, even though it’s very expensive in terms
of life long maintenance. Its high cost is as a result of the incurable nature of PD [3].
Continuous repetitive stimulation (mostly at 130 Hz) causes some long term effects
which result in impaired cognitive abilities and motor functions. It affects coordinated
neuronal communication necessary for proper cognitive functions [21]. Presently, post-
surgery programming of stimulation parameters by trained clinicians can take up to a
year or more [22]. This is because stimulation parameters are adjusted heuristically by
using visual symptoms as the only feedback, after which follow up visits by patients
are required in order to adjust stimulation to changes in patient condition.
In DBS, stimulation parameter setting is a very tedious process as every patient has
a unique set of stimulation parameters. Figure 1.1 illustrates an implantable/internal
pulse generator (IPG) for DBS, showing the unilateral stimulating leads with cylindrical
electrodes at the tip of each lead [23]. In chronic deep brain stimulation, these leads can
migrate which may degrade the effectiveness of the stimulation, requiring the need to
adjust stimulation to these changes constantly. More so, due to the progressive nature
of PD, selected parameters may become obsolete with time, necessitating the need to
track patient pathophysiology. Both of these can be adjusted for using adaptive deep
brain stimulation (aDBS) [24]. There are two forms of aDBS: closed-loop adaptation
and spatial adaptation. Closed-loop adaptation is ideally designed to track changes
in patient pathophysiology and correspondingly adjust stimulation. This is necessary
because continuous stimulation is suggested to result in side effects and shortening of
pacemaker battery life [25]. On the other hand, spatial adaptation adjusts to variation
in lead position and/or stimulation focus, as poor stimulation focus has been reported
to affect therapeutic benefits [26].
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Figure 1.1: Components of a DBS implant and major stimulation sites for clinical DBS
(adapted from [1]).
1.1.1 Theories on How DBS Works
Clinical DBS has emerged as an effective therapy for PD and other movement disorders,
yet its operating mechanism is still intensely under debate. The choice of the stimu-
lation parameters (i.e. pulse width, frequency and amplitude) used has been reported
to affects the effectiveness of DBS in patients [27]. What is not clear is how different
stimulation patterns and parameters influence the efficacy of DBS. There are various
theories on how DBS induces beneficial effects in patients. The main mechanisms
posited for DBS are “inhibition”, “excitation” and “disruption”.
The inhibition hypothesis is the oldest. It was suggested after DBS was found to have
the same beneficial effect on PD symptoms as lesion therapy [28, 29]. STN-DBS and
GPi-DBS were believed to inhibit local neuronal activity, by reducing the firing rate
of surrounding neurons. This was corroborated by recordings obtained around the
stimulation sites of STN-DBS in PD patients and non-human primate models [30, 31].
Using the firing rate model in movement disorders which claims that parkinsonian
impairments result in abnormally increased firing pattern in the STN and/or GPi,
and DBS mitigates the motor symptoms by reducing this increased firing. However,
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others point out that, how then has it been possible to treat motor symptoms in
situations in which the GPi shows low activity [32]. On the contrary, other studies
suggest that the most natural explanation for DBS is the excitation hypothesis, where
stimulation depolarises neuronal elements. They believe DBS activates the STN (or
GPi) output, thus jamming abnormal pathological activity in basal ganglia circuits
resulting from motor impairments [33]. In the disruption hypothesis [32], DBS exerts
therapeutic influence by dissociating input and output signals, thereby disrupting the
flow of abnormal information to the stimulation site. In this theory, therapeutic DBS is
allegedly believed to disconnect the abnormal coupling in the basal ganglia as a result
of PD.
An emerging theory is the nonexclusive hypothesis [34]. Since the other theories present
exclusive mechanisms for DBS, the nonexclusive theory suggests that DBS is a result of
many (nonexclusive) mechanisms including modulation of oscillatory activity, neuroge-
nesis, synaptic plasticity, neurochemical effects and neuroprotection. The mechanisms
vary in importance and manifestation depending on the condition being treated and the
brain structure (target) being stimulated. At present, the mechanisms of DBS are still
under debate and a proper understanding of this mechanisms could lead to improved
therapeutic interventions.
1.1.2 Limitations of Clinical DBS
PD Patients are treated with a combination of medication and therapeutic stimulation;
however, therapeutic interventions are ineffective in 30% of cases. Therapeutic stimu-
lation is rendered ineffective by disease progression, environmental factors, mechanical
factors, and behaviourally induced changes in network activity. As a result, additional
sessions to manually adjust stimulation settings may be required [35]. The procedure
can be very costly and time-consuming. This is because only a fraction of the stim-
ulation parameter space can be practically explored during each session. Moreover,
as PD progresses the dominant symptoms may change which interferes with DBS de-
vice programming and there may need to modify stimulation settings. Programming
is dependent on the stimulated target, electrode orientation relative to the target, the
disorder treated, and the dominant symptoms for the given disorder. Other short-
comings of clinical DBS include stimulation induced side effects for example drooling,
flushing dysarthria, and ocular deviation [26]. They are mainly caused by continuous
stimulation as well as stimulation field spread beyond target areas [24]. Stimulation
induced side effects can be triggered mainly due to three scenarios, namely:
• False-positive detection results in administering stimulation when it is not re-
quired, and this may lead to stimulation induced side effects [36].
• False-negative detection may result in the non-administering of stimulation when
it is required, which may worsen patient condition [37].
• An additional concern is the drift of electrodes in chronic DBS. Based on current
electrode designs, DBS electrodes are cylindrical around the lead. The change in
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electrode position as is normally the case in chronic DBS, inhibits access to target
stimulation sites. The requirements for precision are high as minimal variation in
DBS lead position can cause a large variation in therapeutic outcome. Increasing
stimulation intensity to overcome these may be counterproductive as unintended
targets could be touched which may result in stimulation-induced side effects.
The aforementioned limitations can be resolved using aDBS [24, 38]. For closed-loop
adaptation, stimulation is optimised by controlling the stimulation intensity, timing and
direction using feedback signals from the stimulation site. For adaptation to changes in
lead position, directional steering, which enables control over stimulation focus can be
used. Adaptive DBS has the potential to improve efficacy, reduce power consumption
and reduce side effects. The whole point of aDBS is to implement control techniques
that can adjust stimulation parameters in real-time according to quantifiable and objec-
tive neurochemical, physiological, and behavioural changes while reducing the frequency
of clinical interventions. Such that clinical benefits are optimised while side effects are
reduced; and as a secondary effect battery depletion is also minimised [24,25,38]. This
is necessary because implantable DBS systems have certain resource constraints, for
example, the power density of the surrounding chip has to be much less than the power
density for brain tissue damage, which is 800µW/mm2 [39]. It is against this backdrop
that the major research objectives are identified.
1.2 Objectives
To enable the development of fully implantable systems for adaptive DBS, research gaps
around hardware efficiency in implementations for aDBS were identified and explored.
And in no particular order of importance below is a list of the major research gaps
targeted:
• With hardware implementation in mind, there is a need to identify, quantify
and exhaustively evaluate a combination of algorithms that can be used for PD
detection based on their complexity and accuracy trade-off. Two other contri-
butions resulted from pursuing this objective: the first involved using statistical
methods to generate semi-synthetic local field potentials (LFP) datasets, which
was the first of its kind using real LFP recordings obtained from PD patients.
Semi-synthetic generation of test datasets was necessary due to the paucity of val-
idation datasets. The other contribution presented dynamic detection as a way of
tracking fluctuations in LFP dynamics. It consists of dynamic feature extraction
and dynamic classification. Dynamic feature extraction determines the features
and channels that indicate the best separability between classes of interest (dis-
ease and non-disease states) such that they can be adopted for use. And dynamic
classification uses model selection to select the most compatible classifier for use.
This research objective is achieved in Chapter 4.
• To help in overcoming the power and bandwidth constraints imposed by wirelessly
monitoring biomarkers in PD patients, an on-site real-time hardware-efficient PD
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detection processor is developed. It was prototyped on a field programmable gate
array (FPGA) platform so that it can be made flexible enough to be updated
as more knowledge regarding PD and DBS is obtained. It is ideally designed
to monitor PD events to assist external caregivers or for use with stimulation
devices. To obtain on-chip power and area estimates that could guide future
developments, various implementations of the processor were mapped to 45 nm
CMOS technology. This research objective is achieved in Chapter 5.
• As the need for a fully implantable aDBS system is becoming ever more important,
a robust and resource efficient closed-loop control strategy adopting a critic-actor
control approach was proposed and its feasibility investigated. The critic-actor
configuration models a physician. The critic observes the symptoms against which
disease progression are assessed and the actor takes possible actions to mitigate
the symptoms – which are what a trained clinician does. This research objective
is achieved in Chapter 6.
• Taking into consideration the shortcomings of implants for chronic DBS such as
electrode migration, preliminary work on an output stage that could facilitate
directional steering is presented. Directional steering has been suggested as a
possible solution to overcome spatially dependent changes in chronic DBS. This
research objective is achieved in Chapter 7.
Other research gaps targeted are:
• To provide a direction for multidisciplinary researchers and stakeholders in the
DBS community, a review highlighting the major challenges in DBS both from
the point of view of engineers and clinicians is conducted. This research objective
is achieved in Chapter 2.
• To assist with providing balanced methods for comparing brain-machine-interface
(BMI) technologies, which aDBS systems are part of, the need for standard as well
as custom metrics for assessing their performance are highlighted. This research
objective is achieved in Chapter 3.
The long term goal is to realise fully implantable aDBS systems: for both closed-
loop DBS and spatial adaptation. For that to be achieved, efficacious circuits and
systems with ultra-low power implementations are required. The above objectives are
a precursor to fully implantable aDBS systems.
1.3 Publications
The work reported in this thesis has resulted in the following publications:
• A. Mohammed, M. Zamani, R. Bayford, and A. Demosthenous, “Toward On-
Demand Deep Brain Stimulation Using Online Parkinson’s Disease Prediction
Driven by Dynamic Detection,” IEEE Transactions on Neural Systems and Re-
habilitation Engineering, vol. 25, no. 12, pp. 2441-2452, Dec. 2017.
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• A. Mohammed, V. Valente, R. Bayford, and A. Demosthenous, “Output stage
of a dynamic current steering deep brain stimulator,” in 2015 IEEE International
Conference on Electronics, Circuits, and Systems (ICECS), 2015, pp. 81-84.
• A. Mohammed, M. Zamani, R. Bayford, and A. Demosthenous, “Patient spe-
cific Parkinson’s disease detection for adaptive deep brain stimulation,” in 2015
37th Annual International Conference of the IEEE Engineering in Medicine and
Biology Society (EMBC), 2015, pp. 1528-1531.
• A. Mohammed, R. Bayford, and A. Demosthenous, “Towards Adaptive Deep
Brain Stimulation for Parkinson’s Disease: A Review” Submitted to Neurodegen-
erative Disease Management.
Other potential publications that could result from this work are:
• A. Mohammed, R. Bayford, and A. Demosthenous, “A Framework for Adapt-
ing Deep Brain Stimulation Based on Parkinsonian State Estimates,” Manuscript
in preparation for submission to IEEE Transactions on Neural Systems and Re-
habilitation Engineering.
• A. Mohammed, R. Bayford, and A. Demosthenous, “Complementary Detection
for Hardware-Efficient On-site Monitoring of Parkinsonian Progress in Patients,”
Manuscript in preparation for submission to IEEE Transactions on Biomedical
Circuits and Systems.
• A. Mohammed, R. Bayford, and A. Demosthenous, “Measures and Metrics for
Evaluating Detection and Classification Algorithms in Brain Machine Interfaces,”
Manuscript in preparation for submission to Journal of Neural Engineering.
1.4 Thesis Overview
This thesis consists of eight chapters. Chapter 1 has given a brief introduction on
clinical DBS and the limitations that motivated the work in this thesis. Also, it details
how this work intends to address the highlighted limitations to contribute to existing
research in aDBS.
Chapter 2 provides background and associated literature on aDBS. It details the fun-
damentals of PD, commercial DBS systems, and the future potentials of DBS systems.
Then it describes the major areas in which advancements are needed to facilitate aDBS.
It goes on to describe the major advancements in two forms of aDBS: closed-loop DBS
and spatial adaptation. The major findings in the chapter are summarised at the end.
Chapter 3 delves deeper into the major challenges of physiological signal analysis. Since
closed-loop DBS is an instance of BMIs, it extends the review to BMIs. The chapter
focusses on the analysis of sensing techniques and feedback signals that can be used for
closed-loop DBS with particular emphasis on neural signals. It goes further to analyse
the principal metrics and measures that can be used to evaluate efficacy, complexity
and efficiency of feedback algorithms in closed-loop DBS and BMIs. Afterwards, it
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provides a perspective on the need for standardising and/or customising performance
metrics for feedback algorithms in BMI, such that algorithms could be assessed in a
more objective, fairer and more balanced way. The main points in the chapter are
highlighted at the end.
Chapter 4 addresses the first objective of this thesis through an exhaustive analysis
of various combinations of PD detection algorithms consisting of feature extraction,
dimensionality reduction and classification stages. The analysis was concerned with
hardware-aware implementations; as such, trade-offs in relation to accuracy and com-
plexity were paramount. A new dimensionality reduction method, the MRM, is pro-
posed as part of the algorithms to be evaluated. The chapter goes further to propose
a method for semi-synthetic LFP generation to enable validation of algorithms. It
also demonstrates the use of dynamic detection schemes as a way to overcome the
inconsistencies in feedback signals across time and patients.
Chapter 5 addresses the second objective by providing a hardware-efficient platform for
on-site processing of neural signals such that PD events can be detected and remotely
monitored at a reduced power and bandwidth requirement. The system is the first of
its kind for on-site PD monitoring and detection. The system was prototyped on an
FPGA platform and mapped to 45 nm CMOS process for insights into its microchip
implementation in terms of power and area consumption.
Chapter 6 addresses the third objective by proposing and exploring the possibility of
implementing a critic-actor control approach as a robust and resource efficient closed-
loop control strategy for adapting DBS. The system leverages on a machine learning
model as the critic and a fuzzy controller as the actor. The approach was adopted in
an attempt to individualise therapy since there is still limited understanding regarding
the mechanisms of DBS as well as the progression of PD in patients.
Chapter 7 addresses the fourth objective by proposing and presenting a neuro-stimulation
technique in which stimulation field spread beyond targeted areas can be mitigated us-
ing dynamic current steering. The chapter focused on the design of an output stage
for dynamic current steering. The output stage uses dynamic current sources (DCS)
in implementing 8 push-pull current sources that are interfaced to 16 electrodes so
as to enable current steering. The dynamic current sources operate in two phases -
programming and stimulation. This technique was adopted because it reduces power
consumption and output current mismatch. The 16 electrodes can be driven both as
anodes and cathodes and it is made to be scalable for use with more electrodes. The
circuit was implemented in a 0.18 µm CMOS technology.
Chapter 8 summarises the main contributions of the work and provides future directions
in which the algorithms and implementations in the work can be developed towards
the goal of realising a fully implantable real-time aDBS system.
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Chapter 2
Towards Adaptive Deep Brain
Stimulation for Parkinson’s Disease
Adaptive DBS presents a promising therapy for PD. However, implementing an effective
adaptive system for DBS has not been realisable. This has partly been due to the poor
understanding of the cellular mechanisms responsible for the network effects of DBS
and PD. This chapter presents a comprehensive literature on background and other
works related to aDBS. It starts with the fundamentals of DBS. Then delves into the
various processing stages required to realise an aDBS systems; which is the section on
“Towards Adaptive DBS”. With a firm understanding of the fundamentals, the next
two sections highlight the advances in closed-loop adaptation and spatial adaptation
in DBS. The next section highlights the major developments in the field of DBS. And
the final section summarises the major points in the chapter.
2.1 DBS Fundamentals
The basal ganglia are a group of subcortical nuclei targeted by clinical DBS. They
are responsible for many functions including, posture and movement control. So far,
many studies have confirmed the predominant claims that the basal ganglia exercises
a major role in movement control. Their findings established that dopamine deficiency
in the basal ganglia disrupts the discharge patterns in its nuclei like the globus pallidus
externa (GPe), the STN, the GPi and the SN. This disruption results in an imbalance
between inhibitory and excitatory outputs which leads to the onset of PD symptoms
[40]. Generally, more insights into the physiological causes of PD are still gained. To
alleviate PD symptoms, clinical DBS is used. Even though the mechanisms by which
this happens are still under debate. Clinical DBS systems are mainly marketed by three
companies; Medtronic, Boston Scientific and St Judes Medical. The major innovations
by manufacturers of clinical DBS systems have centred on increasing the specifications
for stimulation parameters; with work on aDBS systems still at the research stage.
Nevertheless, DBS has established itself as the preferred therapeutic intervention during
the advanced stages of PD. This is why its therapeutic benefits have been explored in
more than 40 brain sites for about 30 clinical disorders [41]. Even with all these,
approval has mainly been for its use in three stimulation sites: STN, GPi and Vim.
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And for only three conditions, namely, PD, dystonia and tremor.
2.1.1 The Basal Ganglia
The basal ganglia is located in deep regions of the brain and comprises of a group of
subcortical nuclei, which are directly responsible for posture and movement. The basal
ganglia is notably involved in PD. PD primarily affects the SN (shown in Figure 2.1).
This decreases the production of dopamine, an inhibitory neurotransmitter, which in-
terferes with movement execution in patients. Apart from the SN, other nuclei of the
striatum, the globus pallidus (GPi and GPe), and the STN. The largest nucleus is
the striatum consisting of the caudate nucleus and the putamen, and it contributes to
mainly motor and cognitive functions. The pathological changes in the basal ganglia
play a major role on conditions like slowing of movement, abnormal body postures,
involuntary movements, and/or a combination of these abnormal conditions [42]. The
mechanisms of the basal ganglia that lead to PD are described in the next section.
2.1.2 Parkinson’s Disease
The fundamental networks involved in normal and PD pathophysiology are compared
in Figure 2.2 [3]. Generally, the region below the cortex, which is the basal ganglia, is
mainly involved in movement regulation.
In Figure 2.2, the normal (left side) and PD (right side) networks of the brain are
depicted. Excitation is represented in red and inhibition in blue. Thickened lines
indicate increase in excitation (red) or inhibition (blue), while the broken lines represent
reduction. The major points to note between PD (right) and normal (left) conditions
are:
Figure 2.1: Internal structure of the basal ganglia (adapted from [2]).
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Figure 2.2: Schematic of network imbalance in PD, contrasting non-PD and PD brain. Ex-
citation is shown in red and inhibition in blue. Thickened lines indicate increase
in excitation (red) or inhibition (blue). St is the striatum, GPe is the globus
pallidus externa, GPi is the globus pallidus interna, Th is the thalamus, SN is the
substantia nigra and STN is the subthalamic nucleus (adapted from [3]).
• The SN is the principal area of concentration of the dopamine-containing neurons.
• The striatum receives reduced inhibitory inputs from the SN due to PD.
• This reduced inhibition from the striatum is passed on to the GPe and the GPe
passes it onto the STN.
• The reduced inhibition from the GPe to the STN results in increased excitatory
outputs to the GPi and GPe.
• The GPi then increases its inhibitory outputs to the thalamus, which has direct
connection to the cortex and motor areas of the brain. This imbalance in PD
accentuates the increase in inhibition from GPi to thalamus.
• This creates a phasic and oscillating inhibition from the GPi to the thalamus,
which manifests as PD symptoms in patients. PD therapy is used to decrease
this excessive inhibition moving out of the GPi into the thalamus.
Generally, PD results from a decrease in neural output of dopamine in the SN. As
can be seen in Figure 2.2, the reduction in the concentration of dopamine disrupts the
network balance between inhibition (blue lines) and excitation (red lines) in the net-
work [3]. Disruptions within the interconnections of the nuclei in the basal ganglia can
result in a number of movement disorders which can lead to extreme movement impair-
ment and uncontrollable involuntary movements. Other major diseases instigated by
this disruption include Huntington’s disease, ET, TS, dystonia and many others. The
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dominant symptoms in PD includes resting tremor, bradykinesia, postural instability
and muscular rigidity. The first line of action on diagnosing PD is pharmacological
therapy, mostly levodopa (L-dopa). L-dopa is a chemical building-block that is con-
verted into dopamine by the body, thereby replacing some of the dopamine lost as a
result of PD. Since PD is an incurable and progressive disease, therapy is only pal-
liative. Initially, therapy results in gradual improvement in motor functions; however,
motor impairments becomes resistant to L-dopa therapy, and this leads to additional
symptoms like dyskinesia [43]. This stage is called advanced PD, and other clinical
interventions like DBS may be required to mitigate PD symptoms.
2.1.3 DBS Systems
The main components of a DBS system are the intracranial electrode and implantable
pulse generators (IPG), which are connected through an extension wire as shown in
Figure 2.3.
The surgical procedure for DBS implantation of a DBS device involves two stages.
The first stage is the DBS lead placement and the second is IPG placement. The
Vercise neurostimator in Figure 2.3 uses the Boston Scientific lead model 2201 with
lead dimensions as follows: diameter (d) is 1.3 mm, inter-electrode spacing (s) is 0.5
mm and electrode length (l) 1.5 mm. The Medtronic 3389 compatible with Activa
neurostimulator has dimensions, d = 1.27 mm, s = 0.5 mm and l = 1.5 mm. While the
St Jude 6149 model has dimensions, d = 1.41 mm, s = 0.5 mm and l = 1.5 mm. DBS
lead placement begins by defining targets, common targets are STN, GPi and VIM.
DBS leads are implanted through a burr hole ranging from the cortex to the basal
ganglia as is shown in Figure 2.4.
After DBS lead implantation, optimal stimulation target is identified and patients are
assessed for clinical benefits as well as side effects. When the DBS lead is firmly in
the target position, the IPG is implanted below the clavicle and connected to the leads
Figure 2.3: Boston Scientific’s Vercise neurostimulator (adapted from [4]).
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Figure 2.4: DBS lead placed in STN (adapted from [5]).
through the connecting wires [44].
The operating principle for devices produced by all manufacturers is the same; however,
there are slight differences in technical features. The characteristics of the main DBS
systems marketed by the major manufacturers are summarised in Table 2.1 [45–49].
2.2 Towards Adaptive DBS
There are currently two main methods DBS clinical outcomes can be adapted: closed-
loop DBS and spatial adaptation in DBS. Closed-loop adaptation in DBS involves,
automatic and personalised adjustments of stimulation parameters in response to brain
signals. This is so that therapeutic benefits can be enhanced. Alternatively, therapeutic
benefits can also be enhanced by adapting to changes in ageing-related lead migration,
which will be termed spatial adaptation in this literature. So far, primary focus in DBS
adaptation has been placed on closed-loop DBS.
This section will focus on the major areas that are necessary in driving development
in aDBS, particularly for closed-loop DBS implementations. To enable advancements
in closed-loop DBS, development in four major areas are required: understanding the
underlying mechanisms of the brain, how useful information can be obtained from neu-
ral dynamics through analysis, how the information obtained can be used to trigger
stimulation and how therapeutic stimulation affects brain tissue. This section is struc-
tured to touch on the four highlighted parts as shown. The typical processing chain of
a closed-loop DBS system highlighting the major sections is shown in Figure 2.5.
2.2.1 Spatio-Temporal Neural Dynamics
The brain is populated with neurons whose temporal and spatial dynamics are very
complex. Understanding the brain dynamics is key to understanding PD and other
neurological disorders. Brain dynamics result from the interaction of millions to billions
of neural cells. The neurons are the fundamental computational and signalling units
in the brain. Figure 2.6 shows the structure of a neuron. A neuron consists of soma,
axon and dendrites.
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Table 2.1: Programming settings and characteristics for different DBS systems.
Manufacturer IPG Model
Stimulation Parameters





0 - 10.5 V
2-250 0 - 25.5 mA
Activa RC b c
30 -250 0 - 10.5 V
2-250 0 - 25.5 mA
Activa SCd g
30 -250 0 - 10.5 V
2-250 0 - 25.5 mA
Boston Scientific a
Vercise d f 2 - 255 10 - 450
0 - 20 mAVercise PC f g 2 - 255 20 - 450
Vercise Gevia d f 2 - 255 20 - 450
St Jude Medical e
Libra e f 2 - 240 50 - 500
0 - 12.75 mA
Libra XP c e 2 - 240 52 - 507
Brio c d 2 - 240 52 - 507
Infinity e g 2 - 240 20 - 500
a Uses both current and voltage sources.
b Bilaterally implanted leads with 4 electrode contacts/lead.
c Rechargeable battery.
d Unilaterally implanted leads with 4 electrode contacts.
e Has multipolar configuration. In addition to its polarity (tripolar or quadripolar), multipolar config-
uration can be used in uni/bipolar polarity. Medtronic stimulators in current source configuration
are limited to only uni/bipolar polarity.
f Bilaterally implanted leads with 8 electrode contacts/lead.
g Non-rechargeable battery.
The soma contains the cell nucleus. The dendrites consists of the branches that en-
able connections between neighbouring cells. The axon is the cable-like structure that
transmits nerve signals to target cells via synapses. The synapses allows the passage of
electrical or chemical signals to neighbouring neurons. The axon is made up of a myelin
sheath, which consists of dielectric materials that aid the propagation of impulses. The
Figure 2.5: Typical processing chain of a closed-loop DBS system.
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Figure 2.6: Structure of a neuron.
axon has segments that are divided by regions known as nodes of Ranvier, which am-
plify and transmit signals down the axon. Neurons are organised into layers in the
brain, and they number around 1011 in the brain with each one having about 104 con-
nections. As such, modelling the complete dynamics of the brain is a near-impossible
task. However, various attempts at modelling the brain dynamics have been made,
notably are the single cell models by Hodgkin and Huxley [50]; to the more detailed
single cell models by FitzHugh and Nagumo [51]; and to the aggregate level models
by Wilson and Cowan [52]. All hypothesise that the brain has non-linear dynamics.
And like all non-linear systems, the individual dynamics of its neurons varies from the
superposition of the dynamics of the individual neurons. The Wilson and Cowan model
is the baseline for describing spatio-temporal neural dynamics and several extensions
of it have been used in modelling neural dynamics [6].
The Wilson and Cowan model suggests that all neural processes are dependent on
the interaction between inhibitory and excitatory cells. Wilson and Cowan in their
work [52], found out that interaction between excitation and inhibition in neural cells
was necessary in order to establish dynamic stability in the brain. This led to the
premise that excitatory-inhibitory interplay was crucial to restoring network dynam-
ics in epilepsy [53]. This principle of balancing in neural dynamics by inhibition and
excitation was further affirmed by experimental studies [54, 55]. The Wilson-Cowan
model asserts that there are separate populations of neurons that are excitatory and
inhibitory. The models were made general enough to encompass all possible scenarios
of inhibitory and excitatory interaction. This was done by setting connection strengths
and parameters of the model that represented all possible cortex topologies. Mathemat-





= −E(t) + (1− rE(t))fE [wEEE − wEII + hE(t)] , (2.1)
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= −I(t) + (1− rI(t))fI [wIEE − wIII + hI(t)] , (2.2)
where E(t) is the proportion of excitatory cells active per unit time, I(t) is the propor-
tion of inhibitory cells active per unit time, hE(t) is the external input to the excitatory
population, hI(t) is the external input to the inhibitory population and fE and fI are
the firing rate functions (are sigmoid functions) for the excitatory and inhibitory pop-
ulation. Also, WEI and WIE are the connection between excitatory and inhibitory
populations, with WEI representing excitatory to inhibitory, while inhibitory to exci-
tatory is represented by WIE . In addition, there is interaction within the excitatory
and inhibitory subpopulation and these are represented by WEE for self-excitation and
WII and self-inhibition. And finally, r represents the absolute refractory period. The
model assumed neurons to have three different connections: excitatory, inhibitory and
self-feedback connections. A schematic of this is shown is shown in Figure 2.7. Figure
2.7 (a) maps aggregate populations of neurons on a grid, with each cell on the grid
(aggregate population of neurons) having independent excitatory (green coloured) and
inhibitory (red coloured) neural populations with activity levels xi(t) and yi(t) respec-
tively. The activity levels quantify the proportion of firing neurons in each region at
time t. Also, Figure 2.7 (b) shows the different configuration of connections, connec-
tion strengths and parameters. The left region, a, receives excitatory (green arrows),
inhibitory (red arrows) and self-feedback (blue arrows). It shows weak (dashed arrows)
and very weak arrows (dotted arrow) originating from the right region b. The alphabets
above each arrow indicates synaptic weights. The inhibitory and excitatory network
connections involved in PD pathophysiology explained in Section 2.1.2, were inspired
by neural connections as illustrated using the Wilson and Cowan model [52].
The Wilson and Cowan model has gained wide acclaim because it introduced popu-
lation thinking and statistical theory to analyse brain activity. Its analysis captures
Figure 2.7: Schematic illustration of neuronal dynamics. (a) Showing the cortical region di-
vided into a grid of macroscopic regions. Each region i (blue squares), comprises
of excitatory (green) and inhibitory (red) neural population. (b) Showing all
possible configurations of neural connections (adapted from [6]).
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the mean field activity by showing non-linear wave propagation and non-linear pattern
formation. Consequently, extensions of it have been used to explain the effects of anaes-
thetics, seizures and various stimuli to the brain [3]. The model uses numerical solutions
and phase plane methods to describe the responses of neuronal population to stimuli.
The model established the existence of multiple stable states, oscillations, spatial pat-
terns, traveling waves and hysteresis in neuronal response. Aside from spatio-temporal
dynamics, brain activity measured from several techniques (measuring techniques are
discussed in Chapter 3), are shown to contain frequency specific oscillations [57]. These
macroscopic activities (involving between 108−1011 neurons) are representative of high-
level functions like movement, cognition, memory or perception. In order to understand
the mechanisms involved in such tasks, analysing and interpreting spectral information
is necessary. This is explained further in the next section, which provides some back-
ground on neural signal analysis.
2.2.2 Neural Signal Analysis
In monitoring changes in sensory, motor and cognitive tasks, neural signal as well as
external body signals are potentially useful [58]. A major challenge of closed-loop DBS
is the choice of a suitable feedback signal. Below are some of the requirements necessary
for feedback signals in PD [16]:
• The signals should be bio-markers that reliably reflect all symptoms of the dis-
ease, impairment or disability (such as tremor, bradykinesia and rigidity across
patients).
• Relationship between signals and impairment should not be correlative, but should
be causative.
• The measure should also be instantaneous such that therapy does not lag impair-
ment.
• Invasiveness of the recording technique should be reduced to the barest minimum.
Based on these, neural signals are the most advantageous for use as feedback signals.
They can be sensed using an implanted custom-integrated chip that allows for measure-
ments, processing and analysis [59]. The same leads can be used both for stimulation
and measurements. In addition, they are desirable because signals that are obtained
closer to the stimulation sites are more reflective of patient condition [9]; making signals
obtained from deep regions of the brain more desirable. The type of feedback signal
used determines the bio-signal processing technique adopted. Nonetheless, in most neu-
rodegenerative disorders like PD and epilepsy, biomarkers have a fairly similar signal
processing chain. Figure 2.8 shows the typical signal processing chain for neural signal
processing consisting of feature extraction, dimensionality reduction and classification.
The first step in neural signal processing is the transformation of acquired physiological
data normally in time domain, to a computationally efficient form for further process-
ing. This transformation could be from time domain to a more efficient time domain
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Figure 2.8: Typical neural signal analysis chain used in closed-loop neural systems.
form, from time domain to frequency domain or from time domain to time-frequency
domain. Time domain to time domain transformation may be necessary because rele-
vant information may not be obvious from individual samples, however more detailed
information can be obtained by filtering, smoothing or averaging recordings to create
epochs that make the onset of various events more obvious. In contrast, frequency do-
main features may be required since neuronal networks often use frequency coding to
communicate [60–62]. Hence transformation of time series data into frequency informa-
tion may be necessary in applications were neuronal firing rate signify the occurrence of
certain events. Nevertheless, time or frequency information alone may not be sufficient
in real-time detection of pathological states [9]. Thus, techniques that provide both time
and frequency information may be required. After transforming recorded data into a
useful form, an additional processing stage targeted at reducing redundancy, increase
processing speed and providing computational efficiency is normally used. This addi-
tional processing is termed dimensionality reduction (DR). DR involves reducing the
number of features that will be used for the detection or classification of patient states.
In patient state detection, high dimensionality in feature space increases data over-
fitting, which results in poor generalisation and inefficient detection of patient state.
In brain-machine-interface (BMI) applications, the most primitive dimensionality re-
duction technique is manual feature selection. Manual feature selection is implemented
by selectively retaining the most relevant features. Kung and colleagues [63], proposed
feature selection in genomic signal processing where by redundant genes were identified
so as to sparsify the feature vectors. In another study on epilepsy seizure detection
using electroencephalography (EEG) signals, Lee et al. [64], adopted feature selection
by channel reduction. Channel reduction was implemented by manually identifying
redundant channels, after which they were eliminated. In closed-loop DBS, neuronal
information is used in regulating stimulation. This involves extracting disease rele-
vant features and classifying the patient state using the extracted features in order to
adapt stimulation. Generally, high-order classification models are required due to the
complex nature of the underlying processes in physiological signals. These high-order
models increase the complexity of the computations involved; which in turn makes clas-
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sification incur the most energy across the bio-signal processing chain. The complex
nature of the underlying processes in physiological signals have led to the development
of various machine learning frameworks for classification. These frameworks are not
only concerned with detecting patient states, but can also be used in understanding the
evolution of the patho-physiological processes in patients; thus modelling transitions
between various states in a disease.
2.2.2.1 Challenges of Neural Signal Analysis
The development of fully implanted PD detection processors is difficult due to the com-
putationally intensive nature of neural signal processing. This forms a major bottleneck
in developing closed-loop implantable DBS systems for clinical intervention. The need
for fully implantable PD detection processors is pushing research into the investigation
of resource efficient algorithms and techniques. For hardware platforms targeting con-
ditions with highly unpredictable physiological signals like PD, high-order models are
required. However, for fully implantable systems, the power density for tissue damage
limits the ability to use complex models which can be computationally intensive. Some
of the common challenges when dealing with physiological analysis in BMI applications
are highlighted below.
• Correlations of physiological signals to clinically relevant states are hard to model.
High-order data-driven models may be required to distinguish disease states of in-
terest from non-disease states. This makes current feedback algorithms inefficient
in tracking patient states.
• Identifying precise correlations are difficult because the physiological manifesta-
tion of disease and non-disease states vary from patient to patient. This imposes
a wide range of specifications on sensing devices.
• Feedback signals are inconsistent across time, this makes static feature extraction
unreliable.
The ability to assess physiological signals over a large number of channels will be
essential to model their correlations with disease states. It is for this reason that data-
driven approaches like machine learning are emerging as powerful tools that could be
used to handle this challenge [65,66]. The complexity of brain signals on its own makes
closed-loop DBS very difficult to achieve. The following sections expatiate on some
of the highlighted challenges, as encountered by current state of the art neural signal
processing systems.
Feedback Algorithms: One of the major issues in achieving closed-loop DBS has
been insufficient data relating to various patient states. This has led to poor map-
ping between disease state and biomarkers. These poor mapping coupled with the
dynamic nature of PD biomarkers, have resulted in suboptimal feedback algorithms
that inefficiently track patient states. Thus, having very clear insights into the under-
lying mechanism of PD at the neurological level is necessary to facilitate the design
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of feedback algorithms tailored to suppress PD. In other to facilitate the mapping of
stimulation parameters and biomarkers, several algorithms have been used. The work
in [67] uses search algorithms, adaptive controllers were used in [58, 68] and statistical
methods were used in [69] used to identify the relationship between stimulation and
resulting LFP output. These are computationally intensive methods that are not prac-
tical for fully implantable closed-loop DBS systems due to high power and bandwidth
requirements. Also, they are mainly simulation studies that use assumptions that may
not be practical for real life implementations. Essentially, poor insights into the internal
workings of DBS has inhibited the development of effective feedback algorithms that
can be used in tracking disease states.
Sensing Devices: One major challenge is the type of recording device used and
the noisy nature of recordings. Noise sources originate mostly from the electrode-tissue
interface (ETI) and can degrade signal processing and analysis capabilities [70]. Devices
susceptible to noise have a tendency to obtain recordings that obfuscate disease states
even in conditions with more distinguishable neuronal activity like epilepsy. This can
be more challenging in disorders with less distinguishable disease states. For specific
patterns to be obtained through neural signal analysis, sensing devices that are less
susceptible to surrounding noise are required. In disorders whose mechanisms are still
under debate, the large variability in the physiological manifestation of disease and non-
disease states across patients imposes wide specifications on sensing due to the need for
an increased bandwidth, dynamic range and so on; making the needs of various patient
difficult to fit on a single device.
Feedback Signals: Primarily, feedback could be implemented using neurophysio-
logical signals or external body signals. Neurophysiological signals have proven to be
the most suitable due to their high reliability [16]. Neurophysiological signals can be
invasive and non-invasive; non-invasive measurements are obtained at the stimulation
site. Due to the dynamic nature of PD, recordable signals showing direct correlation to
patient states are yet to be established. Even though correlation has been established
in some patients, enough evidence identifying certain signals as the cause of PD have
not been established. Thus, correlations could be as a result of secondary effects of the
disease. The dynamic and unpredictable nature of candidate signals for PD detection
makes establishing a suitable feedback signal a major challenge. Subsequently, this has
led some studies to suggest the possibility of combining more than one neurophysio-
logical signals [16]. Others have proposed the use of multiple features from the same
neurophysiological signal [58,71,72]. While many have suggested complementing inter-
nal body signals with external body signals. This is in order to maintain consistency in
feedback signals. However, adopting some of this proposals can make analysing physio-
logical signals computationally intensive. As a result, robust signal analysis are needed
to adapt to the changes in the feedback signals. Based on this, having a single feedback
signal as the universal biomarker may not be a sustainable approach towards closing
the loop.
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2.2.2.2 Prospects of Neural Signal Analysis
Due to the complex nature of physiological signals, current laboratory-based closed-loop
DBS systems use multiple external computers to process sensed signals. However, clin-
ically viable realisations of closed-loop DBS needs to be more robust and autonomous
such that all processing is implemented on-site and real-time – this will require high
functionality on-chip processors. The shift towards on-chip processing has necessitated
the need for simple but efficient processing techniques in order to reduce computational
complexity so that processors can be realised in CMOS technology within the power
consumption constraints. The bulk of the power consumed in bio-signal processors for
closed-loop DBS is incurred at the classification stage. Less computationally intensive
classifiers can be adopted if more accurate biomarkers for PD are identified. Cur-
rent bio-signal processing approaches use supervised machine learning methods which
require the use of labelled data for training. In the future, bio-signal analysis for closed-
loop DBS has the potential of utilising unsupervised machine learning techniques for
classification, which will create more robust algorithms that can handle the complex and
dynamic nature of the electro-physiological signals. Online unsupervised machine learn-
ing techniques have been pioneered in spike sorting and other BMI applications [73].
The total shift towards unsupervised learning techniques will eliminate the need for
time-stamped measurements, thus totally eliminating the intervention of trained op-
erators (or clinicians). The first step towards achieving this is by adopting adaptive
algorithms which respond autonomously to changes in physiological signals, as is part
of the objectives of this work. The prospects of bio-signal processing in closed-loop
DBS depends on power consumption constraints and the available insights into the
DBS and brain mechanisms. Better control over these will facilitate the implementa-
tion of effective, autonomous and efficient processing techniques that can be used to
adapt stimulation. To overcome the high efficiency and efficacy demands required in
order to close the DBS loop, effective control strategies can complement the processors
to satisfy the imposed resources constraints. It is for this reason that the next section
will focus on control strategies for neural systems.
2.2.3 Neural Systems Control Strategies
Neural systems control is a highly multidisciplinary field that uses feedback signals from
nervous systems to control functionality. Because of how they are implemented, they are
widely called closed-loop or feedback control. It has been widely established that closed-
loop systems achieve better efficacy and efficiency than their open-loop counterparts.
This has been one of the driving forces in the promotion of closed-loop neuro-prosthetic
systems. Closed-loop neuro-prosthetic systems are envisioned to complement, restore
and improve neural functions like sensory, motor and cognitive tasks. At present, many
of the systems are proof-of-principle, and transition to clinically approved interventions
are still hampered by issues like: establishing relationship between acquired signal
and patient condition, invasiveness of recording devices and how chronic implantation
can be sustained in invasive devices. To circumvent this, most studies have opted to
use models with limited detail to describe the basal ganglia, central nervous system
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(CNS) and so on. This is understandable because of the many inconsistent theories
describing the mechanisms of PD and DBS [3, 30–34]; developing a reliable model
becomes difficult. With no accurate patient models, current closed loop strategies use
a trained clinician to close the loop by adjusting stimulation parameters based on visual
feedback from patients. However, parameters obtained under this condition may not
guarantee sustained therapeutic effects [74]. More so, the procedure is costly and time
consuming. In addition, only a very small proportion of stimulation parameter space
can be explored using trained clinicians in closing the loop. The tediousness of this
process makes it essential to implement control strategies that facilitate parameters
adjustment in real-time based on some quantifiable (and possibly objective) measure.
This reduces the risk and tediousness of constant clinical intervention. The difficulty in
producing accurate models that will provide insights into closed-loop control and the
difficulty associated with frequent programming of stimulation parameters makes the
implementation of closed-loop control a non-trivial task. Nevertheless, several attempts
at closed-loop control have been made. The first step in closing the loop is to identify,
acquire and analyse biomarkers so that they can be used as controller inputs, which was
covered in the previous section. This is necessary because the efficacy of a controller
is partly dependent on the quality of its control input. The following sections describe
the most prominent control techniques that have been adopted in neural systems.
2.2.3.1 Open-loop Approach
This is the only non-feedback control approach. It generates control signals based on
input to the plant without recourse to the output from the plant. An open-loop control
strategy assumes that the system has enough knowledge to provide corresponding out-
put with specific input signals. This assumptions is faulty and misleading and cannot
hold in complex systems. Nevertheless an open-loop system is always the first step
in controller design. All of the currently marketed DBS devices for PD use open-loop
control.
2.2.3.2 Bang-band (Simple Feedback) Approach
A bang-bang controller commonly known as an on-off controller (or hysteresis con-
troller), is a feedback controller that switches abruptly between two levels. Bang-bang
control is a closed-loop control technique that uses threshold crossing to directly gen-
erate the control signal to the controller without prior pre-processing. These are nor-
mally used in low complexity systems. In closed-loop DBS applications, they have
mostly been used as the main control strategy in a number of experimental stud-
ies [24, 61, 74–82]. Nonetheless, they can been used as complementary controllers to
assist more complex controllers [58]. With more discrete levels, they can be used with
more classical controllers like the Proportion-Integral-Derivative (PID) controller. In
this configuration, it uses error signals as input to the controller. The proportional,
integral and derivative inputs are calculated from the systems response to its inputs. In
PD, using a single feedback signal (for example beta band activity) may be suitable for
controlling bradykinesia and rigidity, however this may not be effective for tremor [25].
This approach may be sub-optimal considering how PD consists of various underlying
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symptoms including bradykinesia, rigidity and tremor. The bang-bang approach uses
one-dimensional feedback signals. Many studies in closed-loop DBS have focussed only
on the beta-band activity as input to the closed-loop controller. Using more discrete
levels as well as multi-dimensional feedback signals presents a feedback approach more
sophisticated than the bang-bang, which are described in the following sections.
2.2.3.3 Internal Model-Driven Approach
This is a feedback control approach that incorporates a model of the system, typically a
black box model which is defined based on the input-output relationship of the system.
This uses system identification to establish input-output relationships for a system
that may be difficult to model. At every instant, before providing control commands,
the model provides a prediction of the system behaviour and controller inputs are
determined based on a cost function that determines optimum parameters. Examples
of these include recursive autoregressive models and Kalman filter methods. For DBS,
some computational models have implemented closed loop control using these methods
[69,83].
2.2.3.4 Classifier-Driven Approach
This uses a feedback control approach that relies on mapping between discrete states to
determine input signal to controller [84]. Classifiers can use supervised, partly super-
vised or unsupervised machine learning methods to obtained input-output relationship
from existing. These relationships are used to generalise the relationship on unknown
data [85]. The unsupervised systems segregate the system into states with similar
patterns using only input data without labels. Typical examples are techniques like
k-Means [10] , and the O-sort algorithm used for clustering in spike sorting. The partly
supervised learning algorithms have training data that is partly labelled. For supervised
learning, the main methods are k-nearest neighbours (k-NN), support vector machine
(SVM), logistic regression (LR), linear discriminant analysis (LDA), artificial neural
networks (ANN) and a host of others. When used with a controller, it is typically
used like a bang-bang controller (but with prior pre-processing and multidimensional
feedback signals) since it has binary classes representing healthy and unhealthy states.
Unlike the bang-bang controller, it uses multi-dimensional feedback signals to cater for
all symptoms [64]. It has found wide application in epileptic seizure detection [64, 86].
For epilepsy, an FDA approved closed-loop system, Responsive Neurostimulator Sys-
tem (RNS), marketed by NeuroPace Inc. uses this approach for modulating therapy
for drug-resistant epilepsy [86].
2.2.3.5 Actor-Critic Approach
The actor-critic approach models the relationship between the physician and the au-
tomated neuromodulation system. The critic (like the “trained clinician”) assesses the
state of the system based on a cost function and provides the information to the actor.
The critic learns about the system by studying its input and resulting output responses.
The actor, unlike the error signal of other control techniques provides control signal
based on evaluation from the ‘informed critic’. This method has been adopted for
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neural control in [58], and is gaining wide-spread acceptance for controlling non-linear
systems because it adopts a technique that resembles real-life clinical interventions.
Table 2.2 summarises the advantages and disadvantages of the various neural system
control strategies.
Table 2.2: Advantages and Disadvantages of Neural Systems Control Strategies.
Control
Strategy
Advantages Disadvantages DBS related
study
Open-loop It is simple, straightfor-
ward and easy to imple-
ment.
It is unrealistic and misleading.
It cannot correct for errors and







It is simple, straightfor-
ward and easy to imple-
ment.
It can be unstable as it monitors






Provides a simple ap-
proach for cases with
an established relation-
ship between discrete dis-
ease states and therapy.
Classification algorithms can be
computationally intensive and
directly mapping states to ther-
apy may not provide therapeutic







assist in adapting to
changes in dynamics of
disease or disorder.
They are yet to be attempted in
any investigative studies. They
have only been used in computa-
tional studies.
[69, 83].
Actor-Critic It adopts techniques that
incorporate real-life clini-
cal diagnostics and inter-
vention.
Requires very accurate sensor
that captures and tracks real-
time biomarker fluctuations, so
that they can be “critiqued” to
enable immediate action. State
estimates may not be represen-
tative of symptom severity.
[58]
2.2.4 Neural Tissue Stimulation
DBS pacemakers consists of a small battery-powered IPG (also known as pacemaker)
implanted under the skin near the clavicle with leads that attach to electrodes placed
within the brain at specific locations depending on the condition the device is used
to treat; PD (electrodes located at STN or GPi) or ET (electrodes situated at VIM).
The IPG continuously delivers low intensity, high frequency electrical pulses to parts
of the brain. The following section gives a brief overview on the physiological processes
resulting from therapeutic neural stimulation and the available stimulation techniques.
2.2.4.1 Neural Tissue Excitation
Brain tissue consists of electrically excitable neurons. The first electrical model of
a neural cell was developed by Hodgkin and Huxley in 1952 [50]. This modelled the
physiology of the axon membrane using an electric circuit. The model is shown in Figure
2.9. In the model, the ionic current IION flowing through the membrane is split into
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Figure 2.9: Hodgkin and Huxley model and action potential. (a) Electrical model of a neural
cell (b) Propagated action potentials; theoretical (top) and experimental (bot-
tom).
three components; potassium current (IK), sodium current (INa) and leakage current
(IL). Each cell is represented by a membrane capacitance (CM ), a resting potential
(V ), three ionic channel potentials (VK , VNa and VL), and channel resistance (RK , RNa
and RL). This model describes the characteristics of propagated action potentials; their
shape, amplitude, refractory period, excitation threshold and ionic channels. Primarily,
electrical stimulation generates action potentials by delivering current into a cell such
that its membrane voltage exceeds the threshold voltage, which results in an action
potential. This is termed cell membrane depolarisation and is depicted in Figure 2.10.
The rate of change of the generated membrane potential based on Hodgkin and Huxley
model is [92],
Figure 2.10: Cell membrane depolarisation by stimulation (adapted from [7]).
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dVm
dt
= −−IION + ISTIM
Cm
(2.3)
IION is is the ionic current in the neuron resulting from sodium, potassium and leakage
currents in the neuron. Vm is the membrane voltage, ISTIM is the applied stimulation
current to the cell. This injects a charge during stimulation, considering ISTIM is a
square pulse. The total charge injected is,
Qtot = ISTIM · T (2.4)
where T is the pulse width for a mono-polar stimulation. To ensure that stimula-
tion is safe, a biphasic stimulation protocol needs to be adopted so that zero charge
is accumulated during stimulation to avoid irreversible phenomena like tissue damage
and electrode corrosion, that result from charge accumulation [93]. Biphasic stimulus
paradigms have become the adopted standard. They provide stimulation using a se-
quence of two cycles of different polarity, so that the charge injected during the first
cycle is removed during the second cycle. Additionally, the maximum safe electrode
charge density is not exceeded 1.
2.2.4.2 Therapeutic Stimulation Techniques
Therapeutic stimulation has been in existence for several centuries. It has been used to
mitigate sensory deficits such as blindness, deafness, chronic pain, urinary incontinence,
paralysis, PD, ET among others [95]. In therapeutic brain stimulation, the resulting
effects depend on the stimulation site, stimulation parameters and uncontrolled bi-
ological effects [22]. In therapeutic DBS, it is still not clear which neural elements
are targeted. Nonetheless, basic knowledge regarding the responses evoked by various
stimulation modalities is needed in order to adopt a technique that optimises therapy,
minimises side effects and maximises battery life. The common stimulation techniques
are voltage controlled stimulation (VCS), current controlled stimulation (CCS) and
charge controlled stimulation (ChgCS). Efficiency and safety are the key factors that
result in the selection of one of these stimulation techniques. VCS has been found to be
a very efficient method due to its long battery life span. However, its safety has been
questionable, due to the fact that constant voltage excitation is delivered to an ETI
with a variable impedance. This variation will lead to the accumulation of charge at
the ETI. Generally, the charge at the stimulation site is desired to be within a safe limit
known as the water window [93]. If the charge exceeds this limit, irreversible tissue
damage or electrode corrosion may occur. Conversely, CCS offers better control over
injected charge than VCS. Even though it incurs extra power consumption due to the
conditioning circuit used in producing constant current excitation. This impedes effi-
ciency. As a trade-off between efficiency and safety, ChgCS has been introduced using
switched capacitor based stimulators [96]. Table 2.3 summarises the various stimulation
techniques and their characteristics.
1Conventional DBS electrodes made of platinum-iridium have an electrode charge density of
30µC/cm2/ phase [94]
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Table 2.3: Benefits and Limitations of Therapeutic Stimulation Techniques.
Stimulation
Techniques







tion of charge at
ETI raises serious
safety concerns.
Mainly used by Medtronic
devices: Activa PC, Ac-
tiva RC and Activa SC.











experiencing a shift to-
wards CCS. Most com-
mercial devices in mar-
ket have CCS mode oper-
ation.
ChgCS Offers a trade-off
between safety and
efficiency.




Still at infancy. More
research is still required
before it is commercially
used.
Clinical DBS design is tending towards current controlled stimulation due to its safety.
This has resulted in a surge in the design and development of current neuro-stimulators,
although their therapeutic benefits over VCS are yet to be clinically proven [97]. The
choice of the stimulation technique impacts on the lifespan of the battery. With the
advent of rechargeable batteries, the emphasis on power consumption has reduced [25].
Nevertheless, some patients are unsuited to rechargeable IPG systems [98]. Even pa-
tients who can tolerate the use of rechargeable batteries, would want to recharge as
infrequently as possible. The charging process is tedious and patients may be required
to recharge the system every week [99]. If the battery is allowed to completely run down
three times, then replacements may be required, which means a new surgery. The need
for low power stimulation techniques is ever more important considering the demand
for cranially mounted IPGs where patients undergo only a single procedure, compared
with the current two stage procedure for electrode and IPG placement [100,101]. Ther-
apeutic stimulation techniques are selected based on a trade-off between efficacy, safety
and power consumption.
2.3 Advances in Closed-loop DBS
DBS provides an overall improvement in Parkinsonian patients’ quality of life. Over
time, the efficacy of the therapy is reduced due to disease progression, environmen-
tal factors, mechanical factors, and behaviourally induced changes in network activ-
ity [35]. This is mainly as result of the ability of nervous systems to adjust their
activities in response to new situations or to changes in their environment, which is
termed neuro-plasticity. Additional programming sessions may be required to manually
adjust stimulation settings [35]. Current DBS systems are poorly suited to cope with
the dynamic nature of PD. This has led to growing interest in the design of closed-loop
systems for adapting DBS. In order to implement closed loop systems, existing open
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loop systems can be optimised by incorporating feedback schemes. However, the cur-
rent dilemma has been the poor correlations between feedback signals and the motor
score measured through the Unied Parkinson’s Disease Rating Scale (UPDRS), even
though some correlations between motor states and certain feedback signals have been
identified. These inconsistencies necessitates the need for adaptive feedback schemes
through closed-loop DBS. Closed-loop DBS involves adjusting stimulation parameters
to characteristic changes in biomarkers. Biomarkers for closed-loop DBS are mainly
neurophysiological signals and external body signals. Neurophysiological signals con-
sists of single-unit recordings, multi-unit recordings, local field potentials (LFP), global
field potentials and Neurochemical recordings. On the other hand, external signals
are mainly from electromyographt (EMG) and accelerometer signals. Recently, various
studies in closed-loop DBS have focused more on computational models. However, very
little work has led to clinical studies. Below is a brief overview of different attempts at
closed-loop DBS for PD patients.
2.3.1 Experimental studies
Clinical studies in closed-loop DBS have been carried out using Parkinsonism induced
animal models and in patients with informed consent. These studies have used neuro-
physiological and external signal as biomarkers. Using spike activity, the work in [75] in-
vestigated closed-loop DBS using 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine (MPTP)
induced primate model of PD. The results showed that stimulation triggered by spikes
from primary motor cortex (M1) and GPi, led to a reduction in GPi firing rates, which
were representative of improved condition. The stimulation was triggered based on a
predefined delay of 80 ms. The study presented results that bettered those of continu-
ous stimulation. This provided an interesting proof of principle, however it is not clear
how the technique will fare across patients and over time. Also, Brittain et al. [76],
proposed another approach of delayed-stimulation, however, alternating current tran-
scranial stimulation was used instead. An extension of this technique using external
body signals was presented by Cagnan et al. [77]. It uses a unique stimulation approach
that selectively controls neural synchrony by delivering stimulation to the ventrolat-
eral thalamus. This was timed according to the patient’s tremor rhythm. The study
claimed that DBS can be precisely timed to disrupt disease pathophysiology. It worked
on the premise that stimulation selectively regulates neural synchrony through phase-
specific stimulation [80]. It attained promising results in six of the nine subjects used.
DBS delivered with personalized frequencies has been reported to effectively reduce
UPDRS motor scores [102]. A different study [24], uses the beta band local field po-
tentials (LFP) in triggering stimulation on threshold crossing in eight patients. They
reported 56% reduction in stimulation time and reduction in the energy requirement
of the closed-loop DBS compared to its open-loop counterpart. In a follow-up study
to overcome the shortcoming of the previous study, which were short sessions (10 min-
utes) and unilateral stimulation. Little et al. [78], used 4 PD patients with bilaterally
implanted DBS for a sessions lasting 2 hours, there was a marked improvement in
motor score as against the open loop approach like in [24]. The major limitations of
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both studies were; the thresholds were set heuristically and provisions were not made
to adapt them to changes in patient conditions as feedback signals are reported to be
inconsistent across time and patient [16]. This static thresholds adopted made the
system unadaptable to drift in neuronal characteristics. More so, in another study,
LFP’s were also used as biomarkers for detecting seizure like activity in [58]. Seizures
were induced by high amplitude current stimulation in ovine models, and seizure like
activity was detected using LFP power from pre-defined frequency bands. These power
measurements were classified with a Fisher discriminant and an actor-critic control pol-
icy was used to regulate stimulation. This approach does not make adequate provision
for the dynamic nature of the LFP signals. In an almost similar fashion, Johnson and
colleagues illustrated the promising utility of closed-loop DBS for PD based on STN
beta LFP levels [79]. Stimulation was delivered only when STN LFP beta activity
was elevated. The study used a female rhesus macaque monkey induced by MPTP.
However, it concluded that closed-loop DBS systems may need alternate and comple-
mentary biomarkers and/or algorithms to reach their full therapeutic potential [79].
Similarly, LFP’s were used in [87] for tremor detection in PD patients using a multi-
layer neural network for classification. This method presents a good concept that could
be used for demand driven stimulation. However, its use of static detection scheme cou-
pled with additional complexity introduced by multi-layer neural networks, which could
make it difficult for full implantation, since the neural-networks are trained oﬄine. The
drift in characteristics of neuronal signals over time and across patients, necessitates
the use of a tracking paradigm that will adapt to this changes in biomarkers. Using
microelectrode recordings (MER), Kostoglou and colleagues [88], proposed a random
forest approach for identifying UPDRS improvement in PD patients undergoing DBS –
off dopaminergic medications. The findings suggested that electrophysiological signals
had a strong correlation to improvements in UPDRS score, and they could be used to
predict UPDRS score. Major breakthrough in DBS adaptation can be achieved if a
relationship between motor improvement and electrophysiological signals is achieved.
Alternatively, in terms of using external body signals, the work in [89] used a combi-
nation of surface EMG (sEMG) and accelerometer signals to predict tremors in PD
patients. Even though the study predicts tremor with substantial accuracy, patient
distress in PD ideally precedes symptoms manifestation; which makes the technique
unsuitable for adaptive DBS therapy. Generally, feedback using external body signals
has an accompanying delay in detecting PD coupled with the discomfort associated with
externally attached sensors. This makes them not very viable for use as biomarkers. In
contrast to previous works, attempts using neurochemical biomarkers have been made.
Grahn et al. [74], describes a rat model that uses fast scan cyclic voltammetry (FSCV)
to determine evoked dopamine in the striatum, after which stimulation is regulated
accordingly. Another study that uses neurochemical responses from rat models is the
Mayo Investigational Neuromodulation Control System (MINCS) [103], it is designed
to interface with FSCV. The system recorded striatal dopamine release in anesthetised
rats and stimulation was wirelessly regulated in response to evoked neurochemical sig-
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nals. Studies using neurochemical changes offer improved selectivity, sensitivity and
specificity; however, they are not suitable for real time applications due to the poor
temporal resolution associated with neurochemical sensing. Also, the need to minia-
turise implantable devices makes its use unsuitable, as neurochemical sensors tend to
be bulky. Though they tend to have a better consistency across patients compared





























Table 2.4: A summary of experimental studies using closed-loop DBS.








9 patients (6 had
ET and 3 had
dystonic tremor
(DT))
























































































































7 PD patients 8 patients with
tremor (4 ET
and 4 PD)




























































85.7% for all ET
trials and 80.2%
















As in [74], there




2. Towards Adaptive Deep Brain Stimulation for Parkinson’s Disease
2.3.2 In-silico Studies
Even though the underlying principle of PD remains unclear, various computational
studies have been based on neuronal models. Notable among these are the phase dy-
namics model, firing rate models and the stochastic models. The earlier models at
closed-loop DBS have used phase evolution of neuronal cells to model PD dynamics. In
the phase dynamics model, STN neurons fire in an uncorrelated (desynchronized) way
under healthy condition, and PD onset results in increased synchronised activity of the
neurons. Using this theory, Rosenblum and Pikovsky [80, 104]; proposed a technique
whereby time delayed stimulation is used to suppress self-synchronisation in a neuronal
population. The assumption is that DBS pulses (with a fixed offset) are used to dis-
rupt the oscillatory activity as a result of PD onset. In another study using the phase
dynamic model [81], spatially distributed stimulations were used in addition to time
delayed stimulations. This was to alter neuronal synchronisation by superimposing out
of phase signals so as to desynchronise the local neural population. Lysyansky and
colleagues also presented a study using phase dynamics model [61]. Here, multi-site
stimulation for desynchronising local neuronal population was used, by stimulating at
different sites using the resonant frequency of a local neuronal ensemble. This was in
contrast to the conventional multi-site approach. Additionally, using the phase dynamic
model, closed loop desynchronising strategy in [105] uses a DBS signal in proportion
to the mean field of the neuronal population. Drawing upon the theory that desyn-
chronising stimulation protocols are effective as closed-loop techniques for the control
of synchronisation in ensemble of neurons, Popovych and colleagues used pulsating
closed-loop DBS to restore the desynchronising characteristics in the STN-GPe neuron
model [106, 107]. The amplitude of the stimulation pulses was defined with respect
to the phase delay in the LFP feedback signals. Generally, studies using the phase
synchronisation approach are theoretical in nature and have had some experimental
validation [75–77]; which have been found to be effective within individual patients. A
major shortcoming of implementing the phase dynamics model will involve an under-
standing of the optimal way to keep pathological neurons effectively desynchronised.
In addition, the experimental validation of the phase dynamics have used stimulation
for periods not longer than 30 seconds, this puts to question its performance across
time and across subjects. Most recent studies have used stochastic models and firing
rate models. Using a stochastic model, neuronal activity is modelled using various
stochastic processes, ranging from regular, irregular, random and bursting neuronal ac-
tivities. Santaniello and colleagues [69], using system identification, modelled a system
that automatically adjusted stimulation based on LFP recordings from the stimulation
electrodes. It models PD as a stochastic process having regular, irregular, random
and bursting STN neurons. It then uses a recursive autoregressive model to identify
the relationship between stimulation parameters and the stochastically modelled LFP
recordings. In a simulated PD state, stimulation parameters were determined using
the initially established relationship between LFP power spectrum and stimulation. In
a similar vein, Liu et al. [83], uses system identification to establish the relationship
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between stimulation and neuronal responses. Unlike in [69], which was more concerned
with generating the stimulation pattern that restored neural activity to PD-free state.
The work by Liu and colleagues chose the stimulation pattern that restored neural
activity with the least energy expenditure. However, both models in [69,83], model the
behaviour of the basal ganglia network using less than a hundred neurons. This makes
them inadequate for producing the complete dynamic behaviour of PD. Nevertheless,
they give an insight into the possibility of using feedback from LFP and other neural
activities to restore patient condition if there is an established relationship between
changes in LFP, patient state and stimulation parameters. Other studies have used
firing rate models to characterise the excitation state of different basal ganglia neu-
ronal populations. This was modelled in [82] using the average rectified value (ARV)
of beta band LFP oscillations in firing neurons. Firing rate models are ideally suited
for control theory, as they use the state excitation of different basal ganglia regions. In
addition, Brocker et al. [108], used genetic algorithms to optimise the temporal pattern
of stimulation in a computational model using a firing rate model. This resulted in a
low frequency stimulation for the model and this was validated on a rodent (using 45
Hz stimulation). Likewise, Brocker et al. had proved in an earlier study the temporal
efficacy of properly timed DBS in PD [109]. In [110], firing rate models were used to ex-
plore the use of classical feedback control algorithms for adapting stimulation. The best
controller for suppressing neuronal synchrony was obtained for a configuration using a
full PID control law. Table 2.5 summarises the merits and demerits of computational
studies in closed-loop DBS using different neuronal models.
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drawn from this models remain
true if the number of neurons,
their parameters or network con-
nection are changed [111].
[82, 108–
110].
Generally, simulation studies assess the possibility of implementing real life closed-loop
DBS. Nevertheless, they incorporate many model assumptions whose validity might
vary across patients. This makes their use limited, even though they assist in providing
insight into how algorithms for adapting DBS can be implemented.
2.3.3 Peripheral Devices and IC Implementations
Current implementations of closed-loop DBS use software programs for signal analy-
sis [24, 58]. They have high energy demands that could make them impractical and
not portable for use. Incorporating low-power hardware or IC recording and processing
can reduce some of the limitations associated with practicability and portability [112],
which is necessary for fully implantable closed-loop systems. IC implementations have
mainly focused on neural recording and stimulation stages that can be incorporated into
a closed-loop DBS system. There are however peripheral devices developed as part of or
towards incorporation into a closed-loop system. For ASIC development, [113] presents
a closed-loop DBS system having 64 stimulating channels and 8 recording channels,
which was tested in a rat model. The stimulators were implanted in STN of the rat and
the recording electrodes were implanted in the motor cortex. The novelty in the system
was the adoption of a logarithmic ADC (log-ADC) for data acquisition of electrophysio-
logical signals. The log-ADC is used to implement high dynamic range neural recording
covering spikes at 50 µV to LFPs at up to 5 mV. These recorded LFP and spike ac-
tivities are used to trigger stimulation. The device consisted of off-chip processing of
acquired neural signal via a wireless link. An extension of the work incorporates on chip
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processing [114]. This is done using a logarithmic domain digital signal processor and
a PI controller in order to control stimulation. Making the closed-loop system operate
completely in log-domain; which simplifies multiplication and division operations into
addition and subtraction respectively. The prototype systems present an implantable
system-on-chip (SoC) demonstrating closed-loop DBS algorithms. However, the use of
multiple locations for stimulation and recording makes the system invasive; an ideal
closed-loop concept should work without the need for extra implants. Also, the system
uses static features for detecting PD, which has no provision for the dynamic nature
of PD. Conversely, concurrent sensing and stimulation was implemented in [115] with
the prototype system implementing adaptive stimulation in response to induce seizure
in an ovine model, nevertheless using static features. Salam et al. [116], implemented
seizure detection and suppression on an FPGA platform. Seizures were induced in rats
using intraperitoneal kainic acid injection. Only the population of rats responsive to the
kainic acid injection were used for the study. The study found out that event-triggered
stimulation reduced seizures by 90% compared to continuous stimulation which only
reduced seizure occurrence by 17%. The results presented show the benefits of event-
triggered stimulation compared to continuous stimulation. A major question the study
fails to address is the possibility that seizure suppression could be as a result of some
epiphenomena associated with stimulation spacing (as continuous stimulation has a ten-
dency to induce seizures [58]) rather than event-triggered stimulation. Aside from the
comparison with open-loop stimulation, comparison between intermittent stimulation
and event-triggered stimulation would have more clearly demonstrated the superiority
of event-triggered stimulation compared to other methods. For the most part, very
little effort has been put in the design of application specific IC (ASIC) for closed-loop
DBS. This has largely been due to the insufficient empirical evidence on the behaviour
of the DBS mechanism.
2.3.4 Limitations and Future Directions
Experimental studies in closed-loop DBS are normally carried out within two to seven
days after electrode implantation [25]. After electrode implantation, there is a reduc-
tion in PD symptoms, which is mostly as a result of stun effect. Stun effect results
in a temporary reduction in parkinsonian symptoms and an unresponsiveness in LFP
signals after electrode implantation [117]. This means improvements in patients condi-
tion may not be representative of the new therapeutic regimes, but as a result of stun
effect. It is one of the reasons post-operative programming is delayed [118]. Exper-
imental studies may not easily bypass the stun effect since its exact duration is still
yet to be established [25]. Additionally, closed-loop DBS may need to be tested in
a chronic setting, because the efficacy of conventional DBS has been reported to fall
with time, which is primarily as a result of the habituation effect [21, 119]. Longer
trials are necessary to determine if this is also the case for closed-loop DBS. Most of
the experimental studies have used a bang-bang control approach and have mainly fo-
cused on monitoring beta band LFPs only [24,82,120]. However, using only beta band
activity and setting heuristically obtained (static) thresholds may be ineffective and
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suboptimal, as there are serious questions regarding their ability to track fluctuations
across time and patients [24, 121]. They have been reported to correlate with symp-
toms in bradykinesia and rigidity; however, this is not the case for tremor. In tremor
dominant PD, gamma [16, 122, 123], and tremor [124] band activities have been found
to correlate with PD symptoms. These further questions the use of one-dimensional
feedback signals in a bang-bang feedback approach. Multidimensional feedback sig-
nals using a simple but sophisticated control approach may be more viable for closing
the loop. The main limitation of sophisticated feedback algorithms is their computa-
tional power needs. This could be offset by the less frequent stimulation required as
a result of closing the loop. So far, closed-loop DBS has been hindered by the poor
understanding of the underlying mechanisms that result in improved patient condi-
tions. Better understanding of the underlying mechanism will create a more accurate
mapping between disease states and stimulation parameters; making improved com-
putational models attainable. It is important to have realistic computational models,
which will significantly improve the performance of sophisticated closed-loop systems
incorporating multiple functionalities needed for closed-loop DBS. These will in turn
lead to the development of thorough clinical studies aimed at investigating techniques
that optimise clinical benefits that are tailored to patient’s needs. Tailoring therapy to
patients needs could be advanced by adopting a similar technique as in cardiac defibril-
lators, which uses a combination of dual sensor technology. This technology combines a
short-term sensor and a long-term sensor, in which the short term sensors track immedi-
ate changes from a selected biomarker, and the long term sensor tracks biomarkers with
a slow response rate. Nonetheless, combining sensors with different rate responses re-
quires adequate blending of respective sensor activities. Irrespective of the development
in closed-loop DBS, significant advancement can only be achieved if there are strong
multi-disciplinary collaborations between clinicians, engineers, statisticians, health care
professionals, computer scientists, regulatory experts and most importantly, end-users.
2.4 Advances in Spatial Adaptation
Spatial adaptation allows for the variation of stimulation focus without a corresponding
change in lead position. It is a form of aDBS that adapts to changes or inaccuracies
related to lead position and/or poor stimulation focus in relation to targeted neural
structures [99]. Poor stimulation focus has often affected the therapeutic benefits of
DBS [26]. Directional steering of stimulation is the main form of spatial adaptation,
and it offers a new dimension to DBS therapy by directional control of stimulation, in
addition to the control of normal stimulation parameters like amplitude, pulse width
and frequency. Precise neural targeting has been reported to improve the therapeu-
tic window of DBS by reducing the threshold for beneficial effect and increasing the
threshold for side effects [125]. This reduces the need for high amplitude stimulation.
Figure 2.11 depicts how current steering can be used in providing stimulation focus in
inaccurately placed or ageing-related lead migration [8]. While the deviations appear
to be small; they can result in drastic reductions in therapeutic benefits accruable [126].
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Figure 2.11: Computational model illustrating the effect of current steering on the volume
of tissue activated (VTA). a) Showing accurately placed lead for STN stimu-
lation. b) Depicts the use of current steering to control the activation field in
inaccurately placed DBS leads for STN stimulation (adapted from [8]).
It is for this reason that the prospects of current steering have led to the commercial
development of current steering systems 2. The following sections will provide further
information on directional steering in DBS and its prospects.
2.4.1 Directional Steering
Studies in directional steering have mainly focussed on the computational modelling of
DBS leads and activation field spread, experimental studies, and CMOS implementation
of current steering stimulators. Conventional DBS uses cylindrical electrodes which
provide poor neural selectivity, since the stimulation distributes symmetrically around
the electrode, thus targeting both intended and unintended areas. In order to overcome
this, novel lead designs with electrodes having high contact resolution were modelled
in [8]. The novel lead design uses 64 segmented electrodes which offer a larger electrode
combination necessary for accurate field shaping and directional steering. The novel
lead design shows a finer resolution in the generated potential distribution. This study
motivated another study on current steering using 32-contact electrode leads [125]. The
study uses eight patients to investigate the effects of using segmented electrodes on the
therapeutic window of DBS, that is, the thresholds for beneficial effect in relation to the
threshold for side effects. It was found out that the thresholds for side effects increased
by more than 1 mA, and the thresholds for beneficial effect dropped by 0.5 mA, thus
creating an increase in therapeutic window of about 1.5 mA. In terms of output stages
for multipolar current steering in DBS, the first realisation was implemented in [127].
It uses a voltage controlled resistor (VCR) stimulation circuit and tri-polar current
2Boston Scientific, Sapiens SBS, and Aleva Neuroprosthetics have been aggressively involved in the
development of current steering systems for DBS. Sapiens SBS was acquired by Medtronic, Inc. on
Aug. 26, 2014 for approximately $200 million.
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steering. The adopted tri-polar configuration has a tendency to be scaled to use higher
number of electrodes. In another work, a CMOS circuit for current steering using
multipolar and multisite current steering was also presented [128, 129]. So far, very
little effort has been devoted to the development of output stages for current steering
which are necessary to enable power management.
2.4.2 Benefits of Directional Steering
The cylindrical electrodes for conventional DBS were designed when there was very
little or no scientific understanding of the mechanisms of DBS and neurodegenerative
(and neuropsychiatric) disorders. However, with more insights gained, there is a need
for explicit definition of spatial targets. This has resulted in a surge in the devel-
opment of electrodes and leads for DBS [8, 130, 131]. These electrodes design have
mainly focussed on two strategies for spatial adaptation [101]: 1) employing a num-
ber of small segmented electrodes which could be independently activated in response
to issues like electrode migration in chronic DBS, or 2) customising a number of the
cylindrical electrodes to improve stimulation of brain targets, especially in the more
problematic regions. A typical example is in the stimulation of the Vim of the thala-
mus for ET patients. It has been established that stimulating the ventral caudal (Vc)
nucleus of the thalamus induces parathesia [130]. Due to the proximity of the Vc to
the Vim, there is the possibility that electric field spread could induce paraesthesia
in patients [130]. This is why the major DBS devices manufactures are aggressively
exploring the practicality of leads with provision for spatial adaptation 3. Using seg-
mented electrode provides more flexibility in administering stimulation, but increases
the cost and complexity of the device. In addition, it imposes lower charge injection
limits for safety and creates an impractical parameter search space for clinical DBS
programming. These are the major issues in deciding which of the two possible routes
(either using segmented or cylindrical electrodes) to follow in terms of spatial adapta-
tion. Nevertheless, both techniques have shown that the benefits of accurate targeting
and precise field control outweigh its shortcomings [101, 131]. Beyond the realm of
stimulation, spatial adaptation was used to obtain a more precise biomarker sensing
using high density electrodes [132]. Intraoperative electrophysiological measurements
like LFP beta power, neuronal kinetic responses and neuronal firing have been used to
identify suitable brain targets for neuro-motor disabilities [133,134]. The sensed signal
was used to trigger stimulation in a non-human primate. The results showed that high
density electrodes had the potential to shape stimulation and biomarker sensing, which
improved stimulation efficacy. Development of direction steering lead is necessary so
as to optimise stimulation and biomarker sensing. The optimised stimulation/sensing
offered by customised directional steering will go a long way in conserving energy, there-
fore increasing pacemaker battery life. As it has been highlighted, there are two main
methods by which directional steering can be optimised: novel lead designs and energy
3Boston scientific developed “Vercise”, a 16-electrode array current steering DBS system. Sapiens
marketed the “SureSTIM” which has a 32-electrode lead (Sapiens has now been acquired by Medtronic,
Inc). Aleva Neurotherapeutics developed the “DirectSTIM” which has 8-electrodes.
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efficient output stages. Preliminary work on the latter is presented in Chapter 7 in an
effort to realise a current steering output stage. Correspondingly, the manoeuvrability
introduced by directional steering can lead to the exploration of potentially beneficial
stimulation sites that were previously inaccessible by surgical techniques. Considering
the effects of neuroplasticity, electrode migration and other extraneous effects, spatial
adaptation of DBS has the potential to offer maximum therapeutic benefits without
sacrificing efficiency.
2.5 Development Achieved in DBS
Research activity in the field of DBS has stagnated over the last few years [112]. Table
2.6 summarises the evolution and history of DBS and suggests possible future ad-
vances [1,75,99,100,135–137]. The major innovations in current DBS technology have
mainly resulted in broadening the operating ranges of stimulation parameters; it is still
not clear how this will increase clinical benefits. Nevertheless, it gives clinicians an
increased flexibility and more degrees of freedom (DOF) to search for patient specific
DBS parameters. On the other hand, increased flexibility also increases the economic
cost of stimulation parameter programming due to the time-consuming trial-and-error
process. Other innovations have been the introduction of rechargeable batteries and the
concept of stimulation field shaping. Having rechargeable batteries is essential because
the economic costs associated with DBS have been reported to be largely dominated by
battery replacement cost [138]. As is normally the case in other therapeutic fields, not
every innovation brings about considerable changes that may influence patients’ quality
of life, but many can improve safety, efficiency and flexibility both for patients and clin-
icians. Aside from incorporating additional functionality, technological advancements
could manifest in the form of increased computing capability per chip at a reduced cost.
Due to the short market cycle of electronic devices, continuous innovations are required
to maintain market relevance even if they may have little or no benefit towards im-
proving patients’ quality of life. DBS is becoming more appealing due to the growing
evidence pointing to the benefits of DBS at the early stages of PD [37]. Another con-
tributing factor is the growing number of PD patients expected, which is expected to
reach 8.7 million people worldwide by 2030 [139]. These could drive unit costs down
as manufacturers achieve economies of scale. Low cost devices can translate to better
market penetration particularly in developing countries. Currently, the annual sales es-
timates of DBS devices for PD is approximately $200 million to $300 million worldwide,
but the coming years promise a further surge in sales [140]. It is estimated that more
than 100 000 patients suffering from PD, pathological tremor and dystonia have been
treated with DBS all over the world [141]. With the increase in the number of patients
requiring DBS therapy, there is a need for smarter DBS programming strategies that
can be self-optimising and autonomous. The thinking is that adaptive or smart DBS
has great potential to keep DBS simpler (both for the patient and caregiver) and more
viable. In epilepsy, a closed-loop Vagus Nerve Stimulator, the RNS NeuroPace, has
been approved by the FDA for the treatment of refractory epilepsy [142]. Closed loop
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therapy in epilepsy is easier than that of PD because non-healthy neuronal activity can
be easily distinguished from healthy neuronal activity by trained clinicians, which is
not the case in PD. Nonetheless, considering that both are closely related neurodegen-
erative disorders, it may not be long before fully implantable closed-loop systems are
trialled. As things currently stand, researchers, entrepreneurs and other stakeholders
in the DBS field believe that aDBS will be the silver bullet that will solve the myriad
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2.6 Chapter Summary
There have been various advances in DBS, most of which improve the clinical outcomes
of DBS. As discussed, several factors affect the clinical outcomes of DBS, including
lead positioning, programming technique, feedback signals and algorithms for closing
the loop, recording devices and so on. There are currently two main methods by which
DBS clinical outcomes can be improved: closed-loop DBS and directional steering in
DBS. This chapter has provided some background information and a comprehensive
literature on the various methods for adapting DBS. The discussions in this chapter
can be summarised in the following conclusions:
a) Closed-loop DBS is a form of adaptation in DBS concerned with time-related changes.
To overcome some of the limitations of DBS therapy like stimulation induced side
effects and limitation of pacemaker battery life, closed loop systems would allow
real-time adjustment of therapy according to quantifiable brain response. This will
reduce the frequency of clinical interventions required. Potentially, with closed-loop
DBS, patients are likely to benefit from fewer battery replacement surgeries [24]
which can improve patients quality of life. DBS costs have been reported to be
largely dominated by battery replacement cost [138].
b) Aside from adaptation through closed-loop DBS, spatial targets can be adapted and
this has been found to improve therapeutic benefits.
c) Implementation of closed-loop DBS has mainly focussed on computational models,
with very little breakthrough made in the transition to clinical trials.
d) The major impediment in the development of a fully implantable closed-loop DBS
systems has been poor understanding of the underlying workings of DBS. Lack of
insight has prevented the selection of suitable biomarkers for closed-loop DBS and
has hindered the adoption of an optimum tracking and control mechanism for the
disease. Currently, most experimental studies have relied on bang-bang control
techniques.
e) The ability to deploy powerful feedback algorithms is limited by the allowable power
consumption of fully implantable processors.
f) Promising techniques that adapt stimulation (and sensing) to targeted neural struc-
tures can be implemented using directional steering.
g) With all the research and theories on possible benefits of DBS for various disorders,
there is only evidence and approval to back its use in three conditions: PD, dystonia
and tremor [41]. The primary brain targets are also constrained to three: STN, GPi
and Vim.
h) Finally, the future of research in aDBS is dependent on major breakthroughs in syn-
ergistic and cross-disciplinary collaborations between clinicians, engineers, statisti-
cians, computer scientists, health care professionals, regulatory experts and most
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importantly, end-users. This is the only way a clear understanding of the appropri-
ate strategies needed to incorporate aDBS systems in patients will be achieved.
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Chapter 3
Measures and Metrics for Evaluating
Detection and Classification Algorithms
in Brain Machine Interfaces
Research in BMI has come a long way, so far there have been six international BMI
meetings, in which the most recent took place in 2016. As the field progresses, there
is a need to provide objective methods to compare BMI technologies. It is for this
reason studies like [143] have attempted to provide experimental frameworks on how
to compare BMI. However, a very conspicuous gap has been the lack of standard
metrics for assessing BMI systems. Drawing from Chapter 2, the major challenges
of physiological signal analysis (which is central to BMI and closed-loop DBS devices),
are; feedback signals, sensing techniques and feedback algorithms. This chapter is
designed to delve deeper into these challenges; without limiting the analysis to only
closed-loop DBS, but BMIs in general. The central theme is still closed-loop DBS,
which is an instance of BMI. Thus, in a broader sense, most (or all) of the techniques
applicable for use in closed-loop DBS are suitable for other BMIs, but the reverse
may not be applicable. This prompted generalising and extending the review and
analysis to BMI as a whole. Since closed-loop DBS is a subset of BMI. The chapter is
organised as follows. The first section gives a brief context on BMI. The second section
focusses on sensing techniques and feedback signals that are obtainable from the brain
(external signals were not included). The third details measures that could be used
to evaluate efficacy, complexity and efficiency of feedback algorithms; as well as their
strengths and weaknesses. The fourth section stresses the benefits as well as limitations
of standardising and customising performance metrics for feedback algorithms in BMI,
such that algorithms could be assessed in a fairer, more balanced and objective way.
The final section provides a summary of the salient points.
3.1 Brain Machine Interfaces (BMI)
A BMI transduces brain signals to enable some form of communication between the
brain and a machine – both can take up the role of the transmitter and receiver. Figure
3.1 depicts the bidirectional communication of an idealised BMI system. There are
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Figure 3.1: Idealized bi-directional brain-machine interface.
various ways BMIs can be classified: based on function, level of invasiveness, the origin
of neural signal and by design [144]. However, more focus will be on their classification
based on function. When classified based on functions, they can be broadly divided
into two categories [145]. The first category are devices that relay sensory information
by stimulating relevant regions of the brain concerned with various forms of perception
like sound or vision to mimic their neurological function. The second category decodes
neural activity in real-time to control prosthetics, motor disorders, pain and other
impairment or disabilities. Among the two groups, the former controls perception to the
brain based on sensory information, while the latter controls actuation to a body part
or prosthetics based on recorded neural activity from the brain. Both categories can use
electrical signals to relay sensory and actuation information respectively [144]. They can
also be used to restore, reinforce and facilitate human sensory-motor functions [146].
Advances in neuroscience have led to a surge in BMI research. However, the major
challenge remains translating research into real-life applications. These transition has
mainly been hindered by limitations in sensing technology; unreliable algorithms for
signal analysis and interpretation; and ineffective control strategies [147]. To address
some of the challenges, proper understanding of BMI sensing technology is required as
well as metrics that can be used to evaluate feedback algorithms reliably. These are
highlighted in the following sections.
3.2 Sensing in BMI
In BMI, the sensing stage quantifies brain activity such that it can be used to control
a prosthetic limb or to mitigate neuro-motor disorders. For effective neural record-
ing, cutting-edge techniques that access deep and distant regions of the brain are re-
quired [148]. This has led to an upward trend in the development of miniaturised
recording devices with high spatiotemporal resolution. A notable example of this is the
encapsulated neural acquisition chip that records electrophysiological activities from
the gyri and sulci of the brain [148]. It provides a high spatiotemporal resolution,
which could lead to having more insights into brain dynamics. Major breakthrough
in understanding neurophysiological dynamics is dependent on advances in BMI data
acquisition [149], because the first requirement towards achieving an efficient BMI de-
tection algorithm is acquiring neural signals without compromising their quality. This
section focuses on techniques that have been used in signal acquisition for BMI appli-
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cations. The list is not exhaustive, nevertheless it presents the most prominent signal
acquisition techniques in BMI applications. The major focus is on actuation assis-
tive BMIs which closed-loop DBS can be categorised into. Nonetheless, background
information is provided on perception assistive BMIs.
3.2.1 Perception Assistive Sensing
These are signals that are used to help enhance sensory functions in patients with au-
ditory, visual or any other sensory impairments. Stimulation is triggered using mainly
signals external to the brain. This class consists of visual and auditory prosthesis
like cochlear and retinal implants. Cochlear implants work by converting sound into
patterns of electrical stimuli that are delivered using a collection of implanted micro-
electrodes to the auditory nerve fibre lying on the basilar membrane of the cochlea [145].
By substituting the percepts with sound and the neural system with the auditory nerve,
Figure 3.2 summarises the processing chain of a cochlear implant; which is a typical
example of a BMI that enhances percepts. Sound enhancing prosthesis were the first
successful prosthesis. They were developed as early as the 19th century by Miller
Hutchinson as hearing aids [150]. Making them the earliest BMIs to be commercially
available. In 2013, the FDA approved the first retinal implant [151]. Like the cochlear
implant, the retinal implant uses decoded captured images as control signals, which are
then used to stimulate the optical nerve through a set of electrodes [152]. The retinal
implant uses a similar processing chain to the cochlear implants as shown in Figure 3.2.
With the retinal implants, the percept is vision and the neural system to be modulated
is the optical nerve. Work on retinal implants is still at its early stages, and they have
shown a lot of promise; however, they are still grappling with low resolution, making
it difficult for blind patients to use them for daily living activities [153].
3.2.2 Actuation Assistive Sensing
These consists of the group of neural signals used to rectify, restore and ameliorate
external bodily functions, mainly motor disabilities. Figure 3.3 depicts a BMI using
brain signals to control a prosthetic limb. Prosthetic limbs like this restore grasp and
gait abilities to seriously disabled patients, who may be paralysed or those with severe
neuro-motor limitations. In restoring bodily functions, more neural information can be
obtained using innovative approaches having high spatiotemporal resolution or tech-
niques measuring multiple brain activities [149]. Regarding neural activity measured,
this review broadly classifies them into two categories: electrical and metabolic activity.
Below is a brief description of the various modalities used in obtaining electrical and
metabolic activity from the brain.
Figure 3.2: Processing chain of perception assistive BMI.
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Figure 3.3: Actuation assistive BMI using brain signals to control a prosthetic limb.
3.2.2.1 Electrical Activity Sensing
Neuro-electrophysiology has been used in studying bio-electrical properties of brain
cells and tissues. Notable among, was the revolutionary discovery by Hodgkin and
Huxley in 1952, on the initiation of action potentials in squid axons which eventu-
ally led to a Nobel Prize [154]. Later, there was the discovery by Hubel and Wisel in
1977, about how individual neurons contribute to visual processing [155]. These ground
breaking studies set the pace in neuro-electrophysiology. To extract useful information
from neuro-electrophysiological signals, a good understanding of how these signals are
formed at the neural level is required. Generally, neuro-electrophysiological signals rep-
resent the spiking behaviour of a single neuron, a small neural ensemble and the mean
potentials of a large neural ensemble. The larger the neural population, the higher
the amplitudes as more neurons contribute additively to the signal. The structure of
the neuron was discussed in Chapter 2. Neuro-electrophysiological signals are used for
various applications in clinical settings. Primarily, they have been used in BMI, where
implanted devices are used to record and decode brain signals, which are used in con-
trolling external machines, like prosthetic limbs [57]. Additionally, electrophysiological
signals are used in localising areas where seizures begin in both medically tractable
and intractable epilepsy [156]. They have been proven to be good markers for move-
ment disorders such as PD, ET and dystonia [16]. Their use is extending to tracing
neuropsychiatric disorders like OCD, dementia, attention deficit hyperactivity disorder
(ADHD), Alzheimer’s disease (AD), and schizophrenia (SZ) among others [157]. Fun-
damentally, feedback signals should be selected based on their: level of invasiveness,
resolution, signal content, and clinical relevance. The selection of signals will ultimately
depend on the design of the entire system in relation to the signal processing capability
available. The following sections give a brief description of the sensing techniques and
signals obtainable by electrical activity sensing in the brain.
Neuro-electrophysiological Recordings
Intracellular recording is the measurement of voltage or current within the membrane of
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a cell. This is done by inserting an electrode in the cell and a reference electrode outside
the cell. This could be done using a current or voltage clamp [158]. In a current clamp,
current is injected through the intracellular electrodes and the resulting membrane po-
tential is measured using an amplifier. Whereas, the voltage clamp holds the membrane
potential at a fixed value and the current flowing through the intracellular electrode
is measured. The major techniques used in intracellular recording are measurements
of current, potential and conductance. On the other hand, extracellular recording is
the main method for measuring in vivo neural activity. For a single neuron, extracellu-
lar recording is achieved by placing an electrode close to the neuronal soma such that
the firing rate of the neuron is measured by the number of spikes [159]. Extracellular
recording has been more prevalent due to its ability to provide neuronal activity, cou-
pled with its relative ease of use compared to intracellular activity. Aside from single
neuron activity, research is growing in the study of how a network of neurons influ-
ences various functions like cognition, movement and perception. These studies have
mainly used extracellular recordings using multi-electrode arrays (MEA). Extracellular
potentials provide information consisting of high-frequency spiking activity (> 500 Hz),
which stem from some neurons within the immediate vicinity of recording electrode and
are termed multi-unit activity (MUA). And the low-frequency potentials consisting of
LFP. Figure 3.4 presents the conventional set-up for measuring extracellular activity
from a neural population [160]. An ideal measurement technique is required to be able
to provide activity of single neurons, at the same time providing whole brain activity,
within a microsecond time scale [159]; which might only be achievable by combining
recordings from various techniques.
Figure 3.4: The basic set-up for measuring and analysing extracellular neural signals. The
set-up shows the low noise amplifier (LNA), band pass filter (BPF) and analog to
digital converter (ADC).
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Unit Activity
Using sharp extracellular electrodes as in Figure 3.4, action potentials are generally ex-
tracted from a single neighbouring neuron (single-unit recording) or from an unknown
population of neighbouring neurons (multi-unit recording) [161]. These are mostly
high-frequency extracellular potentials (> 500 Hz). Single unit activity is used in un-
derstanding how a neuron responds to specific stimulus or to understand correlation
between various neurons. This has led to their use in providing insight into patterned
activity within the STN and GPi in relation to movement, cognitive processes and
memory; making them potentially suited as biomarkers for use in closed-loop DBS.
Nevertheless, they are hindered by recalibration (due to drift in neuronal properties),
need for precision on target neuron and unreliability of recording over extended use [16].
Single neuron recordings represent certain movement features; nonetheless, they have
an increased sampling rate requirements, degradation at the neuron-electrode interface
and difficulty maintaining recordings from the same neuron for extended periods of
time. However, the difficulty in maintaining recordings has been as a result of the size
of recording electrodes, which mostly picks up neuronal ensemble activity as against
the required single unit activity [162]. This has necessitated the need for additional
processing, which is spike sorting. It is used to extract single unit activities from mul-
tiunit activities. Compared to other neuro-electrophysiological signals, unit activities
are useful in BMI applications, since high spatial resolution is required. Spikes have
been found to show a clear relationship to movement and behavioural functions as
highlighted by their application in BMI for prosthetic limbs. This has led to their use
as biomarkers for regulating stimulation in closed-loop DBS [75].
Local Field Potentials
LFP are low frequency (< 500 Hz) extracellular potentials obtained from time sam-
pling a localised population of neurons. LFPs can simply be measured with a standard
EEG amplier connected to the implanted DBS electrode, and are generated by sum-
mated postsynaptic potentials resulting from excitation in basal ganglia and cortical
neurons [163]. Unlike unit activity, they tend not to drift over time which makes them
more reliable and stable [162]. Because of their population based nature, they are more
informative, due to their time and frequency response; and offer a better trade-off be-
tween high spatial resolution (common in unit activity) and high spatial scale (common
in global field potentials) than other neuro-electrophysiological signals. Spatial scale
deals with the level of spatial coverage of the measuring technique, that is, on a macro
level. On the other hand, spatial resolution deals with the level of detail in spatial
information that can be obtained, that is, on a micro level.
Another advantage of localised population of neurons is the long-term experience in
signal processing for EEG-like signals researchers have, particularly LFPs. Figure 3.5
illustrates the region where LFP recording can be obtained [9]. Also, LFP processing
algorithms can be easily implemented on microchips, and are therefore ideal for use
in implantable devices. Since LFP processing microchips have been adopted in several
studies, using LFP means no additional work or procedures to be undertaken. This
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Figure 3.5: Candidate neuro-electrophysiological signals and their recording sites (adapted
from [9]).
makes them ideally suited for many applications requiring neural signals for feedback.
As biomarkers for closed-loop DBS, current evidence supports the hypothesis that LFP
activity changes in response to the patient’s clinical state. Basal ganglia LFPs oscillate
in several frequency bands, ranging from; very-low frequencies (3−8 Hz), alpha (8−12
Hz), beta frequencies (13−30 Hz), gamma (> 30 Hz), and very-high frequencies (250−
350 Hz). The most studied and discussed LFP oscillations are beta frequencies because
they seem to reflect the patient’s motor state. Changes in beta LFP activity mainly
reflect basal ganglia responses to dopamine and correlate with motor performance.
Even though the exact mechanisms of DBS are still under debate, ample evidence
shows that LFP oscillations in patients with PD are specically modulated by DBS [164].
Notwithstanding, LFPs have their limitations, some of which are listed below:
• There is evidence that LFPs correlate closely with the individual patient’s motor
status, but correlation across patients is yet to be established [16].
• Recent studies suggest that other activities like cognitive and behavioural func-
tions might modulate LFP [164].
• Abnormal oscillations reflect some clinical impairment in patients, but direct
relationships are yet to be established [60].
• Conversely, there is no correlation between beta band LFP and UPDRS score,
making some studies to downplay its importance [165].
LFP has a relatively better correlation with PD compared to other neuroelectrophysio-
logical signals. Various clinical studies have employed it as biomarker for PD [24,58,87]
and numerous computational studies have been concerned with its manipulation in or-
der to stabilise patients state [61,68,69,80,81,105].
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Global Field Potential
These are activities from a much larger population of neurons than LFP. Like LFPs,
EEG measures the summed electrical activity of many neurons and is measured with
electrodes at the surface of the scalp; though at a larger scale. Figure 3.5 depicts the
recording sites for EEG and electrocorticograhy (ECoG) which are examples of global
field potentials. From Figure 3.5, it can be seen that EEG are subject to filtering due to
propagation through various media such as the cranium, dura mater, cerebrospinal fluid
and other surrounding tissue [159]. Due to this frequency filtering, action potentials
are severely attenuated and are not visible on EEG electrodes. Also, low-frequency
activities such as synaptic potentials dominate EEG signals, since they can propagate
over large distances within the extracellular space. EEG recordings provide average
activities of neurons on the order of 105− 108 [166], this inhibits both their spatial and
temporal resolution. On the other hand, ECoG can be used to overcome some of the
shortcomings of EEG. ECoG measurements are made on the surface of the cortex as
is shown in Figure 3.5, which results in less filtering compared to EEG which is made
on the scalp. Like EEG, ECoG measures the summated electrical activity of many
neurons, to be precise, it uses the summation of between 102− 103 neurons [166]. This
enables ECoG to record frequencies up to 200 Hz compared to the less than 70 Hz
present in EEG [167]. Thus, EEG and ECoG make the same measurements, though
EEG signals have poorer spatiotemporal resolution due to filtering by cortical tissue
and their large coverage area. In BMI, higher frequency contents in signals mostly
lead to more relevant information for decoding patient state and intentions; which are
necessary for BMI control [168]. With the lower frequency-specific information content
of EEG compared to other neuro-electrophysiological signals, their long-term use as
biomarkers may be unsuitable. Nevertheless, they relatively have a higher spatial scale
compared to the other signals since they cover the whole brain; making them suitable
for acquiring more general fluctuations in frequency information across the brain. This
property makes them ideally suitable as complementary signals in BMI applications.
As a result of this, they have found application in responsive stimulation for epilepsy.
Their adoption in epilepsy makes them an option for PD applications since epilepsy is
a neurological disorder impairing movement and other behavioural functions just like
PD.
3.2.2.2 Metabolic Activity Sensing
For PD and DBS, hemodynamic or neuro-transmitter response could be used in obtain-
ing vital brain information. In DBS, excitation and inhibition of neuronal signals occur
as a result of stimulation and improvement in conditions. In addition, other secondary
effects are blood flow changes, modulation of neurotransmitters, neurogenesis and a host
of other metabolic activities [27]. This makes the investigation of metabolic activity for
closed-loop DBS important. In the hemodynamic response, blood releases glucose to
active neurons at a higher rate than in the area of inactive neurons [169]. The glucose
and oxygen released into the blood stream results in an increase in oxyhemoglobin in
the veins around the active region. Hemodynamic changes in PD patients can serve
53
3. Measures and Metrics for Evaluating Detection and Classification Algorithms in
Brain Machine Interfaces
as good biomarkers since DBS and PD induce cortical hemodynamic changes in pa-
tients [170]. These changes can be detected by methods such as functional magnetic
resonance imaging (fMRI), diffusion magnetic resonance imaging (dMRI) and near-
infrared spectroscopy (NIRS). Like in hemodynamic responses, the use of techniques
that measure neuro-transmitter response is pertinent because PD results in degenera-
tion of cells that use dopamine as neurotransmitters [3]. Monitoring dopamine traces
from cerebral metabolites have been reported [16], but miniaturisation of chemical anal-
ysis is a major barrier. In addition to monitoring neurotransmitter and hemodynamic
responses, responses to specific molecules are measured using optical micro-imaging
techniques mostly by using fluorescence measurements. Recent advances in optical
imaging techniques have led to single-cell resolution in functional neuroimaging which
uses a two-photon microscope [171]. Understanding pathological brain processes down
to the single neuron level is necessary towards harnessing the ability of closed-loop DBS
as well as BMIs to restore bodily functions. The advantage optical approaches have
over other methods is that they have high spatial localisation and are relatively less
invasive (∼ 1 - 2 mm in depth) compared to other methods [172]. However, their major
shortcoming is their low temporal resolution compared to neuro-electrophysiological
methods. This is partly due to their high requirement for signal processing and data
analysis [173]. Below is a summary of the major methods used in analysing and ob-
taining metabolic activity from the brain that can be used in closed-loop DBS.
Florescence Measurements
Fluorescence measurements have a distinctive response to the presence of specific
molecules like sodium, potassium or calcium. Fluorescence measurements of neuronal
activity can be classified into two categories: those that are sensitive towards membrane
voltage and those that detect changes in intracellular calcium concentration [173]. Sen-
sors sensitive to membrane potentials produce relatively small signals in response to
action potentials. Currently, calcium-sensitive sensors are orders of magnitude more
sensitive than sodium or potassium sensitive sensors. Since, in principle, initiation and
propagation of action potential can give rise to about a hundred times higher calcium
concentration that under rest [174]. This can be used to measure active and inactive
neurons in the brain.
Near-Infrared Spectroscopy (NIRS)
NIRS uses optical spectroscopy based on infrared light to quantify changes in cerebral
metabolism due to neural activity. Infrared light penetrates the human skull up to a
depth of about 1- 3 cm below the skull. This enables NIRS to measure concentration
of oxyhemoglobin based on light attenuation (absorption and scattering) [175]. The
shallow penetration of light makes it not very ideal for applications like PD that monitor
biomarkers in deep regions of the brain. Nevertheless, it is a promising diagnostic tool
to investigate neurovascular coupling, for example in epilepsy to develop novel early
seizure detection algorithms, because vascular changes occur about 100 milliseconds
after the associated neural activity. Which is an acceptable temporal resolution for both
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closed-loop DBS and BMI applications [176]. In addition, it has a spatial resolution
of within 1 cm. The major advantage of adopting optical modalities like NIRS and
fluorescence measurements in recording neural activity is their high specificity, which
will go a long way in facilitating artefact free closed-loop DBS systems. NIRS was first
used in DBS patients by Sakatani and colleagues [177]. The finding suggested that
therapeutic benefits were reflected by changes in oxyhemoglobin levels in the prefrontal
cortex. Despite its bulkiness, NIRS has been proposed as a suitable measure of neuronal
activity due to its ability to accurately quantify neuronal activity which is reflective of
symptom severity and has been proposed as a candidate signal to adjust the parameters
of DBS in a closed loop configuration [178]. Applications utilising this technology for
BMIs and closed-loop DBS are still in infancy. Thorough studies using a large number
of patients that produce encouraging results are required so as to establish its feasibility.
Magnetic Resonance Imaging (MRI)
MRI is an emerging technology for observing neural activity in the living brain. It has
tremendous potential for use in applications like blood-oxygen-level-dependent (BOLD)
fMRI, which is a non-invasive method for monitoring brain functions [149]. Like NIRS,
fMRI is a measurement based on hemodynamic changes, and it offers a spatial resolution
in the millimetres range. It has been shown to offer tremendous insights into the
underlying dynamics of the human brain [179]. Also, understanding the underlying
mechanisms can give more insight as to why different patients’ brains respond differently
to similar levels of stimulation. Aside from fMRI, the complex activity in the white
matter of the brain can be captured in great detail using dMRI [180]. It captures the
molecular displacement of water within a voxel. This is used to deduce the location and
direction of white matter tracts based on the directional diffusion of water. Changes in
white matter fibre tract have been used to understand the internal working of the brain.
Muetzel et al. [181], confirmed that changes in white matter fibre tract connection
correlated with subject performance in specific tasks in healthy patients.
Fast Scan Cyclic Voltammetry (FSCV)
FSCV is a voltammetry technique that applies a linearly varying potential through
carbon fibre microelectrode (CFM), resulting in redox chemical reactions around the
electroactive molecules [182]. The concentration of analytes is measured by the magni-
tude of evoked current peaks to the redox reaction at the electrode surface. The rela-
tionship between the applied voltage versus the resulting current provides a chemical
signature for the presence of certain neurotransmitters or analytes. FSCV detection
is mainly limited to electroactive analytes; electroactive molecules like dopamine (a
biomarker for PD), adenosine (a biomarker for sleep), and oxygen (which signifies the
presence of anoxic brain injuries). The major limitations of FSCV are its bulkiness
and that the lifetime of CFM is a few months, which restricts the application of FSCV
detection to intraoperative approaches. For DBS, using an anesthetised rat model,
the MINCS in [103], was interfaced to FSCV to wirelessly regulate stimulation as a
proof-of-principle test for closed-loop DBS using neurochemical signals for feedback.
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Intracranial Micro-dialysis
Microdialysis is the most commonly used method to measure the chemical concentration
of analytes in the brain [183]. It uses a dialysis probe that penetrates very small
molecules in the brain. The brain is supplied with artificial cerebrospinal fluid, the
quantity of molecules that diffuse into the probe and the dialysate are collected and
analysed off-line. Its spatiotemporal resolution is not excellent because a certain amount
of dialysate has to be collected before any analysis can be done; which impedes time
resolution. However, it has a very high degree of chemical selectivity and sensitivity.
Due to its poor temporal resolution, it can only be used to measure long-term changes in
analytes or neurotransmitter for use in closed-loop or BMI applications. Its sensitivity
and selectivity make it suitable for applications like home-based monitoring of PD
patients. This could go a long way in reducing the frequency of face-to-face visits.
Table 3.1 summarises some of the characteristics of various feedback signals that are
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3.2.2.3 Electrical versus Metabolic Activity
For effective neural recording, cutting-edge techniques that access deep and distant
regions of the brain are required [148]. These could lead to more insight in brain dy-
namics. Nonetheless, of equal importance are techniques that have spatial coverage. A
breakthrough in understanding neurophysiological dynamics is dependent on advances
in neural signal acquisition [149]. This is the first requirement towards achieving an
efficient closed-loop DBS system. Changes in the bio-chemical environment within the
brain can be representative of intended actions and actual actions in patients. These
characteristics make metabolic activity sensing suitable for quantifying neural activity.
The use of metabolic activity as biomarkers have been investigated in [184]. Their major
shortcomings are safety concerns like MRI compliance and metal artefacts. However,
some other metabolic activity sensors such as NIRS are not affected by metal artefacts,
but have relatively poor temporal resolution compared to electrophysiological activity.
Their large size is a stumbling block towards attaining fully implantable closed-loop
DBS systems. Apart from sensitivity to metal artefacts in fMRI, metabolic activity
offers many advantages compared to electrical activity recording, notably: absence of
electrical noise, simultaneous imaging of a large number of neurons and selective record-
ing from genetically-targeted regions of the brain [185]. Their high SNR, specificity and
selectivity can go a long way towards facilitating artefact free closed-loop DBS systems.
For electrical activity, information content is dependent on spatio-temporal resolution,
with EEG and single unit activity on the extremes of the spectrum: EEG has the
highest spatial scale and the least temporal resolution, while single unit activities have
the highest temporal resolution and the least spatial coverage. LFPs offer a compro-
mise in terms spatiotemporal resolution. Combined with their long-term stability at
the ETI, this makes them very attractive feedback signals for closed-loop forms of
DBS [16]. However, the pertinent question is how informative they are compared to
other neuro-electrophysiological signals?
Closed-loop DBS applications can adopt effective paradigms that combine both metabolic
and electrical activity sensors for acquiring brain responses in real-time which increases
spatiotemporal resolution. This leads to better identification of disease and non-disease
states in patients, as the level of information content is strictly dependent on spatiotem-
poral capabilities of the sensor. This complementary approach takes advantage of the
best of both worlds: the fast response rate of electrical activity, and the slower more spe-
cific, selective and qualitative sensing offered by metabolic activity. The complementar-
ity of sensing electrical and metabolic activity have found application in BMI [149,186].
3.3 Measures for Evaluating BMI Detection (Feedback)
Algorithms
With the advancement in the use of BMI for neural rehabilitation, the rise in the signifi-
cance of detection algorithms as their major building blocks cannot be overemphasised.
In closed-loop DBS or BMI applications, detection algorithms convert recorded brain
activity into useful information that could be translated or used as the control signals
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for the control of sensorimotor functions. Detection algorithms are the first step towards
developing BMIs that uses pathological brain activity to ameliorate, mitigate or restore
bodily function in patients with disabilities such as such as PD, Alzheimer’s disease,
epilepsy, spinal cord injury (SCI) and so on. They are the major cornerstone of the
BRAIN initiative (Brain Research through Advancing Innovative Neuro-technologies),
which is a $100 million investment in research and development with the goal of sup-
porting the development and application of innovative technologies that can create a
dynamic understanding of brain function [187]. Efficient and efficacious detection al-
gorithms could lead to fully implantable BMI systems with real-time capabilities that
could be used to monitor disease progression in patients. Also the economic impact is
another motivation for understanding the various metrics that can be used in evaluat-
ing detection algorithms. Currently, there is an increase in the cost of management for
neuro-motor disabilities both for individuals [188] and health care administrators [189].
As such, it is paramount to review and analyse various performance metrics in BMI
detection algorithm as they influence this cost of BMI detection algorithms. This will
enable proper resource utilisation for hardware efficient implementation. The focus will
be only BMI detection algorithms. The metrics were categorised into three, based on
what characteristic they evaluate. The three categories are complexity, efficacy and
efficiency. Of these three categories of measures, there are more subtle differences be-
tween efficacy and efficiency. Efficacy means the ability to produce the desired results
irrespective of the resources expended. On the other hand, efficiency is not only con-
cerned with achieving results but also concerned with the resources utilised in achieving
the results.
3.3.1 Efficacy Measures
We review various methods that are currently used in assessing the efficacy of detec-
tion algorithms in BMI. Evaluating the efficacy of detection algorithms can be tedious,
as there are several nearly similar measures with rather subtle differences that can be
used. However, some methods are more effective for some BMI applications based on
the peculiar features of the said application. While others perform better at revealing
certain characteristics of the detection algorithms that may ordinarily be less conspic-
uous. More emphasis is placed on metrics that are good at evaluating binary decision
problems, like disease and non-disease states. A potential pitfall in analysing binary
detection algorithms is data redundancy [90]. That is, using a similar sequence of ex-
amples to train and test algorithms could lead to having an overestimated performance
because it only ends up producing the output to a possible training input rather than
interpolating or extrapolating, which is the main aim of a detection algorithm [190]. At
its most basic level, the efficacy of binary detection can be assessed using the confusion
matrix. Other efficacy measures are: difference and information measures. This review
will look at several metrics for assessing efficacy, with the intention of deciding which
metrics are ideally tailored for our application in subsequent chapters.
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3.3.1.1 Confusion Matrix
The confusion matrix or contingency table is a table that contains information on the
actual and detected states for a supervised learning classifier. For a binary classifier
it is a 2 × 2 matrix consisting of the cells in Table 3.2. However, when the detection
problem is an M-ary detection problem, then the confusion matrix can be represented
by an M×M matrix. From the confusion matrix in Table 3.2, the various quantities are
defined as follows: TP represents the true positives, FP represents the false positives,
FN represents the false negatives and TN represents the true negatives. Also, PD+
occurs when an epoch is detected to have a PD state, while PD− are PD-free segments.
However, using a range of numbers to represent performance as in the confusion matrix,
it may not be obvious how well a detection algorithm performs. An alternative will be
to use single performance measures based on a combination of two or more relevant
quantities from the confusion matrix. There is no single measure that gives a completely
fair assessment of the confusion matrix. Nevertheless, there are measures that give a
very good picture such as the F1-score and Mathews correlation coefficient (MCC).
They give a very balanced measure for uneven classes. Below is a brief description of
the various performance metrics obtainable from the confusion matrix that have been
used in various literature on BMI.





































1) Classification Accuracy and Classification Error: Classification accuracy
measures the proportion of correctly classified (detected) states. On the other hand,
classification error measures the proportion of classifications that were wrong. Both
classification accuracy and error are not suitable metrics for measuring classifier quality
in applications with skewed classes. To overcome this, newer metrics like the weighted
classification error (WCE), which applies various weights to errors in the different
classes depending on which error is more likely to occur and which is more (or less)
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(1− α) · FN
TP + FN
) (3.1)
where α is the weight (or penalty) applied to the error in the non-PD class and 1− α
is the weight applied to the error in the PD class. The error in the PD class represents
type I error (false-positive rate), while the error in the non-PD class represents type II
error (false-negative rate).
2) Sensitivity and Specificity: The sensitivity or recall of a detection test gives
the percentage of patients for whom the outcome is positive that are correctly detected
by the test – true positive rate. On the other hand, the specificity gives the percentage
of patients for whom the outcome is negative that are correctly detected by the test –
true negative rate.
3) Positive and Negative Predictive Value: Precision or positive predictive value
(PPV) of a test is the probability that a patient has a positive outcome given that a
positive test result is obtained. This is different from sensitivity, which is the proba-
bility that a patient has a positive test result given that a positive outcome obtained.
Similarly, the negative predictive value (NPV) is the probability that a patient has a
negative outcome given that a negative test result is obtained. In contrast to specificity,
which is the probability that a patient has a negative test result given that they have
a negative outcome.
4) Miss and Fall-out Rate: The miss rate gives the conditional probability of a
negative test result given that the condition being looked for is positive. The fall out
rate gives the conditional probability of detection being positive given an event that it
was not positive. It gives the significance level of the test. In a sense, the miss and
fall-out rate are the opposites of sensitivity and specificity, respectively.
5) Choice Probability (CP): Receiver operating characteristic (ROC) is a plot of
sensitivity and false positive rate and has an area under the curve (AUC) of between 0
and 1. It is used to evaluate the performance of various detection algorithms. The area
under the curve (AUC) of the ROC, also called the choice probability (CP), represents
the probability that the detector will correctly classify an event in a two-alternative
forced-choice classification. This is described in more detail in [192].
6) F1-score: In a model consisting of skewed classes, for example PD = 2% and
non − PD = 98%, classification accuracy is not a good metric for analysing such
models as a randomly guessing classifier that classifiers all test cases as non-PD will
achieve 98% accuracy. This is obviously misleading. In such situation, a single useful
metric that can be used to analyse the performance of a classifier is the F1 score, which
is obtained using the precision and sensitivity (or recall). Mathematically [10],
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From the equation, the F1 score uses the precision (P ) and recall (R) to determine
the performance of a classifier with the lower of the two dominating. This is because
high precision and high recall are required for PD detection to properly modulate
therapy. High precision is required because wrong prediction will result in administering
stimulation when it is not required, and this may lead to side effects [36]. On the other
hand, high recall is also required to avoid missing too many PD cases. As a high
number of PD misses will worsen the patient state since the patient will be starved of
the required stimulation needed to mitigate the effects of PD [37].
7) Mathews Correlation Coefficient (MCC): Another balanced measure for dis-
proportionate classes is the MCC. It is a modified version of the Pearson correlation
coefficient. It has a range between −1 (total disagreement) and +1 (total agreement).
It is normally 0 for totally random predictions, producing a value of 0 for completely
independent variables. Mathematically [10],
MCC =
(TP · TN)− (FP · FN)√
(TP + FN)(TP + FP )(TN + FP )(TN + FN)
(3.3)
The major shortcoming of MCC is that it can only be used when one of the denomina-
tors TP +FN , TP +FP , TN +FP and TN +FN is not a zero [10]. This makes the
F1- score a more practical measure when assessing detection algorithms for test cases
with uneven classes. Table 3.3 summarises the strengths and weaknesses of various
measures obtainable from the confusion matrix.
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The lower of the two be-
tween sensitivity and pre-
cision dominates and in-
fluences the measure.
[195]
MCC A balanced measure for
classification with skewed
classes.
It can only be used when
one of the denominators
TP+FN , TP+FP , TN+
FP and TN + FN is not
zero.
[88]
3.3.1.2 Difference and Information Measures
These are measures that quantify relative discrepancies between the actual results and
detected results. Difference measures are performance measures that identify the num-
ber of positions (or places) at which predictions differ from the actual results. Weighted
distance measures can be used in evaluating skewed classes to account for the dispro-
portionate classes or as a custom accuracy measure in balanced classes. Information
measures give an insight into the amount of information lost when a predictive model is
used to approximate the actual model.Table 3.4 and Table 3.5 summarises the strengths
and weaknesses of difference and information measures respectively.
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Real-time detection in BMI algorithms can only be realised with low computation al-
gorithms. To facilitate implantation, this algorithms need to be optimised such that
their microchip implementations have significantly small scales in terms of size and
power consumption. By leveraging on state of the art CMOS technology and compu-
tational techniques (low complexity, high speed and low-power); on-line BMI detection
processors can be implemented. This could lead to efficient BMI systems that can be
deployed for chronic clinical use.
3.3.2.1 Arithmetic Operators
A critical consideration in processor designs for BMI is to determine the number of
operations required to decode information from neural activity. Arithmetic operations
are required on recorded signals in order to transform them into useful, manageable
or computationally efficient forms [9]. Detection algorithms for BMIs mainly involve
three stages: feature extraction, dimensionality reduction and pattern classification.
Bio-signal processing mainly involves operators that conduct time-domain processing,
spectral processing and a mixture of both in some cases. These processing are mainly
done using fixed-point or floating-point number representation which are outside the
scope of this review. However, arithmetic operations are seen through the lenses of ad-
dition and multiplication, which form the basis for all arithmetic operations. The total
number of arithmetic operations in a DSP computation is dependent on the resolution
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of the digital converter used. Minimising complexity without compromising perfor-
mance can be achieved by optimising the resolution of the digital converter. Also,
complexity can be reduced by discarding (or reformulating) all redundant variables (or
parameters) in a computation [203]. Computationally efficient algorithms are those
that scale logarithmically with an increase in a dependent variable.
3.3.2.2 Hardware Resources
Detection algorithms for closed-loop DBS and BMI applications have essentially car-
ried out off-line processing by tethering patients/participants or wirelessly transferring
the data to high-performance computers. Tethering is impractical as it hinders normal
patient activities. And wirelessly transferring data comes with bandwidth and power
restrictions that may not be easily met. Hardware resources are determined by key pa-
rameters like power and area. For low-power implementation, there is a shift towards
the use of microchip technologies that embed signal processing. Recent advancements
in microchip technology have led to the development of detection algorithms for BMI
applications. Several microchip implementations of closed-loop DBS systems using
neural features and incorporating stimulation have been reported for various applica-
tions. Table 3.6 summarises those published between 2014 to date. All the systems
are proof-of-concept implementations using mostly oﬄine processing and were mostly
used for closed-loop DBS control of epileptic seizures [114, 204–208]. From Table 3.6,
it is clear that applications using signals with low spatial scale (and high temporal
resolution) e.g. spikes (unit activity) employ less processing area and power than ap-
plications with much large spatial scale (and low temporal resolution) like ECoG and
EEG. These confirms the view expressed [209], that event-related potentials have been
shown to be more effective in BMI applications compared to spontaneous signals such
as EEG because they do not require large storage requirements and lengthy training
periods. The requirements for chronically implanted microchips are becoming more
and more stringent to avoid neural tissue damage. This makes the need for minimising
power and area in state-of-the-art microprocessors ever more important.
Table 3.6: Closed-loop DBS systems with online recording and stimulation.
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3.3.3 Efficiency and Optimality Measures
This introduces efficiency metrics used in evaluating detection algorithms. In detection
algorithms, efficiency metrics or measures provide information on the trade-off between
resource utilisation and the performance of detection algorithms.
3.3.3.1 Energy Efficiency
Energy efficiency is a metric defined around operations like multiplications, additions
or delays. This is the number of useful operations divided by the energy required to do
them. It is measured in operations/Joules, and it gives the average number of Joules
required for each operation. It is a metric that can be used to assess how optimal an
algorithm is compared to other algorithms performing the same function [211].
3.3.3.2 Energy-Delay Product (EDP)
EDP gives the average energy consumed per switching event. In this context, switching
events are the decisions made by the algorithms. A variation of the EDP is the power-
delay product (PDP), which gives power consumed per switching event. PDP is a
misleading metric compared to EDP because it favours a processor that operates at
lower frequencies [212]. EDP gives the average energy multiplied by the time it takes
to do the computation. Thus, EDP takes performance into account.
3.3.3.3 Area Efficiency
With the increase in lab-on-chip techniques, there is an ever increasing need to minia-
turise platforms for clinical diagnostics. The need for miniaturisation is becoming
inevitable because of the proliferation of chronically implanted devices at very invasive
regions in the body. Miniaturisation ensures that the obstruction of normal internal
and/or metabolic activity is mitigated [211]. Area efficiency is a metric that provides
information on the useful area per operation in a microchip. It is obtained by dividing
the number of operations by the chip area occupied to do those operations.
3.4 To Standardise or to Customise Performance Mea-
sures?
A major hurdle in the deployment of standalone BMI systems are the clinical trial
costs involved in developing such systems. Due to their sensitive nature, medical de-
vices require excessive regulatory oversight; well thought-through deployment strategy;
substantial design and manufacturing cost and most importantly, a rigorous validation
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process. The validation process starts prior to preclinical experiments, because for
clinical translation to field, it is necessary to ensure that devices perform desired func-
tion with high certainty. A major bottleneck in validating algorithms are the choice of
performance measures and metrics.
Accurate selection of appropriate performance metrics are the cornerstone for a bal-
anced, objective and fair evaluation of detection algorithms. Performance evaluation
is essential in BMI; however, it varies from application to application. Due to the
multitude of non-standard performance measures in use for BMI, the performance of
the same algorithm can be interpreted differently. For example, a single algorithm can
have a ‘high’ measure in one metric and a ‘low’ measure in another metric, both of
which intend to measure the same property. Inconsistencies like this further obfuscates
the validation process. This is not far-fetched considering the rise in use of words like
‘high/increased accuracy’, ‘low/reduced delay’, ‘low/reduced complexity’ and so on to
describe BMI performance. Words like these, instead of providing more insights, end
up creating more unanswered questions like; what sort of accuracy or complexity met-
rics were adopted? How do the selected metrics compare to other adopted metrics?
How beneficial are these measures/metrics to the application? How does this system
compare to other current systems that use a different metric? All these questions could
be avoided if standardised measures are used, such that every current work adopts a
standard metric.
Another common issue that reinforces the argument for standardisation, is that per-
formance measures with the same meaning sometimes have different names. A typical
example of this is the classification accuracy sometimes called success rate, mean accu-
racy, non-error rate, probability of success and many more names. This inconsistency
in nomenclature can lead to misinterpreting the metric and discrepancies in reporting
performance. As against the argument for having standardised measures for BMI ap-
plications, customised measures can be created for various applications. Customised
measures using weighted efficacy and complexity measures could be used to more ac-
curately measure application specific efficiency or optimality. Since the efficacy needs
of various applications are dissimilar as highlighted and issues like complexity affect
applications differently depending on the need for chronic or non-chronic implantation;
and how invasive, semi-invasive or non-invasive the implant is. For customising per-
formance metrics, metrics that emphasise more on the current needs and trends of the
industry can be selected. Currently, efficacy is of primary importance as most studies
are proof-of-concept studies. Until BMIs achieve performance levels that allow patients
accomplish routine activities unassisted, efficacy remains the most important require-
ment for BMI systems. Afterwards, focus can then be shifted to other metrics that asses
complexity and efficiency. In spite of the breakthroughs in BMI, there is still a long way
to go before they can find large scale application [213]. As stated earlier, their appli-
cability is highly dependent on ease of use. Similarly, the adoption of different metrics
for evaluating detection algorithms in BMI is dependent on their ease of measurement
and how universal they are. In the rest of the work, performance measures are selected
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based on the research issues addressed by each work. The unavailability of standard
measures for BMI detection algorithms prompted the need for a thorough review and
commentary on performance measures in BMI detection algorithms so that suitably
tailored measures are selected that are fully representative and compatible with set
performance targets.
3.5 Chapter Summary
As stated in Chapter 2, the major challenges of physiological signal analysis are: sens-
ing devices, feedback signals and feedback algorithms. This was what prompted the
focus on this three. For feedback algorithms, a major challenge is the unavailability
of standard measures for evaluating feedback algorithms in closed-loop DBS and BMI
applications. For feedback signals, signals are required that clearly distinguish disease
and non-disease conditions and are consistent across time and patient. For sensing
devices, characteristics like implantability, spatio-temporal resolution and invasiveness
are essential. In the rest of the work, performance measures are selected based on
guidance from this review. Below is a summary of what the chapter covered:
a) BMI are rehabilitation tools in which neural functions are modulated through feed-
back that is triggered by either decoded external percepts or brain activities. These
are respectively representative of the two main categories of BMI. Category one
controls perception to the brain based on external sensory information, while cat-
egory two controls the actuation of a body part or a prosthesis based on recorded
neural activity from the brain, of which closed-loop DBS is an example. The review
focusses on category two BMIs, which are central to closed-loop DBS.
b) To facilitate closed-loop DBS, there are a wide range of neural signals that could be
obtained using various signal acquisition techniques. Neural activity measurements
consisting of metabolic and electrical activity are the preferred choice for use as
feedback signals.
c) Metabolic activity measurements are more selective, specific and quantifiable than
electrical activity measurements. On the other hand, electrical activity has a faster
response than metabolic activity. Of all electrical activity measurements, LFP has
the optimal trade-off in spatio-temporal resolution as well as stability. This makes
it a prime candidate for closed-loop DBS.
d) For optimal performance, detection algorithms in BMI systems are required to have
high efficacy, low complexity and high efficiency. To ascertain this requirements,
the first challenge is to choose which metrics or measures to use as performance
indicators. So far in BMI applications, performance requirements are to an extent
dependent on the type of application. Because a measure that is evidently ‘high’ in
one application may be evidently ‘low’ in some other application. Thus, standard-
ising and customising metrics for evaluating performance remains a big challenge.
Nevertheless, various applications have gravitated towards certain metrics and stan-
dards based on their simplicity and popularity of use in state of the art designs. An
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example of such is the use of classification accuracy. For all its inconsistencies, the
classification accuracy seems to be the most widely used metric for measuring effi-
cacy. This can be attributed to its simple and straightforward nature – even though
it is sometimes misleading. However, for a more accurate assessment of efficacy,
more balanced measures like F1-score, MCC and many more customised metrics
that incorporate one or more reliable efficacy measures could be used.
e) Finally, for BMIs to facilitate unrestricted interaction by patients, the goal re-
mains real-time detection algorithms at the highest achievable accuracy (approach-
ing 100%), and hardware efficient algorithms. However, current research is still
miles away from this mark. The major bottleneck is the great scientific challenge of
understanding how the brain works. Notwithstanding, there seems to be so much
potential in BMI applications. Who knows, BMI applications could take a dramatic




Towards On-Demand Deep Brain
Stimulation Using Online Parkinson’s
Disease Prediction Driven by Dynamic
Detection
4.1 Introduction
Clinical DBS for PD uses continuous, high frequency voltage or current pulses to miti-
gate PD. The major setbacks of present clinical DBS are stimulation induced side effects
and shortening of pacemaker battery life [24], which can be addressed using on-demand
DBS. It regulates stimulation by controlling the stimulation intensity and timing using
feedback signals from the stimulation site [163]. On-demand DBS has the potential
of improving stimulation efficacy, reducing power consumption and reducing side ef-
fects [24]. Several studies have proposed different ways of obtaining minimally invasive
feedback signals for on-demand DBS. Primary focus has been placed on internal, e.g.
LFP, ECoG [24, 163]; and external (e.g. EMG) electrophysiological signals [89]; bio-
chemical signals [214]; and mechanical signals [89]; some of which have shown promising
results. Electrophysiological signals obtained from external measurements are less suit-
able for detecting spontaneous PD activity due to their low correlation with rigidity
and bradykinesia, [38, 215]. The discomfort experienced by patients due to externally
attached sensors may also be an issue. Using biochemical signals, detection may not be
instantaneous and may be hindered by the need for bulky and complex devices in some
cases. Internal electrophysiological signals such as LFP are known to be indicative of
PD symptoms such as rigidity, slowness of movement or tremor [16]. Also, recordings
can be obtained from the same electrodes that are used for stimulation [115], making
them minimally invasive. However, LFP correlations to bradykinesia and rigidity are
functionally different from those of tremor [216]. This reinforces the need to identify
distinguishing features in the data for individual patients. Various studies have mainly
focused on monitoring beta band LFPs only [24, 82, 120]. However, using only beta
band LFPs may not be sufficient, as they have not displayed satisfactory consistency
across time and patients [24,121]. Furthermore, the correlation of gamma [16,122,123],
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and tremor [124] bands with PD symptoms, raises more questions on the suitability
of using beta band activities alone. In essence, triggering DBS using characteristics
from only a single band may be ineffective. Alternatively, to create robust (effective)
feedback algorithms, identifying the most relevant recording channels (in multichannel
recording) and frequency bands can provide a better mapping between LFP recordings
and disease states. Hence, for every patient and at certain intervals of time, the chan-
nels and/or frequency bands that display the most pronounced variation between PD
and non-PD events can be determined and used to detect PD states; this implies using
fewer features, which are dynamically updated. The mapping between the LFP fea-
tures and PD states may not be straightforward, which can cause the selected features
to perform poorly. Detection accuracy can be improved using an additional dynamic
stage consisting of dynamic classifiers. The processing chain is depicted in Figure 4.1.
The implementation of a robust PD detection scheme is necessary because inaccurate
detection results in administering stimulation when it is not required, and this may
lead to stimulation induced side effects [217]. Or, inaccurate detection may result in
the non-administering of stimulation when it is required, which may worsen patient
condition [37].
This chapter examines and evaluates a subset of BMI algorithms suitable for on-chip
implementation of PD detection in real time with high performance and low complexity.
Computationally efficient on-chip (online) PD detection would facilitate the develop-
ment of fully implantable closed-loop DBS systems that could automatically adjust
stimulation parameters by the brain response in real time. The optimum combination
of algorithms in terms of detection accuracy and computational complexity consist-
ing of feature extraction (FE), DR and dynamic classifier algorithms are identified. A
novel DR technique, the MRM is proposed. The algorithms are tested using represen-
tative PD and non-PD datasets to choose the best algorithm combination for real-time
hardware implementation.
The chapter is organized as follows. Section 4.2 details the semi-synthetic LFP genera-
tion method. Section 4.3 describes the methodology for evaluating the algorithms. The
Figure 4.1: Typical bio-signal processing chain of PD state determination during on-demand
DBS. PSD represents Power Spectral Density.
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candidate algorithms for evaluation are described in Section 4.4. Section 4.5 compares
the performance of the examined algorithms in terms of accuracy and complexity. Dis-
cussion and chapter summary are presented in Section 4.6 and Section 4.7 respectively.
4.2 LFP Generation
To evaluate the performance of the algorithms, accurately labelled LFP recordings
for PD patients are needed. Studies have used modelled STN LFP recordings for
controlling DBS [69, 82]. These may be inadequate since LFP recordings have been
reported to be modulated by cognitive, emotional and behavioural tasks [16, 123,218],
which introduce unpredictable variations. Using real physiological recordings produces
better models that incorporate the dynamic variations present in LFP signals. So far,
studies in PD detection have been hindered by the unavailability of standard databases
of Parkinsonian LFP signals that could be used for evaluating algorithms. A possible
solution is to use LFP recordings from PD patients subjected to L-dopa, a common
pharmacological therapy for PD patients, consisting of periods in which patients are
ON and OFF L-dopa. The ON L-dopa periods are periods when L-dopa medication
is effective and is normally accompanied by little or no PD symptoms, while OFF
L-dopa periods are when PD symptoms return, signifying periods of motor deficit
[219, 220]. The test datasets used were LFP recordings from the STN of subjects
exhibiting a combination of bradykinesia and/or rigidity during the onset of PD, with
less noticeable tremor. Recordings were made from nine patients with PD who had
bilaterally implanted DBS electrodes in their STN and are referred to as dataset A –
I. Each patient recording contained separate ON and OFF L-dopa data between 5 to
10 minutes long. The data was obtained from the Department of Clinical Neurology,
University of Oxford. Recordings were made prior to the connection of a subcutaneous
DBS pacemaker and stimulation was completely off during recording. Details on the
daily drug dosage, on and off UPDRS score and dominant symptoms for eight of the
nine patients are summarized in [24]. The permanent quadri-polar macro-electrode
used was model 3389 (Medtronic Neurologic Division, Minneapolis, MN) consisting
of 4 platinum-iridium cylindrical contacts. Its contacts are numbered 0, 1, 2 and 3,
with 0 being the most caudal and 3 being the most cranial for both right and left
electrodes – making a total of eight monopolar channels for each patient. ON and
OFF L-dopa LFP data are referred to as non-PD and PD data respectively. Figure 4.2
shows a snapshot of OFF and ON L-dopa recordings of the left DBS lead for dataset
A. In order to increase the length of recordings which mimic the unpredictable nature
of LFP recordings, semi-synthetic datasets can be modelled using the LFP recordings
from each dataset. There are a number of approaches to achieving this as summarised
below.
4.2.1 Semi-Synthetic Data Generation Techniques
Semi-synthetic data generation provides the flexibility to manipulate the signal charac-
teristics such that all underlying conditions are represented. This enables conclusions
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Figure 4.2: A snapshot of OFF and ON L-dopa recordings of the left DBS lead of dataset A.
that could be extended to an entire population. LFPs are extracellular activities ob-
tained from a localised population of neurons, making it necessary to utilise inherent
statistical properties that maintain the information modelled by individual samples, as
well as segments of the signal. Nevertheless, there are many ways this could be done,
depending on the property to be exploited. Some statistical properties could be ex-
ploited including, Gaussianity and stationarity of the signals. Below are a list of ways
semi-synthetic data can be generated by exploiting statistical properties.
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4.2.1.1 Resampling Based Methods
To use resampling methods for semi-synthetic data generation, the original LFP data is
divided into epochs. The epochs are recycled randomly to create new LFP data which
is representative of the underlying conditions. In statistics, resampling methods are
used for many reasons, notable is their use for validating models. For use in validating
models, the major techniques include random permutation sampling and data recycling
methods like bootstrapping and jackknifing.
1. Random permutation sampling : In random permutation, LFP epochs are ran-
domly ordered and are selected without repetition. Its major shortcomings are
that the set to be selected from is required to be long enough since there are no
repetitions. Also, the quality of its resampling is dependent on the major source
of randomness, that is, its pseudorandom epoch selector.
2. Data recycling : Data recycling involves random sampling of epochs with replace-
ment. The major methods are bootstrapping and jackknifing. In bootstrapping,
data is selected from the same data pool randomly. In contrast to this, the jack-
knifing method deletes a selected number of observations say, N each time data is
selected. A major advantage of data recycling is its simplicity in recreating new
datasets. However, an apparent disadvantage is the possibility of data leakage,
such that the training set leaks into the test data set.
Using resampling-based methods may not be suitable as the signals are not long enough
to be used with random permutation sampling. For data recycling, a major issue is
data leakage, which will provide results that may not be statistically valid.
4.2.1.2 Blind Source Separation (BSS)
For brain signals, the pattern of activity from statistically independent sources that con-
tribute to the parent signal can be obtained using spatial source separation techniques.
Contributions from various spatial sources can be modelled to create semi-synthetic
data sources. This is pertinent because the brain models information in a statistical
way using multi-physiological activity [221]. This consists of linear mixtures of signals
from various statistically independent sources. Blind source separation (BSS) can be
used to recover the sources of a signal. A major BSS technique is the independent
component analysis (ICA). ICA is a method for finding the underlying components in
statistical data. ICA does this by finding components that are statistically independent
and non-gaussian. In most signals, the dominant form of non-gaussianity is sparsity.
Sparsity in signals can manifest in time, frequency or space. Mathematically, ICA can





where sj are the m-independent source signals (s1, s2, .sm) and xi is a discrete point
in the original signal, and aij is the mixing matrix. ICA tries to find approximations
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for the mixing matrix based on assumptions that the various sources are statistically
independent and non-Gaussian. ICA is a classic case of unsupervised learning. A major
shortcoming of ICA is that it gives a number of components and does not provide
sufficient information on the statistical significance of the components (in the case
of neural signal separation, neural sources). Hyvarinen [222] proposed a method by
which to overcome this shortcoming by using inter-subject consistency to assess the
significance of a component. For the original signal to be broken into its component
sources, it has to be non-gaussian and its sources sj have to be statistically independent.
For our original LFP signals, there is a need to investigate if they can be broken
down into their independent components. This is necessary because LFP activities
are activities from a localised population of neurons, and as earlier stated contributions
from various spatial sources can be modelled to create semi-synthetic data sources. The
first step is the visual inspection for non-gaussianity, which is summarised in Figure 4.3.
From Figure 4.3, after detrending and filtering to within 50 Hz, the resulting signals
are Gaussian, as such their independent components cannot be obtained. Thus we can
investigate the use of stationarity to model the underlying conditions.
4.2.1.3 Autoregressive and Moving Average Models
In time series analysis, when successive observations are dependent, future values and
underlying conditions could be predicted from past observations. In neural signals,
due to the various interconnections between localised populations of neurons, there is
a tendency for future neural activity to have some dependency on past observations
(activity). All the hypothesis that model the brain dynamics have alluded to the fact
that it has a non-linear dynamics [50–52]. And like all non-linear systems, the individual
dynamics of its neurons varies from the superposition of the dynamics of the individual
neurons. This makes time series data from the brain stochastic; the more exact models
are called deterministic models. Stochastic processes are statistical phenomenon that
evolves in time according to probabilistic laws [223]. The time series data may appear
to be ‘random’, however, some of this randomness could be explained in terms of
probability models, like the autoregressive (AR) or moving average (MA) models. This
could be done for signals exhibiting stationarity. Stationarity could be strict sense or
weak stationary. For AR, MA and autoregressive moving average (ARMA) processes
the mathematical models that describe these are explained as follows.
Moving Average (MA) Process
In a stochastic process, a moving average process models current observations based
on linear dependency on past values. As an example, a process Xt can be represented
as a moving average process with order q [223],
Xt = µ+ β0Zt + β1Zt−1 + · · ·+ βqZt−q (4.2)
where µ is the mean of the series and Zt−q, Zt−q−1, . . . , Zt are independent white noise
error terms. Also, β0, β1, . . . , βq are the parameters of the model.
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Figure 4.3: Probability distribution of LFP Amplitude for selected channel of dataset A. a)
Channel L0. b) Channel R1. c) Channel L2. d) Channel R3.
Autoregressive (AR) Process
Another representation of stochastic process can be obtained using the AR process. Like
the MA process, current observations are dependent on past observations, however in




αiXt−i + Zt (4.3)
where c is a constant term, Zt represents white noise; α1, . . . , αp are the parameters
of the model. To use for forecasting, it has to be wide sense stationary (WSS). As an
example, an AR(1) process is stationary if | α1 |< 1. In a broader sense, an AR (p)
model is WSS if the roots of its polynomial [223],
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p = 0 (4.4)
lie within a unit circle, that is, all its | zi |< 1. The stationarity test will be discussed
in later sections.
ARMA Process
Since AR processes can be used to represent WSS processes, ARMA models represent
parsimonious alternatives of this representations. An ARMA (p, q) model has AR
process of order p, and a MA process of order q [223]. As an example, an ARMA (1, 1)
can be represented as [223],
Xt − µ = α1(Xt−1 − µ) + Zt + β1Zt−1 (4.5)
where the observations are X1, X2, . . . , XK , with Xt as the current observation and
Xt−1 as the previous observation. With µ as the mean, α1 and β1 are the AR and
MA parameters respectively. While Zt is a purely random process with mean zero and
variance σ2Z .
Stationarity Test
In a broad sense, a time series is stationary if there is no systematic change in mean,
variance, and if there are little or no periodic variations [223]. In essence, the statistical
properties of the various sections of the data are more or less the same. But in the strict
sense, it may be difficult for a time series data to be stationary. Stationarity can only be
associated with a model, as such a stationary time series infers that the time series data
exhibits properties that suggest that a stationary model could be ‘reasonably’ fitted to
the data. A time series is strictly stationary if the joint distribution of X(t1), . . . , X(tk)
is the same as the joint distribution of X(t1 + τ), . . . , X(tk + τ) for all t1, . . . , tk, τ . In
essence, shifting the time series by a translation τ does not affect the joint distribution.
However, for our signal, it is clear that the distribution X(t) cannot be the same for
all t. As such, we can explore the possibility of it being stationary in a less constrained
way. For WSS, the following condition has to be satisfied [223],
E[X(t)] = µ
Cov[X(t), X(t+ τ)] = γ(τ) (4.6)
where E[X(t)] is the expectation (first moment) of the joint distribution X(t).
Cov[X(t), X(t+ τ)] is the covariance (second moment) of X(t) and X(t+ τ). X(t+ τ)
is a time differenced version of X(t). The Dickey-Fuller test can be used to test for
non-stationarity in an autoregressive model, by testing wheather a unit root is present.
However, since our signals are brain signals that have the possibility of having higher
order AR(p) processes, then we will use the Augmented Dickey-Fuller (ADF) test for
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unit root will be appropriate. The presence of a unit root signals non-stationarity,
which could lead to difficulties in statistical inferencing. The ADF test assesses the
null hypothesis of a unit root using the model [223],
yt = c+ δt+ φyt−1 + β1∆yt−1 + ...+ βp∆yt−p + εt (4.7)
where ∆ is the differencing operator, that is ∆yt = yt− yt−1, p is the number of lagged
difference terms and εt is a mean zero innovation process. For the null hypothesis of
a unit root, φ = 1, and under the alternative hypothesis φ < 1. If a test fails to
reject the null hypothesis, then it fails to reject the possibility of a unit root. For
non-stationary signals, without seasonality, an autoregressive integrated moving aver-
age model (ARIMA) can be used. While for seasonal non-stationary data, seasonal
ARIMA models can be used. The original LFP recordings rejected the null hypothesis
of a unit root against the autoregressive alternative. This makes them suitable for
fitting AR processes. In place of AR processes, ARMA processes will be fitted as a sta-
tionary process may be adequately modelled using ARMA models consisting of fewer
parameters than a pure AR or MA process on its own [223]. Thus, ARMA models
would be used to synthesis new LFP recordings. ARMA models have been used in
bio-electrical signals in [224].
4.2.2 LFP Data Synthesis
Table 4.1 summarises the various benefits and shortcomings of the highlighted data
generation techniques. Based on Table 4.1, ARMA models were used to generate
semi-synthetic datasets. Nevertheless, techniques from resampling methods were also
incorporate in the LFP synthesis process. The following sections describe the complete
procedure.




Simple and straightforward. If datasets are not long enough, there
is a tendency for data leakage between
training and test datasets.
BSS Modelling contribution from sta-
tistically independent sources is
essential because the brain mod-
els information in a statistically
sophisticated way using multi-
level physiological activity [221].
Original data has to be non-Gaussian
for ease in separation to its indepen-
dent components. However, most neu-
ral signals are Gaussian [225], making




Takes advantage of probabilistic
models in estimating the proper-
ties of a population from a sam-
ple.
Signals are required to be stationary
or WSS to be used. Nevertheless, for
non-stationary signal, a transformation
could be used stationarise the data.
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4.2.2.1 Estimating Parameters of the ARMA Models
For model fitting, the original LFP signal was low-pass filtered (10th order Butterworth
filter, with cut-off frequency at 50Hz which is in the range of PD relevant LFP [123]),
down-sampled to fs = 128 Hz (from 2048 Hz) and detrended. When dealing with
ARMA models, the first step is to identify the order of AR(p) and MA(q) processes
required, and then estimate the parameters of both processes. In determining the order
of the AR and MA processes, visual inspection of the autocorrelation function (ACF)
and the partial ACF (PACF) are useful. The PACF gives the partial correlation of
a time series with its own lagged values by adjusting for the values of time series at
all shorter lags [226]. As an example, given a time series yt, if α(k) is the partial
autocorrelation at lag k, then γ(k) can be defined as the autocorrelation between yt
and yt+k with the linear dependence of yt on yt+1 through yt+k−1 removed. That is, it
is the autocorrelation between yt and yt+k that does not completely account for lags 1
to k − 1. Mathematically [226],
γ(k) =
{
Cor(yt+1, yt), for k = 1
Cor(yt+k − Pt,k(yt+k), yt − Pt,k(yt)), for ≥ 2
}
(4.8)
where Cor(yt+k, yt) is the autocorrelation between yt and yt+k, Pt,k(yt) is used for
adjusting for the values of time series at all shorter lags and it denotes the projection
of yt onto the space spanned by yt+1, . . . , yt+k−1. The PACF plays an important role
in defining the order of an AR, MA or ARMA models. The ACF of AR processes is
normally a mixture of sinusoidal and damped exponential functions. While that of an
MA(q) process cuts off at lag q. In addition, the PACF of an AR(p) process cuts-off
at lag p. On the order hand, PACF of an MA process will generally die out slowly.
The AR and MA have reverse properties with respect to their ACF and PACF. In
estimating the parameters, an iterative procedure is used. The residual sum of squares
on a suitable grid of AR and MA parameter values are used. The point at which the
curve plateaus, is the point at which additional parameters may be redundant. This
represents the values which give the minimum sum of squares. This can be visualised
using a plot of the residual sum of squares for corresponding values of p and q. This is
termed residual analysis. Mathematically [223],
residual = observation− fitted value (4.9)
In time series modelling, the observation is the original time series, the fitted value is
the one step ahead forecast and the residual is the forecast error. The residuals are
generally random for a model with a good fit. For a good model, more than 95% of
the residual autocorrelations should lie within the range ±2√
K
, where K is the number
of observations. Ideally, the residuals are supposed to have an autocorrelation like that
of white noise, such that there are no significant values present in the correlogram. In
using Figure 4.4 to identify the order of the ARMA (p, q), both the ACF and PACF
decay slowly. This means there is both AR and MA signature. The ACF cuts-off at a
lag of 5, which means it requires an MA with an order of 5 or less. The PACF slowly
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Figure 4.4: ACF and PACF for LFP signal of channel L0 in dataset A. a) ACF b) PACF.
decays, but it is not clear exactly when and where it cuts-off. So, a diagnostics test is
run using BIC and residual analysis to ascertain the optimum order of the AR and MA
processes.
The test determines the AR and MA pairs that give the lowest BIC. Also, the percentage
of residual autocorrelations that are outside the error bound is essential; 5% residual
autocorrelations is representative of residuals of white noise which is what is desired.
As is shown in Figure 4.5, the combination 5% residual autocorrelations is obtained
from ARMA (18, 5) and ARMA (19, 4). The model with the lowest BIC is chosen as it
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Figure 4.5: a) Residual for ARMA(p, q) terms. b) BIC for ARMA(p, q) terms.
represents the most parsimonious model. The differences between the two models are
not fundamental which means both models can be used to fit the dataset.
4.2.2.2 Epoch Segmentation and Concatenation
To create semi-synthetic datasets with PD and non-PD episodes that imitate the pro-
gression of LFP signals in PD, segments of newly created LFP data need to be attached
together to create long recordings. Segmentation is used to fragment continuous record-
ings into a series of epochs with a defined length. In addition to that in this context,
they are used to subdivide the epochs into three regions based on their similarity. This
segmentation aimed to ensure that any three succeeding PD epochs attached to create
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long PD periods were selected from different segments, which introduces a distinctly
different characteristic. Due to the difference in amplitudes between segments of the
original LFP signal, similarity is measured using the normalized cross-correlation be-












where n is an integer, 0 ≤ n ≤ N − 1, and a[n] and b[n] are the two data sequences.
Each epoch consists of 1 second PD or non-PD LFP data. As such, a 300-second LFP
data consists of 300 epochs. So, for the data segmentation, a 300 epoch dataset is
divided into three segments consisting of approximately 100 epochs (templates) per
segment. All epochs in a segment are ensured to be nearly similar such that when syn-
thesising long periods of PD or non-PD data, successively attached epochs are selected
from different segments. This is important because it enables the assessment of the
PD detection algorithms’ robustness to instantaneous changes within the same patient
state. In order to maintain all frequency components present in the original signal and
to avoid introducing unwanted frequencies, successively attached epochs were slightly
overlapped and averaged at the overlapping points [227]. To find the optimum overlap
for successively attached epochs a similarity test was conducted. The test involved the
original time-stamped LFP signal and newly created signals (not synthetic or semi-
synthetic). The newly created signals were of the same length as the original signal
and they were created by randomly attaching epochs to different section while using a
specific number of overlapping samples. After which the normalised cross-correlation at
lag zero of the frequency spectrum of the original signal and that of the newly created
signal were found. Since the maximum value for normalised cross-correlation is one,
the obtained value was subtracted from one to obtain the normalised cross-correlation
error which represents the level of difference between the two signals (original and newly
created). A sweep was conducted for samples covering between 0 to about 20% overlap.
This was done for each channel of each dataset and the average of each dataset is found
as tabulated in Table 4.2. Figure 4.6 shows a plot of the sweep for Dataset G. It can
be seen that the local minima is at 14.0625%, which represents 18 samples overlap for
128 samples epoch. An overlap of 18 samples represents nine samples overlap at the
beginning and end of each epoch. This was the process carried out in computing the
optimum overlap in Table 4.2. From Table 4.2, the median overlap is 10.94% overlap,
which represents 14 samples for a 128 sample/epoch.
4.2.2.3 Poisson Model for PD and non-PD Periods
PD and non-PD events contain point processes whose occurrence can follow a Pois-
son distribution. To create long recordings consisting of alternating PD and non-PD
episodes that imitate the progression of LFP signals in PD; a Poisson distribution was
used to define the duration of the PD and non-PD episodes. This was done to observe
82
4. Towards On-Demand Deep Brain Stimulation Using Online Parkinson’s Disease
Prediction Driven by Dynamic Detection
Table 4.2: Optimum overlap for each dataset




10.94 20.31 1.56 10.94 20.31 1.56 14.06 1.56 1.56
Figure 4.6: Normalised cross-correlation error for Dataset G.
how well the algorithm performed when tested with few and rampant PD episodes
that mimic real-life situations [228, 229]. The duration of LFP signals was synthesised
to imitate the non-linear progression common in PD which consists of three phases –
improvement, stability and acute progressive decline [228]. The phases are defined as:
• PD improvement due to DBS intervention, with a mean PD rate (r) of 10% to
8%. That is, PD occurs 10% of the time (non-PD occurring 90% of the time) and
it later reduces to 8% of the time. This represents a temporary improvement.
• Stability to PD rate (r) of 10%. From PD occurring 8% of the time it later
deteriorates temporarily but stays within 10% for an extended period of time.
• Progressive decline as PD rate (r) increases in steps of 2% up 20% at its most
advanced stage. After stabilising to 10%, it progressively deteriorates and occur-
rence increase gradually to 12%, 14% in steps of 2% up to about 20% at its most
advanced stage. The 2% progression was chosen because motor disability score
for L-dopa patients was reported to deteriorate annually by 2% [229].
The three highlighted stages were fitted within 12 hours duration, with each stage
occurring about one-third of the time. The changes in PD rate (r), were defined over
a 100 seconds (∆t) interval using the Poisson distribution below [230],
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where, r is the mean PD rate, that is the proportion of time in which PD episodes are
present. A PD event is defined to be one second, d is the number of PD events during
∆t and where r∆t is the average duration of PD events in an interval (∆t). Figure
4.7, shows example Poisson distributions for PD duration at each of the three phases of
PD progression. Figure 4.7 (a) shows that of improvement in which proportion of PD
duration reduces by two percentage points. Figure 4.7 (b) shows the stable PD stage
in which PD events more or less occurs 10% of the time. Finally, Figure 4.7 (c) shows
the third stage in which PD deteriorates rapidly until it reaches up to 20% average
occurrence time at its most advanced stages.
4.2.2.4 Using ARMA Models for LFP Data Synthesis
The preceding sections describe the various techniques that are adopted for the LFP
data synthesis process. Below is a brief description and summary of the complete
process. For each channel in each dataset, a suitable ARMA (p, q) model was fitted
to the original LFP signal – for both PD and non-PD data. An ARMA (p, q) model
has autoregressive (AR) process of order p, and a moving-average (MA) process of
order q [223]. For model fitting, the original LFP signal was low-pass filtered (10th
order Butterworth filter, with cut-off frequency at 50Hz which is in the range of PD
relevant LFP [123]), down-sampled to fs = 128 Hz (from 2048 Hz) and detrended.
In selecting the appropriate order and parameters for the AR and MA terms, residual
analysis was used. After fitting the appropriate models for both PD and non-PD data,
longer recordings consisting of PD and non-PD periods are created. The process is
summarized as follows:
1. The PD data is firstly divided into one-second epochs. A 300 second PD recording
thus consists of 300 epochs. These epochs are used as templates for the semi-
synthetic data generation.
2. All the epochs are segmented into three regions based on their similarity – mea-
sured using the normalized cross-correlation between epochs. Thus, a 300 epoch
dataset is divided into three segments consisting of approximately 100 epochs
(templates) per segment. The aim of this segmentation was to ensure that any
three succeeding PD epochs attached to create long PD periods were selected
from different segments, which introduces a distinctly different characteristic.
3. Using the fitted ARMA models, inferred residuals and individual epochs, a num-
ber of possible forecasts can be realised. Using an original epoch, Figure 4.8 shows
forecasts from two possible Monte Carlo paths taken by a semi-synthetic epoch.
For each one second original epoch, 100 Monte Carlo forecasts (with one-second
duration) are made. Thus, for LFP recordings consisting of 300 templates, 30,000
semi-synthetic epochs were created.
4. Steps 1 – 3 are repeated for the non-PD data.
5. To create long recordings consisting of alternating PD and non-PD episodes that
imitate the progression of LFP signals in PD; a Poisson distribution was used to
84
4. Towards On-Demand Deep Brain Stimulation Using Online Parkinson’s Disease
Prediction Driven by Dynamic Detection
Figure 4.7: Poisson distribution for PD duration used for synthesing non-linear progression
in PD. a) PD Improvement. b) PD Stability. c) PD deterioration.
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Figure 4.8: Semi-synthetic LFP generation showing an original epoch and two of its possible
forecasted paths based on Monte Carlo simulations.
define the duration of the PD and non-PD episodes. This was done to observe
how well the algorithm performed when tested with few and rampant PD episodes
that mimic real-life situations [228,229]. The original and newly generated epochs
in steps 1- 4 were used to synthesise 12-hour long LFP recordings.
During LFP synthesis, random permutation sampling was used for epoch selection. To
maintain all frequency components present in the original signal and to avoid introduc-
ing unwanted frequencies, successively attached epochs were slightly overlapped and
averaged at the overlapping points [227]. Figure 4.9 (a) shows a sample of the syn-
thetically generated LFP recordings indicating PD (blue) and non-PD (red) periods.
Figure 4.9 (b) shows the overlapping point averaging procedure. From Figure 4.9(b) it
can be seen that the data overlap and averaging avoids the introduction of unwanted
frequencies. The encircled regions of Figure 4.9 (b) depict this clearly: if concatenated
at circle one without averaging, high-frequency components will be introduced while
concatenating at circle two introduces low-frequency components. The overlapping and
averaging of overlapping points serves as a trade-off to avoid introducing unwanted fre-
quencies. Portions of the synthetic LFP were used to train the system to detect the
patient state for unseen recordings. During FE, in instances where the sliding window
selects segments of LFP data that have nearly equal proportions of non-PD and PD,
are tagged as transition states.
4.3 Evaluation Metrics and Assumptions
4.3.1 Complexity Estimation
Complexity is quantified using a weighted cost of the number of operations (NOP)
and the estimated microchip area. The smallest unit for the NOP is a 1-bit addition.
Subtraction is considered to be equal to addition. Each multiplication or division is
considered to be L-additions, using a quantisation of L bits/sample. Microchip area is
divided into logic and memory area. Adders, subtractors and comparators are assumed
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Figure 4.9: Semi-synthetic LFP generation showing a) Epoch concatenation. b) Averaging at
overlapping point.
to be the same size. Following the procedure in [231] for a 90 nm CMOS process,
each 1-bit adder is estimated to be 20.46µ m2. The size of multipliers and dividers
are assumed L-times the size of adders for L bits/sample quantisation. Memory is
calculated based on the number of registers needed for each computation. A 1-bit
register size was reported to be 15µm2 for a 90 nm CMOS process [231]. By labelling
a combination of PD detection algorithm as a, its complexity cost is CompCosta. The








where NOPa and areaa are respectively the NOP and area for the combination labelled
a. The number of combinations of algorithms is v and max(. . . ) computes the maxi-
mum value of the various combinations. The complexity cost assigns a 50% weight to
both NOP and area. A maximum complexity cost of 1 can be obtained for a combina-
tion concurrently having the largest area and the largest number of operations. Table
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4.3 summarises the various costs used in evaluating the algorithms.
Table 4.3: Metrics for evaluating algorithms.
Error Cost Complexity Cost Combined Cost
F1-score NOP Error Cost
Choice Probability Area Complexity Cost
4.3.2 Detection Accuracy Calculations
The PD detection scheme consisting of feature extraction (FE), dimensionality reduc-
tion (DR) and dynamic pattern classification, were tested in MATLAB. Combinations
consisting of all the three stages in the PD detection scheme were evaluated using the
algorithms in Table 4.4. Each combination was evaluated using the following metrics
which were discussed in Chapter 3.:
1. Classification error.
2. F1-score.
3. Choice probability (CP).
4. And a customised metric, the “Error cost”. Each complexity cost (CompCosta),
has a corresponding error cost (ErrCosta) that is calculated at 10% classification
error and is
ErrCostn =
(1− F1) + (1− CP )
2
(4.13)
A maximum error cost of 1 can be obtained for a combination having an F1-score
of 0 and a CP of 0.
4.3.3 Assumptions
The algorithms evaluated were chosen based on their efficiency in previous BMI and
bio-signal processing applications. The process involved evaluating a subset of FE,
DR and machine learning models used in pattern classification. The detection scheme
uses ON and OFF L-dopa signals as representative data for non-PD and PD cases
respectively. It is also assumed that training occurs only once a day.
Table 4.4: The various algorithms to be evaluated.





DWT MRM Dynamic k-NN
STFT PCA Dynamic LR
NMF Dynamic SVM
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4.4 Algorithms
4.4.1 Feature Extraction (FE)
In order to extract meaningful information, acquired physiological data which is nor-
mally in the time domain, is transformed to a computationally efficient form for further
processing. In applications like PD state detection where power at certain frequencies
can serve as biomarkers that indicate pathological states, time-frequency analysis is
required. Frequency data provides information on where the power is concentrated
for each pathological state, and the time domain data provides the instant they oc-
cur. Short time Fourier transform (STFT) and discrete wavelet transform (DWT) are
examined and compared.
4.4.1.1 Short-Time Fourier Transform (STFT)
STFT uses the fast Fourier Transform (FFT) to obtain time-frequency data. This is
achieved by dividing the signal into windows and FFT is applied to each window [232].
STFT is given by [232],







where x[t+n] is the discrete input signal at t which is the discrete time index, W is the
window length into which the signal is split and f is the discrete frequency index. For
this application, the time-stamped measurements are split into 2 seconds overlapping
epochs, with 50% overlap between epochs. Also, the power bands (features) are divided
into 5 Hz bands, with 3 Hz overlap between bands; 0 to 5 Hz, 3 to 8 Hz, . . . 45 to 50
Hz. This provides a total of 16 features. The window is chosen such that a balance
between time and frequency resolution is obtained.
4.4.1.2 Discrete Wavelet Transform (DWT)
It is a time-frequency representation that uses multi-resolution transformation. Math-
ematically DWT is given by [233],






where x(n) is the input signal, u is the translational parameter representing the time
axis, 2j (j is an integer) is the scale parameter representing the frequency axis and Ψ is
the wavelet function [233]. Based on the scale parameter in Equation 4.15, at each level
(j), it is down-sampled by 2 to the power of that level (2j). For the DWT, a 4-level
decomposition using the Haar wavelet was obtained. The average power at each level
of decomposition consisting of 2 seconds overlapping epochs, with 50% overlap between
epochs are obtained as features. The five features are defined as detail coefficient level
1 (32 - 49.5 Hz), level 2 (16 - 32 Hz), level 3 (8 - 16 Hz), level 4 (4 - 8 Hz) and
approximation coefficient level 4 (0.5 - 4 Hz).
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4.4.2 Dimensionality Reduction (DR)
To increase processing speed and computational efficiency, extracted features are com-
pressed using additional processing termed dimensionality reduction (DR). DR involves
reducing the number of features that will be used for patient state detection. A high
number of features increases the possibility of data over-fitting, which results in a poor
generalisation of unseen data. Also, periodically changing the extracted features used
results in dynamic FE. This work explores linear DR methods, and proposes the use of
maximum ratio method (MRM) (which is eventually chosen for this work).
4.4.2.1 Linear DR Methods
In BMI applications, the most primitive dimensionality reduction technique is feature
selection. Feature selection is implemented by selectively retaining the most relevant
features. Kung and colleagues [63], proposed feature selection in genomic signal pro-
cessing whereby redundant genes were identified to sparsify the feature vectors. In
another study on epilepsy seizure detection using EEG signals, Lee et al. [64], adopted
feature selection by channel reduction. Channel reduction was implemented by man-
ually identifying redundant channels, after which they were eliminated. Apart from
manual DR techniques, to ease computation for on-chip implementation and because
we intend to employ machine learning models for classification, we will be concerned
with linear DR methods. Linear or projective DR methods can be represented by [85],
A = UT ·B (4.16)
where A is the reduced feature vector, B is the original feature vector and U is the
projection matrix. All linear DR methods use the same set-up, nevertheless they differ
on the criteria for choosing the projection matrix (U). The technique used in choosing
the projection matrix determines the algorithms. However, due to the evolving nature of
neural signals, linear DR methods may not be ideal for fully implantable applications.
This is because there is a need to update the projection matrix periodically as the
signal changes. Two linear DR methods are suitable for use with the proposed feature
extraction methods: principal component analysis (PCA) and non-negative matrix
factorisation (NMF).
Principal Component Analysis (PCA)
In PCA, the orthogonal basis (or principal components) that indicates the principal
directions in which data varies is calculated [85]. In Equation 4.17, high dimension
features X can be reduced to low dimension features A,
A = PCTi ·B (4.17)
where B Rm×n consists of the training examples, m is the number of training features
and n is the feature vector dimensions. Additionally, PC  Rn×n contains the coeffi-
cients of all principal components, PCi Rn×i contains the coefficients of the principal
component up to the i-th principal component, making i the reduced feature vector
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dimension and Z Ri×m consists of the new training features with reduced dimensions.
Non-negative Matrix Factorisation (NMF)
Since the features are extracted (power features) at the FE stage are all non-negative,
NMF will be ideally suited for DR. It is similar to PCA in that it assigns weights to a
set of bases to blend a representative observation. However, unlike PCA, all its weights
are constrained to be positive. Where PCA gives negative weights, it gives zero weights,
and this produces a sparse representation of the data assuming it has an underlying
structure [234]. NMF can be represented by [234],
A ·H = B (4.18)
where A  Rm×i is the reduced feature vector, B  Rm×n is the original feature vector.
The matrix A  Rm×i and H  Ri×n are two smaller matrices which when multiplied
approximately reconstruct B  Rm×n.
Preliminary Analysis of Linear DR Methods
To conduct a thorough analysis, preliminary analysis may need to be conducted such
that one of the projective DR methods (PCA or NMF) is dropped. Using both al-
gorithms increases the possible combination of detection algorithms consisting of FE,
DR and classification. Since both methods project unto a subspace, their performance
will be assessed based on their ability to retain the existing variations in the signals
even after projection. The metric that will be used to assess this is the projection (or
reconstruction) error, which was represented in Chapter 3.
The projection error for various features on each channel of each dataset was found.
The average projection error was computed and is represented in Figure 4.10 (a) using
DWT and Figure 4.10 (b) using STFT for feature extraction. From Figure 4.10 (a),
it can be seen that the NMF has less reconstruction error compared to the PCA when
one or two features are used, while the PCA does better when three or four features
(zoomed portion) are used. The performance for the DWT does not provide conclusive
evidence on the superiority of the two methods for use on the dataset. However, Figure
4.10 (b) presents a more consistent performance for the PCA compared to the NMF.
Even though the NMF does better for features less than five, however, the PCA has
a gradual increase in performance compared to the NMF. It is clear from Figure 4.10
(b) that the NMF has more variations in terms of projection error. This makes PCA a
more trusted DR technique that is resistant to noisy data. Based on this preliminary
analysis, the PCA will be adopted.
In addition to feature dimension reduction, the PCA will be used for channel selection
since there are eight recording channels and only activity from a single channel may
be necessary to enable classification. This is necessary because PD tracking using
recordings from all channels may introduce redundancy as recordings from various
channels might provide nearly similar information, as can be seen in the spectrum of
the channels in Figure 4.11 which have nearly similar characteristics. On the other
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hand, randomly selecting any one of the channels for FE can be counterproductive, as
the channel with the least variation between PD and non-PD clusters may be selected.
Figure 4.10: DR projection error using: a) DWT for FE. b) STFT for FE.
Figure 4.11: The power spectrum (for PD dataset) of some of the channels in dataset C,
shown having nearly similar characteristics. L or R for left or right electrodes
respectively, which are numbered from 0 to 3 (caudal to cranial contacts).
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This necessitates the use of a methodical approach for channel and feature selection.
For PCA, the channel with the least two-dimensional projection error is selected for
use.
4.4.2.2 Maximum Ratio Method
Drawing upon the principles of Fisher separability criterion, the properties below are
necessary to select features that produce the best separation in binary classification [85]:
• Features must be oriented such that they maximise the Euclidean distance be-
tween class means in the feature space. That is, maximising interclass distance
is important for separability.
• Also, they must contain few outliers such that their within class variance in the
feature space is minimised. That is, minimising intra-class distance is important
for separability.
Unlike linear DR methods, the novel MRM is a DR method that uses labelled samples
during training. It takes advantage of Fisher’s criterion for separability. Since there
is no need to quantify feature and channel separability in absolute terms, the MRM
method finds a simple mathematical method for ranking the features and channels in
terms of separability. The approach is targeted for hardware-aware implementations
for DR. The process of MRM starts by identifying the channel having features with the
most pronounced variation in activity. The goal is to obtain the feature space depicted
in Figure 4.12 which makes classification easier. Figure 4.12 gives the most desired
orientation for the clusters. The following section provides an analysis of the MRM
and then details the implementation.
Analysis
The above properties as highlighted by Fisher [85], are essential for classification be-
cause the between class distance represents how separable PD events are from non-PD
events; while the within class variance represents how clustered PD and non-PD features
are. These two properties are vital in making classification easier. Given a vector of
training examples O = [o1, o2, . . . , oD]
T having a total of D observations, with each ob-
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This means O is a D×n matrix, where each observation oi is an n-dimensional vector.
If each of the observations belongs to one of classes in, C = [C0, C1, . . . , Ck] with each
class having a total number observations D0, D1, . . . , Dk respectively (where total ob-
servations D = D0 +D1 +D2 · · ·+Dk) . The mean µi and variance σ2i for class Ci can
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Figure 4.12: Two-dimensional depiction of the desired orientation for the clusters (PD and
non-PD) to create the largest variation using two features (f1, f2). (a) Scenario
1: feature space formed when one of the clusters (Non-PD in this case) has
much higher f1 values, and the other cluster (PD in this case) has much higher
f2 values. (b) Scenario 2: feature space formed when one of the clusters (PD in
this case) has much higher values for both f1 and f2.
The Fisher’s separability criterion, is inspired by the idea that separability is improved
when the spatial distribution of observations from differing classes is high, while the
spatial distribution of observations from the same class is low. That is, the criterion
attempts to maximise the Euclidean distance between classes. To avoid features with a
wider range to dominate those with a smaller range, such that each feature contributes
approximately proportionately to its distance, the Euclidean distance is normalised
by the variances for each feature [235]. For binary classification, we would like to
maximise the ratio between the interclass distance (SD) and intra-class variance (SV )
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i ]. Maximising separability translates to improved classifiability
of the data. For binary classes the Fisher criterion J(SD, SV ) for the n-dimensional
features can be represented as,
J(SD, SV ) = max[
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where µ1 and µ2 are the mean values for the feature vectors in class one and two (since
it is a binary classification problem). The respective variances for classes with mean µ1




2. The features that maximise J(SD, SV ) represent the











Since the original LFP signals are Gaussian in nature, with mean values around zero
in various frequency bands; and the power characteristics of LFP signals in different
bands are used as features, the mean values are proportional to the standard deviations
as represented by Equation 4.24 and depicted in Figure 4.13 which represents a 2-D
feature space of dataset B obtained using MRM.
µi ∝ σi (4.24)
where µi is the mean for class Ci, σi is standard deviation. From Figure 4.13, it can be
seen that the means (µ1and µ2) are approximately three times the standard deviations
Figure 4.13: Feature space depicting mean and standard deviation of clusters for Dataset B.
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(σ1 and σ2). For the objective function in Equation 4.22, rescales the Euclidean distance
using the class variances such that feature separability is assessed relative to feature
variance rather than the absolute Euclidean distance. In machine learning, there are
different methods of feature scaling, it could be done using the or variances, as well as
the mean value of the feature [235]. In our case in Figure 4.13 is can be seen that the
standard deviation (and variance) for each feature is proportional to the means of the
two classes. Instead of using the variance to rescale in Equation 4.22, the means of one




2 ) can be used to rescale the Euclidean norm in Equation
4.22. Assuming µ
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2 is used to rescale the euclidean
norm, for the i-th feature, then Equation 4.22 is transformed to,
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Equation 4.26 represents the MRM which can be used to obtain an approximate of rank-
ing the n-dimensional features from the most separable to the least separable. Ranking
the features in terms of separability is necessary because using the most separable
features for classification makes classification more accurate and less computationally
intensive. The ranking can be represented more visually by Figure 4.14. In Figure 4.14,
a sweep is conducted for the x-axis values in Figure 4.13, that is, µ1(f1) ranging from
µ1x − σ1x → µ1x + σ1x and for µ2(f1) for values between µ2x − σ2x → µ2x + σ2x.
Figure 4.13 above, then Figure 4.14 represents the plot of the cost function obtained
using Fisher’s separability criterion and MRM. It can be seen that the MRM and Fisher
separability criterion have nearly similar patterns for the cost function for corresponding
values of µ1(f1) and µ2(f2). The MRM approximates to the Fisher criterion in ranking
features. Even though the exact values of the cost function are different. However, since
features are ranked and arranged in relative terms, the absolute values in terms of the
cost function may not necessary be the same, but it is important that the ranking are
the same as shown by the surface plot in Figure 4.14. By taking advantage of the
characteristic of our features (i.e., class means are proportional to class variances), the
MRM estimates the feature ranks in terms of separability for the various features.
Aside from feature selection, the MRM can be used for channel selection. Based on the
value of the separability cost function of the features for different channels, a weighted
metric is used to assess separability for various channels. Channels are assessed based
on a weighted separability cost function, with higher weights provided to the features
with the highest ranks for each channel. The cumulative weights for each channel are
used to assess separability by channel. The complete implementation for the MRM is
summarised in the next section.
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Figure 4.14: Cost function obtained using Fisher criterion and MRM for feature (f1) in Figure
4.13.
Implementation
Unlike PCA, the novel MRM is a DR method that uses labelled samples during training.
The process of MRM starts by identifying the channel having features with the most
pronounced variation in activity. The goal is to obtain the feature space depicted in
Figure 4.12 which makes classification easier. The MRM is a computationally simple
method. Using example values, the steps are described in Figure 4.15 and are outlined
below:
1. LFP recordings from each monopolar channel are split into M training epochs
with an equal number of PD and non-PD training examples. In Figure 4.15,
M = 128 results in 64 epochs for both PD and non-PD.
2. Each epoch is divided into N -bands (features). For each feature, the sum of that
feature for all training examples for both PD and non-PD cases are obtained. In
Figure 4.15, N = 5 is selected with the power in each of the five bands for both
PD and non-PD training examples shown.
3. For the summed features (calculated in step 2), the ratio of correspondingly in-
dexed features for PD and non-PD are calculated. The smaller of the two is made
the divisor. The division is indicated in red in Figure 4.15 with the obtained result
shown in step 3 of Figure 4.15.
4. The ratios are arranged in descending order. This order shows the relative vari-
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Figure 4.15: Detailing the MRM. This shows a situation where the channel and feature se-
lection for MRM uses only the two prominent features in ranking the channels.
ation for each feature between PD and non-PD for the training examples – from
the largest to the smallest.
5. The maximum ratio is multiplied by 4 and the second maximum ratio is multiplied
by 2 and the rest are unchanged. If k-features are used for classification, the
weighted sum of the first k-features gives the channel weight. In Figure 4.15, if
weights based on two features are required, step 5 shows the channel weight in
red which is 38. The channel weight gives a low computation approximation of
the channel with the largest Euclidean norm between PD and non-PD clusters for
the selected features. The approximate Euclidean norm rank is obtained using a
modified version of [236].
6. Steps 1 to 5 are repeated for the rest of the channels. The channel with the largest
weight is selected and recordings from that channel are used for classification until
another training phase, after which the new highest ranked channel is adopted.
Using the values in step 6 of Figure 4.15, the channel with the maximum weight
is selected, which is channel #0 with a weight of 38.
4.4.3 Dynamic Pattern Classification
Dynamic classification uses a modified version of traditional pattern classifiers to ac-
curately track the non-linearities in the extracted features. The classifiers must not be
so simple that they are unable to distinguish between classes, yet not so complex as to
over-fit the training data [85]. The best classifier will be selected based on a trade-off
between computational complexity and performance. The dynamic pattern classifier
steps through three orders of the traditional pattern classifiers to be evaluated. The
first order classifier is used if it achieves a classification accuracy greater than 90% on
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validation data, else a higher order classifier is invoked until the criteria is satisfied. If
the criteria is not satisfied, the best performing classifier of the three is used. Below is
a brief description of the evaluated pattern classifiers.
4.4.3.1 Dynamic k-Nearest Neighbour (k-NN)
k-NN uses a non-parametric method for classification. Amongst the various classes to
distinguish between, it uses the predominant k closest samples in the feature space in
classifying unlabeled points, where k is a natural number [10]. The function fkNN (λ)





where λ is the test case, Υn are the labels for the closest training datasets, Nk(λ) is
the index of k-nearest neighbours of λ in the training set. Generally, k-NN does not
require the normal iterative learning phase necessary in order to fit the training data
to a classification model. The dynamic k-NN steps through 3-NN, 5-NN and 7-NN in
that order. Odd nearest neighbours are employed for the dynamic classifier because
there are two classes and simple majority voting is required.
4.4.3.2 Dynamic Logistic Regression (LR)
LR uses probability of class membership for predicting a test case. Considering a binary
classification problem, with class membership Υ {0, 1} , 1 for PD cases and 0 for non-
PD cases, λ(i) the extracted features for test case i, with a corresponding label Υ(i).






which produces an fLR(λ) between 0 and 1, in order to predict the binary states. θ
is a vector of threshold and weight parameters that is specific to a dataset. Using the




1 if fLR(λ) ≥ 0.5
0 if fLR(λ) < 0.5
}
(4.29)
where true PD detection is signified as 1, and false PD detection as 0. The polynomial
order of the function θTλ determines the type of LR. For the dynamic LR, it steps
through a linear function, third order and fifth order classifiers in that order. Functions
having only odd degree polynomials are tested since the exponential parameter in the
logistic function fLR(λ) in Equation 4.28, needs to be raised to a negative power.
4.4.3.3 Dynamic Support Vector Machine (SVM)
SVM uses the widest margin between differing states to discriminate. In Equation 4.30,
the discriminating function fSVM (λ), used in classifying test cases is obtained using
the training examples as [238],
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ΥiρiK(λi, λ) + ω (4.30)
where λi are the support vectors and their labels Υi, λ is the test case, K(λi, λ) is the
kernel transformation, ρi is a weight vector and ω represents the classification threshold.
To handle the complex nature of physiological signals, the decision function can be
transformed for use with different kernels, notably the linear kernel, polynomial kernel
and the radial basis function (RBF). This can be achieved by replacing the K(λi, λ)
in the kernel transformation, with the appropriate kernel function. For dynamic SVM
classification, a linear kernel, quadratic kernel and RBF are used in that order.
4.5 Results
The results were tested in MATLAB on the described LFP test datasets.
4.5.1 Feature Space
A visualization of the feature space formed by the two features selected using MRM
for dataset C is shown in Figure 4.16. The STFT shows a clearer separation (for PD,
Trans and non-PD training examples) compared to the DWT, due to the use of a
reduced frequency band by the STFT. A reduced band provides better confinement
of the relevant frequencies and reduces sensitivity to outliers. The two methods are
compared to identify the optimum performance in terms of detection accuracy and
complexity. Generally, STFT is ideal for capturing sinusoidal features, and the DWT
is ideal for detecting non-continuous frequencies. This was concluded in [233] using the
Haar wavelet.
For toolbox based analysis of DWT (such as FieldTrip and EEGlab), Morlet wavelets
are used. For toolbox based STFT, spectral smoothing is introduced using multi-
Figure 4.16: Feature space formed using MRM for the two prominent features of the selected
channel of dataset C using: (a) DWT (32 - 49.5 Hz band power and 16 - 32 Hz
band power) (b) STFT (21-26 Hz band power and 18- 23 Hz band power). LFP
epochs at transition points (consisting of PD and non-PD of equal length) are
labelled “Trans”.
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tapering. However, time-frequency analysis in this work was guided by considerations
for hardware implementation, which are not fundamental for toolbox based analysis.
For hardware implementation, the possible improvement in accuracy due to spectral
smoothing, is not commensurate with the computational cost incurred. As demon-
strated in Section 4.5.2 on accuracy, all the examined combinations achieve less than
10% classification error even without spectral smoothing. Both DWT (Haar wavelet)
and STFT (without multi-tapering) have been shown as suitable in hardware-aware
implementations for time-frequency analysis [211].
4.5.2 Accuracy and Complexity Measures
Various measures such as choice probabilities, classification error and F1-score were
used in order to evaluate the detection methods. In each case the average result from
100 runs of Monte Carlo analysis was found to obtain the general trend.
4.5.2.1 Optimum Parameters
For the classification error averaged over all datasets, the goal was to obtain the min-
imum parameters (minimum number of features, minimum level of quantisation and
minimum training examples) that resulted in 90% classification accuracy (10% classi-
fication error), to compute the complexity of each combination. Figure 4.17 presents
the effect of varying the features used in classification. In Figure 4.17(a), the results
for the combinations that use DWT for feature extraction are presented; the k-NN
based algorithms (combinations) present the best performance, having a classification
accuracy greater than 90% irrespective of the number of features used for classifica-
tion. The second best performance was obtained by the SVM based classifiers, with the
DWT-MRM-SVM having a superior performance compared to the DWT-PCA-SVM,
even though both require at least two features to attain the 90% accuracy mark. The
LR based algorithms behave in a similar way as the SVM based algorithms; however,
they have a more gradual slope. In Figure 4.17(b), the combinations using STFT for
feature extraction have nearly identical characteristics as those using DWT for feature
extraction. That is, the k-NN based classifiers have the best performance, followed by
the SVM based classifiers and then the LR-based classifiers. Like the DWT algorithms
in Figure 4.17(a), the STFT algorithms in Figure 4.17(b) achieve an accuracy of 90%
with two or less features.
With respect to the minimum training examples, Figure 4.18 presents the performance
of the classifiers. For a classification accuracy of 90%, the SVM based algorithms require
few training examples compared to the LR and k-NN based algorithms. In all three
cases of Figure 4.18, algorithms using MRM for dimensionality reduction require many
fewer training examples compared to their PCA counterparts. Another notable charac-
teristic is that the combinations using STFT require fewer training examples compared
to those using DWT. This may be attributable to the narrower frequency bands used
in STFT, which makes it easier to discern patterns with few training examples – wider
frequency bands like in DWT may be more susceptible to noise.
However, in Figure 4.19 which summarises the required quantization for the various
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Figure 4.17: Effect of feature vector dimension on classification error using: (a) DWT (b)
STFT. The plots with the dashed lines are those using PCA for DR, while those
without dashes use MRM for DR. The goal is to determine the minimum number
of features that achieve a classification accuracy of 90% (10% classification error).
algorithms The PCA requires fewer quantization bits than the MRM based algorithms.
The PCA based algorithm requires fewer quantisation levels possibly because of the
need for less detail in the number representation after PCA transformation. Training
examples are less packed together after PCA transformation because PCA transforms
features to a new feature space with a higher variance. The need for less detail after
PCA transformation enables the use of fewer quantisation levels.
4.5.2.2 Compexity Measures
The minimum parameters needed to achieve a classification accuracy of 90% for the rest
of the algorithms is summarised in Table 4.5. It can be seen that the k-NN and LR based
algorithms have a higher median number of training examples, compared to the SVM.
This is because the k-NN and LR are population dependent algorithms that extrapolate
properties more accurately when larger training sets are used. In Table 4.5, it can be
seen that 7 combinations require only one feature to achieve 90% classification accuracy.
Regarding the quantisation, the median is 6 bits resolution. Table 4.5 also summarises
the parameters that achieve 90% classification accuracy if all features are used for
dynamic detection. From Table 4.5, when the maximum number of features are used,
the required training examples and quantisation needed to achieve 90% classification
accuracy are reduced. However, for the STFT-MRM combinations (STFT-MRM-KNN,
STFT-MRM-KNN and STFT-MRM-SVM) using all features presents a lower NOP
for 90% classification accuracy compared to its low feature alternative. This may be
because computing STFT and extracting power from a single band (single feature)
requires slightly less computation than extracting power from all the allocated bands
(16 in this case). However, the extra computation incurred is offset by the fewer
training examples and quantisation levels required when all the bands (features) are
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Figure 4.18: Optimum values of training examples to achieve 90% classification accuracy for
classification using: (a) k-NN (b) LR (c) SVM.
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Figure 4.19: Optimum quantisation (bits) to achieve 90% classification accuracy for classifi-
cation using: (a) k-NN (b) LR (c) SVM..
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The training NOP is divided by 86400 because it is assumed that training occurs once
in a day (86,400 seconds), and the patient state is updated every second during normal
operation.

















1 7 58 0.26 0.84
5 5 14 0.61 1.48
DWT-PCA-
KNN
1 6 110 0.24 0.81
STFT-MRM-
KNN
1 8 24 0.90 2.12
16 4 22 0.36 1.15
STFT-PCA-
KNN
1 6 58 0.56 1.40
DWT-MRM-
LR
2 5 16 0.24 1.05
5 8 8 1.51 3.98
DWT-PCA-
LR
2 6 236 0.39 1.84
STFT-MRM-
LR
1 8 28 0.89 2.70
16 4 20 0.31 1.26
STFT-PCA-
LR
2 6 102 0.56 1.96
DWT-MRM-
SVM
2 5 14 0.24 1.05
5 4 8 0.39 1.25
DWT-PCA-
SVM
2 6 30 0.37 1.45
STFT-MRM-
SVM
1 8 26 0.89 2.70
16 4 8 0.29 1.11
STFT-PCA-
SVM
1 6 170 0.57 1.94
4.5.2.3 Choice Probability and F1-score
Using the optimum combination for quantization, features and training examples that
achieved 90% classification accuracy (as summarised in Table 4.5), Figure 4.20 presents
the performance of the algorithms in terms of their F1-score and choice probability. For
the classifiers, it is clear that the k-NN based algorithms present the best performance
(having the least error cost), followed by the SVM-based and then the LR-based. The
STFT-MRM-KNN has the least error cost of 0.0075 [Figure 4.20 (b)], while the STFT-
PCA-SVM has the maximum error cost with 0.0778 [Figure 4.20 (d)].
4.5.3 Combined Cost
The combined cost represents the cost incurred by a given combination. This is sum-
marised in Table 4.6. Figure 4.21 shows a plot of the normalised error cost versus
the normalised complexity cost. An ideal detection algorithm is required to have a
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Figure 4.20: Plot of choice probability and F1-score (SMRM is STFT-MRM, DMRM is DWT-
MRM, SPCA is STFT-PCA and DPCA is DWT-PCA). (a) The plot of choice
probability and F1-score for different combination of algorithms; (b) Plot of
error cost for algorithms using k-NN for classification; (c) Plot of error cost for
algorithms using LR for classification; (d) Plot of error cost for algorithms using
SVM classification..
combined cost at the origin of Figure 4.21. The error cost is obtained at 10% clas-
sification error and consists of costs resulting from a low average choice probability,
and a low average F1-score. The choice probability is included because it shows how
well a detector ranks PD cases compared to non-PD cases. The F1-score is included
because it shows how good the precision and sensitivity of the detector is. These two
factors are not apparent when only classification error is used in assessing the error
cost of a detector. They are added to ensure that the error cost is robust enough to
cover all accuracy measures. For the complexity cost, the NOP and estimated area are
used as the measures. In Figure 4.21, the detector with the low costs are indicated by
blue markers, and are the DWT-MRM-KNN, DWT-MRM-SVM and DWT-PCA-KNN.
There are six medium cost detectors indicated by green markers. The high cost detec-
tors are indicated by red markers and are the STFT-PCA-SVM, DWT-PCA-LR and
STFT-PCA-LR. The algorithms using DWT for feature extraction, are mainly closer to
the origin. Hence the DWT based algorithms have the optimal trade-off between com-
plexity and accuracy. For dimensionality reduction, the MRM based algorithms have
the lowest cost while for classification the k-NN based algorithms have the lowest cost.
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Table 4.6: Summarising the error and complexity costs of different combination of algorithms.













Figure 4.21: The combined cost for different combinations of algorithms. Both axes are nor-
malized such that the maximum cost in each case is equal to 1.
Thus, the combination closest to the origin is the DWT-MRM-KNN, which represents
the optimal trade-off between accuracy and complexity; while the worst performing
algorithm is the STFT-PCA- SVM.
4.6 Discussion
4.6.1 Semi-Synthetic Datasets
Semi-synthetic data was generated by taking advantage of statistical properties in the
data to fit ARMA models. Moreover, for every single epoch, a range of Monte Carlo
forecasts were simulated based on the underlying variations. To the best of our knowl-
edge, there is no literature on semi-synthetic LFP data generation using real-life record-
ings. However, for other signals such as spikes and ECG, there is extensive literature.
107
4. Towards On-Demand Deep Brain Stimulation Using Online Parkinson’s Disease
Prediction Driven by Dynamic Detection
Using statistical parameters like the ones used in defining spike [239] or ECG [240]
activity could be misleading; because they have a unique morphology which can be
varied using simple measures, such as the amplitude or shape. On the other hand,
LFPs result from the activity of a localised population of sources; hence using statistics
that are not population-based corrupts and destroys the signal fidelity. In this chapter
some properties were exploited, among which are:
1. Statistical Similarity : To measure the sensitivity of the algorithms to all forms
of PD and non-PD variations, it was ensured that statistically dissimilar epochs
(measured using the normalised cross-correlation) were attached together during
periods of long PD or long non-PD synthesis. This introduced some randomness
by attaching epochs with varying similarity, which enabled the assessment of the
algorithms’ robustness to instantaneous changes within the same patient state.
2. Dispersion and Random Permutation Sampling : Dispersion was introduced us-
ing ARMA models to forecast a range of Monte Carlo variants for each epoch.
This was to create a large diversity pool that overcomes sampling bias (since
sampling bias can lead to poor generalizability). Epoch selection using random
permutation sampling was applied to avoid data leakage which can cause over
generalizability.
3. Poisson Distribution Defined PD and non-PD Duration: Signal length was de-
fined using a Poisson distribution to make PD and non-PD episodes pseudo-
random. This ensured that a “randomly guessing” algorithm that changes state
prediction based on a predefined pattern is flagged because of the pseudo-random
PD and non-PD periods.
4.6.2 Spectral Bands and Maximum Ratio Method
In the normalized autospectra shown in Figure 4.22 the largest variation between the
PD and non-PD autospectra is between 10−25 Hz, which mostly lies in the beta band;
13−30 Hz. The gamma band (> 30 Hz) shows little relative activity. However, in Table
4.7 where the two frequency bands with the most activity for each of the nine datasets
are summarised, it can be seen that the gamma band is not strictly without activity.
Datasets A, F and G have their most pronounced variation in the gamma bands (level
1 detail coefficients) when DWT is used for feature extraction. While using STFT,
it was only visible for dataset G. The little activity in gamma bands is corroborated
by [122], in which there are occasions where there is little activity, while at other times
they have the most pronounced activity.
The frequency bands for the STFT and DWT in Table 4.7 appear to be unexpectedly
different. This is due to different sized frequency bands. For instance, in the dataset
for patient D, the 0.5− 5 Hz band presents the most pronounced variation for STFT,
while the 4 − 8 Hz band provides the most variation for DWT. This shows that most
of the power is within the 4 − 5 Hz band, giving rise to the dominance of the bands
containing these frequencies. The difference between the STFT and DWT in other cases
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Figure 4.22: Average normalized autospectra for all the datasets. The PD and non-PD plots
are normalized such that the total autospectra sum in each case is equal to 1.















A 6-11 9-14 32-49.5 4-8
B 12-17 15-20 16-32 8-16
C 21-26 18-23 32-49.5 16-32
D 0.5-5 6-11 4-8 8-16
E 12-17 15-20 8-16 16-32
F 18-23 15-20 32-49.5 16-32
G 45-49.5 42-47 32-49.5 16-32
H 36-41 33-38 0.5-4 4-8
I 18-23 21-26 16-32 32-49.5
can be explained because the most pronounced variation is dependent on the relative
power between PD and non-PD. That is, there are cases in which a PD band can
have the greatest absolute activity compared to other PD bands. But when compared
to its corresponding non-PD band, it may not have the most pronounced variation.
This was the case for datasets A and H. As a result of the varying frequency spread
present, particularly in the DWT, only the activity of the much lower bands of the
DWT should be expected to show some semblance in behaviour to the STFT. These
are the cases where the frequency spread is quite close and at the higher frequencies,
they cannot be compared because a single DWT band covers more than five STFT
bands. In Figure 4.23 , it is shown that the MRM algorithm can detect the bands with
the most pronounced variation even though the training examples are a small fraction
of the entire population. In Figure 4.23 (a), it accurately detects the band with the
most pronounced variation for all 100 runs while in Figure 4.23 (b) it accurately detects
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Figure 4.23: Shows the mean plot of how the MRM algorithm ranks the frequency bands
using: (a) DWT for feature extraction (b) STFT for feature extraction. The
rank is from the band with the most pronounced variation (ranked 1) to the
least pronounced (ranked 5 for DWT and 16 for STFT).
the three prominent bands for all runs. Most of the average ranks approximate to the
real rank showing that most of the time, it ranks the bands in their right order. This
demonstrates that the training examples used have enough diversity present in the
entire signal. The MRM algorithm also assists in channel selection by approximately
determining the channel with the largest Euclidean norm between PD and non-PD
clusters. Hence, instead of using all eight monopolar channels for detection, only the
channel with the most pronounced variation is selected. This makes classification less
computationally intensive.
4.6.3 Dynamic Detection
The dynamic schemes are used to obtain a classifier that is compatible with the dynamic
FE and at the same time achieves the right balance between complexity and classifi-
cation accuracy. The dynamic classifier operates in two phases – concurrent detection
and training, and detection only. Compatibility between dynamic FE and dynamic
pattern classification is determined periodically during the concurrent detection and
training phase. The dynamic detection operates in real-time since both phases involve
detection. Determining compatibility is necessary because high order classifiers may
sometimes provide inferior performance compared to low order classifiers, making the
use of high order classifiers redundant. A classic example of this is shown in Figure
4.24(a), which uses the STFT-MRM-KNN algorithm. Apart from the region where
few features (one to four features) are used in which there is a struggle for dominance,
the 3-NN completely dominates when five or more features are used. Thus, making
the higher order classifiers (5-NN and 7-NN) redundant. Nevertheless, the benefits of
dynamic detection are obvious since a mean reduction of 0.019% in classification error
is obtained between the dynamic classifier and the 3-NN. This is because different ker-
nels are selected for different datasets (A–I). In the long term, these slight differences
of 0.019% between the dynamic classifier and the best performing static classifier can
cumulatively lead to more beneficial effects in therapy since there is a higher likelihood
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Figure 4.24: Comparison of the classification error for static and dynamic detection schemes:
(a) using the STFT-MRM-KNN detector; (b) using the STFT-MRM-SVM de-
tector.
of detection. Conversely, in Figure 4.24(b), which depicts the result for the STFT-
MRM-SVM algorithm, there are two regimes of operation: when eight features or less
are used for classification, the RBF, which is the highest order kernel dominates. On
the other hand, when more than eight features are used the lower order poly kernel
dominates, similar to Figure 4.24(a). This shows that dynamic detection takes advan-
tage of the best operating regimes of various kernels to produce performance superior
to those of static classifiers as is shown in Figure 4.24. As a result, the three different
classifiers in the dynamic scheme are complementary.
4.7 Chapter Summary
The major contributions presented in this chapter are:
a) We presented dynamic detection as a way to overcome the unpredictable nature of
PD pathophysiology.
b) It was demonstrated that the change in power characteristics of LFP signals, can
be tracked using a combination of algorithms consisting of FE, DR and dynamic
pattern classification.
c) For hardware efficient implementation of dynamic PD detection, a subset of algo-
rithms consisting of the aforementioned stages were evaluated based on customised
performance metrics. The metrics were chosen to reflect detection accuracy and
computational complexity trade-offs.
d) The combination with the the best trade-off between computational complexity and
detection accuracy, consisted of DWT for feature extraction, MRM for DR and
dynamic k-NN for classification. The results presented show that on-chip (online)
PD detection is possible.
e) To enable a fair and balanced evaluation of the algorithms, semi-synthetic LFP
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datasets were generated from real LFP recordings. Also, the paucity of validation
datasets also motivated the semi-synthetic data generation. Semi-synthetic LFP
generation was achieved using statistical properties of the original LFP signals. For
example, time series forecasting using ARMA models were used to create semi-
synthetic LFP signals. To ensure that the synthesised LFP signals mimicked the
non-linear progression in PD, PD events were defined in a pseudo-random manner
using Poisson distributions. And, to avoid training data leakage into test data,
random permutation sampling was used for LFP epoch selection and concatenation.
f) The MRM, inspired by Fisher’s separability criterion, was presented as a computa-
tionally efficient implementation of DR. To facilitate fully implantable aDBS, com-
putationally efficient implementations of each of the stages in the processing chain
are required.
g) In addition to PD detection, the algorithm could be extended to other applications





Disease Progress in Parkinsonian
Patients
5.1 Introduction
PD has complex mechanisms [241], and to optimize therapy, a better understanding
of its dynamics is required. Currently, the standard for diagnosing and monitoring
parkinsonian progression in patients is through visual feedbacks from patients [22].
These may be insufficient since it is only monitored during follow-up visits. Research
in disease monitoring has ranged from using mobile devices that have short message ser-
vice (SMS), web-based applications and Bluetooth capability to measure the frequency
of symptom onset so that medical interventions could be delivered or better diagnosis
could be made [188]. These systems could be implemented on software application
running on the patient’s commercial smartphone and connected to the clinician’s infor-
mation systems [242]. Rossi et al. [243] proposed and developed a webbased system for
collecting clinical and neurophysiological data, the WebBioBank, specifically created
for DBS management, that also can be connected to the patient’s mobile apps and can
safely be used for web-based tele-monitoring and caregiver support [188]. Also, disease
monitoring can be used to provide a more refined therapy and for biomarker selection
based on patient data collected. The power required to transmit data in neural signal
processing systems is shown to dominate that for recording and data conversion [244].
As such oﬄine processing based on transmitting raw time series data as suggested
in [188, 243], is an inefficient approach. Hence, based on the power and bandwidth
constraints involved in continuously sending neural signals, it will be more resource
efficient to periodically send patient progress as state estimates after on-site and online
analysis. Such an integrated platform for on-site and online analysis and monitoring of
PD signals is still unavailable.
For on-site and online analysis, there is a need to develop miniaturised real-time plat-
forms that could monitor disease progress. This specialised hardware platforms will
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facilitate mobile diagnostics for better disease management. Ambulatory platforms
for PD diagnostics could provide more in-depth information and reduce the number
of face-to-face visits required to optimize therapy. In PD monitoring, the aim is to
provide long-term monitoring of the patient’s condition for clinicians to better under-
standing the symptoms such that therapy could be tailored to patient needs. There
are two major components to personalised health monitoring, namely; disease diagno-
sis and disease management. The focus here will be on disease diagnosis. This work
presents an interface that can process LFP signals such that Parkinsonian states are
communicated and logged onto an external platform. The processing chain is shown in
Figure 5.1. The PD detection processor detects PD events and sends these events over
a communication interface (instead of sending raw neural data) to a PD event log. This
reduces the amount of data sent over the communication link, which in turn reduces
communication energy as well as bandwidth requirements of the entire system.
The platform was implemented on FPGA. The benefits of FPGA are that they lie
midway between micro-controllers (high flexibility and low speed) and ASIC (low flexi-
bility and high speed) on the flexibility and speed spectrum. Also, the relative ease with
which they can be translated into ASICs as well as programming languages for micro-
controllers is an added advantage. The long-term plan is to implement fully implantable
systems that adapt DBS therapy. The first step towards this is the implementation of
hardware platforms for monitoring PD progress.
The chapter is organized as follows. Section 5.2 details the major functional units of
the PD detection processor. Section 5.3 describes the FPGA prototyping platform for
the processor. The obtained results are described in Section 5.4. Section 5.5 discusses
the prospects and challenges of personalised monitoring. The major points addressed
in the chapter are summarised in Section 5.6.
5.2 System Overview
For detection algorithms, the more complex algorithms mostly provide the best per-
formance. As such, the choices in choosing algorithms along the processing chain is
guided by efficacy and complexity measures. Fully implantable hardware is expected to
operate under high-reliability requirements and strict power-density regimes. For us to
strike the optimal balance between efficacy and complexity, algorithmic and hardware
optimisations were adopted for each stage on the processing chain. The PD detection
algorithm performs feature extraction, feature selection and classification. Hardware
efficient and implementable realisations of each of the listed stages are adopted for the
Figure 5.1: The functional block diagram of the PD monitoring platform.
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full system. Figure 5.2 shows the top-level block diagram of the PD detection pro-
cessor. The PD detection processor consists of five major functional units: feature
extraction for training, feature extraction for detection, processor finite state machine
(FSM), memory banks and k-NN unit. The PD detection processor has two operating
regimes: concurrent training and detection, and detection only. During concurrent de-
tection and training, time multiplexing is used to acquire training data from each of
the recording channels. This is done through the feature extraction for training unit,
which sends the extracted features to the memory banks for storing training data. The
training examples stored are used to train the MRM (for feature and channel selec-
tion) as well as the k-NN classifier. In order to avoid interrupting PD detection, two
feature extraction unit were used: the first serves training purposes and the second for
detection. All these units are coordinated by the ‘PD detection processor FSM’. The
PD detection processor has four input clocks: clk1 operates at 128 Hz and controls
real-time acquisition of LFP data; the second is clk2 which operates at 1 Hz and con-
trols feature extraction. Features are computed from 256 samples/channel, with 50%
overlap in samples. Five features are computed from the buffered 256 samples. Feature
extraction is necessary because directly using time-series data as input to classifiers
for detection may be impractical for real-time detection as these may increase the dy-
namic power of the classifier. This necessitated the need for two preliminary processing
stages before classification, which are: feature extraction and feature selection. The
MRM is used for feature and channel selection and it has two operating clocks: clk1
and clk3. MRM training is conducted sequentially per channel and is controlled by clk3,
whose frequency varies for various implementations of the PD detection processor. It
varies between 1/81 Hz to 1/756 Hz depending on the implementation (the various
implementations are discussed in later sections). A major consideration that drove the
exploration of various architectures of the PD detection processor was to obtain a bal-
ance between performance and hardware resources utilisation. The final clock is clk4,
which is only used by the ‘PD detection processor FSM’ to trigger a new training cycle;
clk4 is made 200 times slower than clk3. The following section describes the functional
units in more detail.
5.2.1 Feature Extraction
Feature extraction is the first stage of neural data manipulation. During feature ex-
traction, neural signals are transformed into features that separate non-PD from PD
events. Another goal of FE is to extract as few useful information as possible to min-
imise the computational complexity of the detection process. A common algorithm that
is widely used for time-frequency analysis of neural signals is the DWT. To extract useful
information, DWT decomposes a signal into different levels based on frequency con-
tent. DWT is suitable for FE because the decomposition into different levels enhances
the SNR of the neural signals; which facilitates the identification of PD and non-PD
events. Examples of DWT algorithms are Morlet wavelet, Haar wavelet, and other
Daubechies wavelets. The Haar wavelet has been commonly used due to its favourable







































Figure 5.2: The functional units of the PD detection processor.
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The Haar wavelet is ideal for capturing non-continuous frequencies [233]. In biomedi-
cal applications, the Morlet wavelet transform is widely used to discriminate abnormal
behaviour due to its sensitivity to discontinuities like in Haar wavelet and its ability to
offer multiple dimensions to time related changes. This advantage is leveraged upon
in toolbox based analysis of DWT and it is used in applications like the detection of
abnormal heartbeat behaviour. Since, time-frequency analysis in this work was guided
by considerations for hardware implementation, which are not fundamental for toolbox
based analysis. For the hardware implementation, the possible improvement in accu-
racy due to Morlet wavelet, may not be commensurate with the computational cost
incurred. As demonstrated in Chapter 4, the Haar wavelet implementation presents
high accuracy measures. Also, Haar-wavelets have been shown as suitable in hardware-
aware implementations for time-frequency analysis [211]. An approach using four-level
decomposition was adopted because it separated the features into desired brain wave
bands as follows:
• Gamma band is greater than 30 Hz and the level 1 detail coefficients produce
LFP characteristics between 32 − 49.5 Hz. The input LFP signal is band-pass
filtered between 0.5 − 49.5 Hz, and then downsampled to fs = 128 Hz such that
the maximum frequency is 64 Hz. A frequency domain demonstration of this is
shown in Figure 5.3.
• Beta band activity is between 13−30 Hz and Level 2 detail coefficients characterise
LFP activity into frequencies between 16− 32 Hz as can be seen in Figure 5.3.
• Alpha band activity is 8− 12 Hz and level 3 detail coefficients are representative
of LFP activity of frequencies between 8− 16 Hz.
• Theta band activity is between 3− 8 Hz and level 4 detail coefficients of the LFP
activity are between 4− 8 Hz.
• Delta band is between 0.5 − 3 Hz and the level 4 approximation coefficients ob-
tained represented LFP activity between 0.5− 4 Hz.
Each level of decomposition results in down-sampling by two at each successive level,
after four-level decomposition, further decomposition levels may not be desired be-
cause it will result in reduced frequency bands which may contain little or no relevant
information.
5.2.1.1 Hardware Implementation
The two operating phases of the processor FSM are detection, and concurrent detection
and training. During concurrent detection and training, a separate feature extraction
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Figure 5.3: A frequency domain illustration of four-level wavelet decomposition.
stage is used to store training data from each of the channels while the other is used for
detection. This is why there are two feature extraction units. Two feature extraction
units are required so that real-time detection is not interrupted during training. One of
the feature extraction units is always active and is used for detection, while the other
is only active during training. To extract the five features in hardware, three major
blocks are required:
1. A four-level Haar DWT block that computes the wavelet coefficients at each
decomposition levels.
2. A power calculation block that computes the features at each level based on their
corresponding coefficients.
3. And a first-in, first-out (FIFO) memory block to synchronise the four-level Haar-
wavelet block with power calculation block.
Figure 5.4 (a) and (b) shows the structure of the two implementations of the feature
extraction units. The four-level Haar wavelet block is synchronised to operate at the
same sampling rate as the input data (clk1 = 128 Hz ) because the system is designed to
adopt real-time PD detection. However, features are updated every one second. Thus,
the power calculation block is synchronised to operate at clk2 = 1 Hz. The power
features are obtained using 2-second window (256 samples) of LFP signals with 50%
overlap between windows. This means features are updated every second. The average






‖ xi[n] ‖2 . (5.1)
where Ni is the number of DWT coefficients xi[n] at level i, with n representing the
index for each sample. Ni is 128 for level-1 detail coefficients, 64 for level-2 detail
coefficients, 32 for level-3 detail coefficients and 16 for level four coefficients. The four-
level Haar wavelet block is synchronised to the power calculation block using a FIFO
memory. The FIFO block is a dual-port RAM consisting of a memory and controller
block. It also has separate read and write pointers that are used for controlling reading
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and writing operations in the feature extraction unit. Below is a brief description of
the two implementations of the feature extraction units.
Feature Extraction for Training
The feature extraction unit in Figure 5.4 (a) interfaces with the memory bank. During
the processor FSM training phase, the feature extraction for training collects LFP
training data from the multiple input channels through time-multiplexing. Data from
all the channels use a common data path through the multiplexer. The active channel
is controlled by input signal from the processor FSM. All coefficients from the four-level
Haar wavelet are transferred to the power calculation block through a five-level FIFO
corresponding to coefficients from each level. The FIFO for level 1 detail coefficients is
made up of 128 memory locations, level-2 detail uses 64 memory locations and so on;
with level 4 approximation coefficients consisting of 16 memory locations. Besides, the
Figure 5.4: Feature extraction units. (a) Feature extraction for training. (b) Feature extrac-
tion for detection.
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‘Feature label accumulator and FIFO’ block collects ground truth information from
training data. Each epoch of training data consists of a stream of labels for input
samples which are used as ground truth information for training purposes as well as to
validate performance.
Feature Extraction for Detection
The features are obtained using a 2-second window of LFP signals with 50% overlapping
windows. Since, 50% of buffered coefficients are reused the feature extractor FSM con-
trols reading samples from the FIFO. However, the number of samples buffered varies
depending on the features selected. The feature extractor controls the reading and
writing based on the feature selected. Channel and feature selection is communicated
to the feature extractor FSM from the PD processor FSM. In addition, the ‘Feature
extractor FSM’ controls power calculation. The computation of average power of the
coefficients in each level varies depending on the feature selected, because the number
of samples Ni used in computing the average reduces by a multiple of two for every
decomposition level. The feature extractor FSM provides the Ni, which is the number
of samples required for computing the average power. The obtained features are sent
to the classifier for classification.
5.2.1.2 Four-Level Haar Wavelet
The decomposition represents filtering using binary-scaled frequency bands that main-
tain the temporal information present in original signal. Figure 5.5 (a) shows the
configuration for obtaining the approximation and detail coefficients for a four-level
DWT decomposition. To obtain the detail and approximation coefficients at the i-th
level, approximation coefficients from the previous level ai−1 serve as input as is shown
in Figure 5.5 (a). These are convolved with a half-band low pass filter (LPF) h0 gen-
erating the approximation coefficients ai, and with a half-band high-pass filter (HPF)
g0 to generate the detail coefficients di. The convolution and downsampling operation








g0(n) · ai−1(2k − n) (5.3)
where n represents the index of the filter coefficients (low and high pass filters), k
is the index of the input signal (approximation coefficients, ai−1). The first part of
the equations for both approximation and detail coefficients show a down-sampling by
two at each level before filtering. This was to discard redundant information that must
have been acquired in the previous decomposition level. Computationally efficient Haar
wavelet adopts the polyphase implementation [211]. This is shown in Figure 5.5 (b).







· [1, 1]. The symmetry of the coefficients is exploited by the polyphase
implementation in Figure 5.5 (b) such that a single multiplier is shared between both
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Figure 5.5: (a) Four-level Haar wavelet decomposition. (b) Hardware implementation of Haar
wavelet for each level.
filters. The frequency of the input clock clk1 is divided by two to generate a new
clock that is used in controlling the adder and subtractor in the LPF and HPF block
respectively. The newly generated clock is also used as the input clock to the next level
of the four-level Haar-wavelet. The down-sampling at each level implies that half of
the outputs are discarded at each level. This means half of the computations can be
avoided. The implementation process exploits this in computing the DWT coefficients
of the HPF as well as that of the LPF. It starts by splitting the data stream into odd
and even streams. Filtering is implemented such that only the outputs that need to be
retained are computed. This approach is depicted in Figure 5.5 (b). The lower part
implements the low pass filter and the upper part implements the high pass filter. The
adder and delay toggle at every clock cycle. The polyphase implementation ensures
that computation occurs half of the time by taking advantage of the down-sampler.
5.2.2 Memory Bank
To facilitate concurrent training and detection, and proper sharing of other computa-
tional resources, the PD detection processor consists of a memory bank that is used
for storing training data. The major functional units of the memory bank are shown
in Figure 5.6. The memory bank unit includes eight channel random access memory
(RAM), and static RAM (SRAM) write control and an SRAM read control. Each chan-
nel RAM is used for storing training data from its corresponding channel. The memory
locations of the channel RAMs are scalable depending on the number of training exam-
ples required. The number of training example stored depends on the implementation
of the PD detection processor (mainly determined by the k-NN configuration adopted).
The training data for each channel is ensured to be made up of half PD examples and
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Figure 5.6: Functional units of the memory bank.
the other half consisting of non-PD examples. This is to ensure proper generalizabil-
ity for both PD and non-PD events. Training data storage is controlled through the
SRAM write control. The input data width for each memory is 121 bits (five features
of 24-bits each with a corresponding 1-bit label as ground truth). Data writing is con-
trolled through the ‘storing channel’ control signal from the processor FSM. The data
write frequency clk2 is 1 Hz. The input data consists of five features (24 bits each)
and a label (1-bit). Data reading is also controlled by the processor FSM through the
‘Training channel select’ control signal and data is read at a frequency clk1 = 128 Hz.
Data writing uses a slower frequency because it occurs in real-time, while reading data
from the memory bank occurs during MRM and k-NN training.
For MRM training, 121 bits data (consisting of five features and a label are used for
training). While the k-NN training data depends on the feature and channel selected
after MRM training which is controlled by the processor FSM. Training data for k-NN
is obtained through the multiple input multiple output (MIMO) multiplexer, and for
each training example 49-bits (two 24-bit features and a 1-bit label) are sent to the
k-NN unit for training. The memory bank adopts power and clock gating to reduce
leakage and dynamic power respectively when the units are not in use.
5.2.3 Feature Selection
As stated in the Section 5.2.1, feature extraction obtains the most useful information
for classification. However, in hardware-efficient applications, an additional stage is
required to reduce the number of features used for PD detection. This reduces compu-
tation complexity. Feature selection chooses the most relevant features so as to reduce
the memory and computational resources. Also, it reduces data over-fitting at the
classification stage, since some features are noisy and can lead to degradation in clas-
sifier performance. Feature selection results in significant reductions in the area and
power of the PD detection hardware. For multichannel application, the classification
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phase has to be trained channel by channel either in sequence or parallel. And the best
performing channel may be selected for use. This can be computationally intensive.
Alternatively, the MRM estimates the most informative channel and uses the features
from this channel; as against using all channels [90].
Figure 5.7 shows the function units of the MRM: accumulator bank, MRM division and
feature sorting, channel sorting and selection, and the MRM FSM. The ‘MRM FSM’
controls the MRM training for each channel and the ranking of channels based on the
separability of their features by specifying the number of features required to measure
separability between PD and non-PD events for each channel. This is done using the
‘number of features’ control signal from the MRM. Also, feature and channel ranking
is done in a time-multiplexed manner to enable logic reuse. The MRM process starts
by loading the training data of each channel sequentially. For each channel, training
examples for PD and non-PD events are accumulated and stored in the PD and non-PD
coefficient stack in Figure 5.7. The MRM dividend and divisor are determined based on
the MRM process described in Chapter 4, for each of the five features of PD and non-PD
training examples. The ‘division and sorting FSM’ controls this. Both PD and non-PD
events have five features. The separability of each feature is determined using the ratio
of PD and non-PD examples for that feature. This is done sequentially for each of the
five features using the ‘efficient division of unsigned numbers’ as demonstrated in [245].
After the ratio of all the features for each channel is obtained the channel weight is
obtained using the ‘feature sorting and channel weighting’ unit. The Channel weights
and feature ranks are sent to the ‘channel sorting and selection’ unit, where the channel
weights and feature ranks of each channel are stored. The process is repeated for the
other channels until the channel weight of all the channels are obtained. After which it
is used to assess the most separable channel and features for use in PD detection. This
is communicated to the processor FSM through the ‘MRM selected channel’ and ‘MRM
selected feature’ signals in Figure 5.7. During the entire process of MRM, the MRM
stage is continuously communicating to the processor FSM through the ‘MRM state’
signal. The MRM feature selection is computationally simple and estimates the most
separable features and channel. The only intensive operations it implements are the
bubble sort, and efficient division of unsigned numbers. To rank features and channel
weights, the MRM requires a sorting algorithm. Efficient sorting is required to limit
the time as well as computational complexity required. The bubble sort algorithm
was adopted. It sorts data by repeatedly stepping through the list to be sorted and
comparing adjacent samples and swapping them if they are in the wrong order. The
process is repeated until no more swaps are required. It was adopted throughout the
PD detection processor for sorting because it requires a maximum of n2 clock cycles to
complete the sorting task (where n is the number of samples in the list). In addition, it
only requires one extra memory location (temporary register) to enable data swap. This
makes it time and resource efficient for sorting a small number of data set. More details
on other sorting algorithms are provided in [246]. Efficient division of unsigned numbers







































Figure 5.7: Functional units of the MRM.
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5.2.4 PD Classifier
Machine-learning algorithms offer the benefit of understanding disease progression in
patients. However, their computations are not well supported by conventional DSP
platforms; particularly when high order models are used. That is why pre-processing
stages like feature extraction and feature selection are used to reduce the computational
demands of detection algorithms. In PD monitoring, the classifier is required to iden-
tify PD events from non-PD events using acquired neural signals. The PD classifier
produces binary outputs, with one representing a PD event and zero representing a
non-PD event. The detection results are intended for use either by caregivers or inter-
faced to stimulation devices. PD monitoring and event detection can be implemented
either by using online or oﬄine classification. In oﬄine classification, obtained features
or neural samples are transmitted to external devices for classification. In other cases,
features are processed internally but other parts of the processing at the classification
stage is delegated to an external device. As a result, oﬄine classification can be partly
oﬄine or completely oﬄine. For partly (hybrid) oﬄine classification, the training phase
(which is computationally intensive) is implemented externally from the system due to
its computational complexity; with detection implemented in real-time. On the other
hand, in completely oﬄine classification, the classifier is external to the system. Of-
fline classification employs powerful classification algorithms. This makes them more
accurate than online classification algorithms. However, for real-time implementation,
transmission of raw data imposes power and bandwidth constraints which may be un-
desirable for fully implantable systems. Also, their computational and memory storage
requirements make them impractical for fully implantable bio-electronic systems. On-
line implementation of PD classifiers allows real-time operation but at the cost of a
reduced accuracy due to the power and area constraints of online processing. To facil-
itate the shift towards fully implantable on-demand DBS systems that can be used to
monitor and mitigate PD in real-time, this work deployed an online classifier for PD
detection. The PD classifier adopted a k-NN classifier based on the evaluation con-
ducted in Chapter 4. The overall architecture of the k-NN classifier is shown in Figure
5.8. The k-NN classifier consists of four functional units: training examples and label
block, level median stack, k-NN controller and kd-tree block. Training data from the
memory bank is stored in the training examples and labels block. This data is used to
obtain the various medians for different levels of the kd-tree search (nearest neighbours
are obtained using kd-tree search).
The medians in the level median stack are used for kd-tree implementation of the k-NN
classifier. The k-NN classifier uses a kd-tree approach. The kd-tree was chosen because
it uses a hardware efficient implementation of k-NN. The k-d tree distance metric uses
the minimum number of computation even though it comes with a reduced accuracy.
It is for this reason this platform investigates its use in various k-NN configurations.
The performance of various implementations of kd-tree are investigated using different
levels of the kd-tree search as well as nearest neighbours. The kd-tree implementation







































Figure 5.8: Functional units of the complementary k-NN block.
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different implementations to produce a classifier with a strong confidence level from
three disparate and weak classifiers. This is particularly important since the kd-tree
implementation uses an approximate distance measure, as such the complementary
configuration compensates for this. The following section provides more detail on kd-
tree implementation.
5.2.4.1 k-dimensional Tree Implementation
PD classification using k-NN usually compares the input feature vector to the k-closest
training examples. This distance is computed using different metrics, namely; Eu-
clidean [247], LP distances [248], Mahalonobis distance [249], and approximate distance
metrics like k-d tree implementations [250]. Among those mentioned above, the k-d
tree implementation is the least computationally intensive. The k-d tree uses a binary
decision tree to drill down n-levels, with each level generating a splitting hyperplane
that divides the space into two parts, known as half-spaces. The splitting hyperplane
is chosen such that every node in the tree is related to one of the k-dimensions (in
our case two-dimensions, since we have two dimensional features) and its direction is
perpendicular to the axis it splits as indicated in Figure 5.9 (a). Figure 5.9 (a) shows
a four-level kd-tree search. The two dimensional features in Figure 5.9 (a) are level
1 detail power (32 49.5 band) and level 2 detail power characteristics (16 32 band).
The feature space is divided into 16 compartments by the kd-tree search. For N level
k-d tree, there are 2N nodes, and as shown in Figure 5.9 (b) each test case has to visit
N nodes before it is classified. In Figure 5.9 (a), for level 1, a splitting hyperplane is
chosen at the median of the x-axis (feature 1) values, all points with a value smaller
than the median are categorised in the left sub-tree (consisting compartments labelled
I - P) and those greater than the median are categorised to the right tree (with com-
partments labelled A - H). In this situation, the hyperplane is determined by the x-axis.
However, for level 2 splitting, two new hyperplanes are used to further split the left and
right compartments of the feature space into four compartments. The process of binary
splitting returns to the x-axis in level-3, further splitting each of the four compartments
into eight compartments. Level 4 splitting then splits the eight compartments into 16
compartments. These 16 compartments are shown for the feature space of dataset C,
with each compartment having four training examples making a total of 64 training
examples. Figure 5.9 (a) shows how the 3-NN can be used to classify a test case, as the
three closest training examples from compartment ‘H’ are used. However, to use 5-NN
or 7-NN classification, only three level kd-tree can be used. As such, for 5-NN or 7-NN
classification, the nearest neighbours from compartment ‘G’ and ‘H’ in Figure 5.9 (a)
are used in classifying the test data. In the k-d tree implementation, each node is a
hyperplane, and at each node, a decision is taken to go either left or right on the tree as
can be seen in Figure 5.9 (b). The two feature test data starts by testing feature 1 (f1)
at the first level to determine where to go, for the kd-tree in Figure 5.9 (b), if f1 is less
than the level-1 median (M1), it takes the ‘yes’ route otherwise it takes the ‘no’ route.
The process is continued by alternating between features f1 and f2 at each level until it
reaches a node which is at level-4. The various nodes in the kd-tree are shown in Figure
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5.9 (b) (A - P from right to left). Their respective compartments are shown in Figure
5.9 (a) on the feature space. This work uses a maximum of five level kd-tree. Various
implementations for the 3-NN, 5-NN, 7-NN and the complementary k-NN (which will
be indicated by X-NN from now onwards) are discussed in the following section.
5.2.4.2 k-NN Implementations
For each input test case, classification begins hierarchically from the root node in
Figure 5.9 (b) and terminates at a leaf node, where a label is assigned (either PD or
non-PD event). Different levels of kd-tree search, as well as nearest neighbours, are
implemented and tested for accuracy and hardware resources trade-offs. The classifiers
studied include k-NN with three, five and seven neighbours; and an ensemble of the
classifiers which is tagged complementary configuration. The ‘k-NN controller’ block
in Figure 5.8 controls the sorting of features in the training examples and the storing
of the hyperplane (median) points for each level of the k-d tree. In the complementary
configuration, a multi-classifier vote is adopted based on the outputs from each of the
three order classifiers and the simple majority vote is used to generate a consensus.
Below is a brief description of the various implementations.
1. 3-NN kd-tree: The 3-NN kd-tree implementations are designed to terminate the
search at nodes with three training examples such that each test case is classified
according to the class dominated by the node it falls into using simple majority
vote. Implementations using three, four and five levels kd-tree using 24, 48 and
96 training examples respectively, are investigated for accuracy and hardware
resource trade-offs.
2. 5-NN kd-tree: The 5-NN kd-tree implementations are designed to terminate the
search at nodes with five training examples such that each test case is classified
according to the class dominated by the node it falls into using simple majority
vote. Implementations using three, four and five levels kd-tree using 40, 80 and
120 training examples respectively, are investigated for accuracy and hardware
resource trade-offs.
3. 7-NN kd-tree: The 7-NN kd-tree implementations are designed to terminate the
search at nodes with seven training examples such that each test case is classified
according to the class dominated by the node it falls into using simple majority
vote. Implementations using three, four and five levels kd-tree using 56, 112 and
224 training examples respectively, are investigated for accuracy and hardware
resource trade-offs.
4. Complementary kd-tree: In the complementary configuration, a multi-classifier
vote is adopted based on the outputs from each of the three order classifiers (3-
NN, 5-NN and 7-NN). A simple majority vote is used to generate a consensus
between the three classifiers. The kd-tree implementation of this consists of nodes
with four training examples such that 3-NN could be obtained from the final
nodes, while 5-NN and 7-NN are obtained from the last but one level, since it is
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Figure 5.9: (a) Feature space depicting kd-tree compartmentalisation. (b) kd-tree search
method.
a node with eight training examples. A typical example of this implementation
is in Figure 5.9 (b), which uses 3/4 kd-tree levels. Whereby 5-NN and 7-NN are
obtained at level 3, while 3-NN is obtained at level-4. Implementations using
3/4 kd-tree levels have 64 training examples and implementations using 4/5 kd-
tree levels have 128 training examples are investigated for accuracy and hardware
resource trade-offs. Table 5.1 summarises the various kd-tree implementations
and their training data requirements.
5.2.5 Operating Modes
The PD detector has two modes of operation: concurrent detection and training, and
detection only. During both modes, real-time PD detection continues and both operat-
ing modes use fully on-site computation. During concurrent detection and training, the
PD detector concurrently detects PD events and trains to determine the appropriate
input channel and features for PD monitoring as well as the k-d tree hyperplanes for
each level. This mode requires the most computing and memory requirement. Never-
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theless, it only lasts for 5.5% of the time. It involves three sub-modes: training example
storage, MRM training and k-NN training. These sub-modes take 4%, 1% and 0.5% of
the time respectively. Table 5.2 summarises the active functional units during each of
the sub-modes of concurrent detection and training. The second mode is PD detection
only, which happens most of the time. During this mode, the PD detector transmits
PD events at one-second intervals. Only three functional units are active for majority
(94.5%) of the time as summarised in Table 5.2.


























* Training frequency measured relative to X-NN (4/5), which is trained once a day.
Table 5.2: Operating modes of the PD detection processor.
Operating Mode Sub-mode Period
(× 1clk3 ) **







8 Feature extraction for training,
memory bank, feature extraction
for detection and k-NN.
MRM training 2 Memory bank, MRM, feature ex-
traction for detection and k-NN.
k-NN training 1 Memory bank, feature extraction
for detection and k-NN.
Detection only – 189 Feature extraction for detection
and k-NN.
** clk3 varies for each implementation. For X-NN (4/5) it is 1
432
Hz: this frequency has to be
multiplied by the relative training frequency in Table 5.1 to obtain the equivalent value of clk4 for
other implementations of the PD detection processor.
5.3 Physical Implementation
The objective is to provide a hardware platform for real-time processing of acquired
neural data such that PD events can be distinguished from non-PD events. A fully
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online implementation performs on-site and real-time PD detection such that only PD
events are transmitted to caregivers or stimulation devices to trigger actionable out-
puts. The most suitable candidate is an FPGA-based platform since it provides more
flexibility for investigating various implementations of the PD detector as against an
ASIC implementation which is hardwired. Currently, the mechanisms of PD are still
under debate and the PD detection algorithms may need to be updated as a deeper un-
derstanding of the mechanisms of PD are gained. In essence, an FPGA based platform
offers the best compromise between adaptability and portability. Moreover, register
transfer level (RTL) implementations used on FPGAs are easy to translate for ASICs.
The PD detection processor was modelled using Verilog hardware description language
(HDL), and was programmed on an Artix-7 FPGA as shown in Figure 5.10 (a). The
FPGA based PD detection tool was implemented in three major layers: the MAT-
LAB layer, universal asynchronous receiver/transmitter (UART) layer and the FPGA
layer. This is shown in Figure 5.10 (a). Synthesised LFP data is transferred from
MATLAB to the FPGA board through the serial communication link (USB-JTAG ca-
ble in Figure 5.10(b)) to the Artix-7 FPGA for processing. Processed data is sent
back to MATLAB for performance evaluation of the PD detector (using signal ground
truth stored in MATLAB). For serial communication, the UART layer interfaces MAT-
LAB and FPGA, using a UART script in MATLAB and an interfacing UART receiver
and transmitter implementations for deserialising and serialising input and output data
from the FPGA respectively. The UART layer mainly controls data flow between MAT-
LAB and the FPGA platform as is shown in Figure 5.10 (a). The following section
further provides details on the justification for FPGA implementation, the target hard-
ware selected (FPGA board) for validating the platform and the input-output interface
(UART) adopted.
5.3.1 FPGA Implementation
FPGA is hardware platform that is configured using HDL. Compared to micro-controllers
and ASIC, FPGA provides the best trade-off between speed and flexibility. ASICs are
known to have a fixed architecture, since each chip is designed strictly to perform a spe-
cific function. They are designed such that power and area consumption are optimised.
This limits their flexibility but improves their speed and possibly their efficiency. On
the other hand, micro-controllers are highly flexible because they can be programmed
and reprogrammed to perform almost any operation. However, their inherent and sin-
gularly defined structure for performing programmed instructions limits their operating
speed as every programmed instruction is performed in a nearly similar pattern [245].
FPGAs have a blend of the fixed architectures in ASIC and the structured programme
execution style synonymous with micro-controllers; this makes them in between the two
extremes regarding speed and flexibility and serves as a good compromise. They are
manufactured such that they contain standard hardware building blocks like: look-up
tables (LUT), memory, adders, multipliers and a reconfigurable interconnect structure
that enables connection between its different blocks. Their ability to be programmed
using HDLs to perform complex sequential and combinational logic functions in a sim-
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Figure 5.10: FPGA implementation of PD detection.
ilar fashion as ASICs results in their speed and flexibility compromise. It is for this
reason that the hardware-efficient implementation of the PD detector is validated on
an FPGA platform. Also, since it is structured to perform complex operations in par-
allel like in ASIC and the long term goal is to implement fully online and real-time
implantable ASICs that can be deployed for PD monitoring and DBS modulation, it
serves as a ‘semi-ASIC’ platform. Among all the reasons that influenced the choice of
an FPGA based PD detector, of paramount importance is the need to implement and
validate on a platform that provided room for modifying the PD detection algorithm
such that it can be updated and performance of various functional units investigated.
5.3.2 Targeted Hardware
The targeted hardware is the Nexys4 DDR processing board from Xilinx with Artix
-7 FPGA. The Nexys 4 DDR uses its own expansion system and has 60 I/O pins that
can be interfaced to external devices as is shown in Figure 5.10 (b). The board uses
3.3V I/O. It has on board peripheral devices that are accessible to the Artix-7 chip as
peripheral I/O devices. Its high capacity FPGA is the XC7A100T-1CSG324C. Table
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5.3 summarises the FPGA packaging and device details based on the guide from [251].
Apart from the FPGA chip, the Nexys4 DDR boards consists of a number of peripherals
devices such as, LEDs, switches, temperature sensor, accelerometer, a speaker amplifier,
microelectromechanical systems (MEMS) digital microphone, and a number of input
and output devices that enables it to be used with a host of interfaces [252]. Of primary
importance is its USB-JTAG port which was used for FPGA programming and data
streaming through UART as is shown in Figure 5.10 (b). For communication with
a host PC and programming the Artix-7 FPGA, it uses a USB mini-B connector.
Its configuration bit files are held in a 128Mbit serial peripheral interface flash chip.
Finally, it has a 128 Mbit synchronous dynamic RAM chip on board.



















The synthesised LFP signals used as input data are described in Chapter 4, and are
fed from MATLAB. The LFP data is initially represented in double precision floating
point number. It is then quantized to 8 bits fixed point representation, with one
sign bit and one fractional bit. Serial communication is implemented using UART
protocol, in a full-duplex configuration. From Figure 5.10 (a), the input data from
MATLAB is divided into packets of 8 bits which are sent in serial format to the FPGA
platform. The UART receiver block in the FPGA receives the input serial data and
deserializes it. The deserializer block implemented in Verilog HDL takes in serial input
data from MATLAB, buffers them until a complete word is obtained before it sends
it as input to the PD detection processor. Also, the UART data packets are sent
with a channel identifier packet to determine the recording channel from which the
LFP signal originates from. The obtained packet and channel identifier are used to
demultiplex the input signal to the appropriate channel of the PD detection processor
for PD detection. After PD detection, labels are assigned to input signals. The binary
labels are sent through the UART transmitter block of the FPGA back to MATLAB
as PD and non-PD events. The complete architecture of the data streaming interface
is shown in Figure 5.10 (a).
5.4 Results
To evaluate the performance of the proposed PD detection method, semi-synthetic
neural signals constructed from the real LFP recordings as described in Chapter 4.
Semi-synthetic neural signals were used as against experimentally recorded neural sig-
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nals because all underlying conditions in original LFP signal can be modelled alongside
ground truth information. In addition, semi-synthetic signals offer the opportunity to
synthesise longer LFP recordings from real LFP recordings with short duration. The
results describe the detection performance as well as hardware resource utilisation. De-
tection performance results were obtained from FPGA while hardware resources were
obtained both from FPGA and post-synthesis power and area estimates when mapped
to 45 nm CMOS process.
5.4.1 Detection Performance
For hardware test, performance measures were obtained over a complete training and
test period clk4. It has a period of 186400 Hz for the X-NN (4/5) implementation and for
other implementations, the frequencies are multiples of X-NN (4/5) clk4 as summarised
in the relative training frequency in Table 5.1. Before performance evaluation, training
is conducted which lasts 5.5% of the time. Then for the other 94.5% of the time, test
cases were detected. The bar plots in Figure 5.11 represents the bar plots of the F1-
score for the various implementations. It can be seen that the F1-score increases with
an increase in the number of training examples, except in the case of 5-NN(5), 7-NN(3),
X-NN(3/4) and X-NN(4/5). In the case of 5-NN(5), this could be attributed to outliers
in the training examples due to an increased number of training examples. Outliers tend
to bias the classifier model. In the case of 7-NN(3), the use of seven nearest neighbours
in a training set consisting of 56 training examples can increase susceptibility to outliers.
That is, if outliers make a large part of the training examples.
With a median F1-score of 95.02%, the X-NN(3/4) has a better performance than the
5-NN(5) and 7-NN(4) which have 67.75% and 92.54% respectively. However, they use
more training examples than the X-NN(3/4). The improved performance in X-NN(3/4)
can be attributed to the complementary detection it uses. For the X-NN(4/5), its
median F1-score trails that of the best, which is the 7-NN(5) by less than 1% even
though the 7-NN(5) uses 228 training examples compared to 128 training examples
used by the X-NN(4/5). The top three implementations in terms of F1-score are: 7-
NN (5) with a median of 96.29%, X-NN (4/5) with a median of 95.34% and X-NN(3/4)
with a median of 95.02%. The classification accuracy measures in Figure 5.11 (b) follow
almost the same pattern as the F1-score. However, the major difference is that the X-
NN(4/5) has a better classification accuracy performance than the 7-NN(5). The top
three in terms of classification accuracy are: X-NN (4/5) with a median of 91.93%,
7-NN (5) with a median of 89.66% and X-NN(3/4) with a median of 82.14%. From the
foregoing, it is clear that the complementary k-NN configuration improves on detection
performance. As it outperforms any of the normal k-NN configurations that use about
the same number of training examples.
5.4.2 Hardware Resources
Hardware implementation of a PD detector using Haar Wavelet-based FE, MRM based
feature selection and k-d tree based implementation of the k-NN classifier were realized
using Verilog HDL. This was tested in FPGA. For ASIC resource requirements, various
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Figure 5.11: Detection accuracy for PD detection processor. (a) F1-score for various con-
figuration of PD detection processor. (b) Classification Accuracy for various
configuration of PD detection processor.
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implementations of the architecture were synthesised and mapped into a 45nm standard
cell library. The following section gives more details on hardware resources.
5.4.2.1 FPGA Resources
The major building blocks for the FPGA implementation are: LUT slices, register slices,
multiplexers and DSP units. The Artix -7 FPGA has 63400 LUT slices, 126800 register
slices, 240 DSP slices and 47550 multiplexer slices [252]. The resource utilisation for
the various implementations are summarised in Table 5.4. It can be seen that only
six DSP slices were used. These were used in the feature extraction unit. Other
resources increase with an increase in nearest neighbours as well as kd-tree levels.
Figure 5.12 (a) and (b) show the proportion of resources consumed by the four major
blocks (excluding the PD detection processor FSM). Figure 5.12 (a) shows that of the
3-NN(3) implementation which consumes the least resources, while Figure 5.12 (b)
shows that of the 7-NN(5) which consumes the most resources. From Figure 5.12, it
can be seen that the k-NN and memory bank dominate in terms of resources as the
kd-tree level grows. The feature extraction units and the MRM stay relatively the same
throughout. DSP slices are only used in the feature extraction block for multiplication
to compute the power of the coefficients from the four-level Haar wavelet.
5.4.2.2 On-Chip Power and Area
The mapped implementation resulted in post-synthesis estimates of dynamic power per
channel and area per channel for different configuration of the PD detection processor
and are summarised in Table 5.5. On-chip power and area estimates were obtained by
mapping the various implementations to 45nm NanGate digital cell library [253]. The
power is analysed based on a core voltage of 1.1 V. The 7-NN (3) configuration has the
lowest dynamic power requirements, while the 3-NN (3) has the lowest area require-
ments. Form Table 5.5, it can be seen that the area consumption is commensurate with
FPGA resource utilisation. However, this is not the case for the dynamic power con-
sumption, as dynamic power is dependent on the activity in the circuit mostly resulting
from control and clock signals.






slices (%) slices (%) slices (%) slices (%)
3-NN
3 8377 13.21 6139 4.84 236 236 6 2.5
4 11071 17.46 7492 5.91 619 1.30 6 2.5
5 17135 27.03 10140 8.00 1078 2.27 6 2.5
5-NN
3 10284 16.22 6953 5.48 331 0.7 6 2.5
4 15351 24.21 9033 7.12 987 2.07 6 2.5
5 23855 37.63 13017 10.27 2512 5.28 6 2.5
7-NN
3 11514 18.16 7656 6.04 696 1.46 6 2.5
4 17675 27.88 10646 8.25 1674 3.52 6 2.5
5 29839 47.06 15997 12.62 3636 7.66 6 2.5
X-NN
3/4 14194 22.39 8284 6.53 885 1.86 6 2.5
4/5 20993 33.11 11560 9.12 1904 4 6 2.5
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Figure 5.12: FPGA resource utilisation.
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Table 5.5: Table summarising performance for various implementations.
S/No. Implementation















3 2.28 0.0433 0.0012 51.29 49.74
2 4 2.37 0.1175 0.2479 56.69 55.70
3 5 2.31 0.1915 0.3513 68.20 64.76
4
5-NN
3 2.23 0.0465 0.1608 56.12 60.00
5 4 2.34 0.1651 0.3275 68.43 69.48
6 5 2.53 0.2873 0.5081 68.11 77.96
7
7-NN
3 1.80 0.0496 0.1315 50.20 51.18
8 4 2.49 0.2126 0.482 78.37 79.79
9 5 2.73 0.3815 0.6422 92.68 89.66
10
X-NN
3/4 2.22 0.1414 0.3542 86.18 82.14
11 4/5 2.26 0.2384 0.6162 91.38 91.93
Nevertheless, there is an increase in clock activity for each implementation with an
increase in the number of kd-tree levels adopted. To put the complexity measures
in perspective, Figure 5.13 (a) shows the MCC vs dynamic power and Figure 5.13
(b) shows the MCC vs area. The various implementations of the PD processor are
represented by the serial numbers in Table 5.5.
The plots are divided into four regions: Q1, Q2, Q3 and Q4. Q1 represents the imple-
mentations that have an average MCC greater than 0.5 and also have dynamic power
lower than the average dynamic power for all implementations. In Figure 5.13 (a), only
X-NN (4/5) implementation makes this category. This is the most desirable outcome in
terms of dynamic power, that is, having a classifier to produce a model that accurately
classifiers test cases as well as having a dynamic power lower than the class average.
The other quadrants in Figure 5.13 are: Q2 which represents an average MCC greater
than 0.5 and a dynamic power greater than the average which is 2.32 µW/channel.
This represents a good detector but at a higher power consumption than Q1. Q3 rep-
resents the unwanted condition, in which the detector consumes more power than the
class average and produces an MCC that is less than 0.5, which signifies weak positive
correlation.
The fourth scenario, is Q4 where the implementation results in a weak positive cor-
relation (MCC < 0.5) and a power consumption less than the average for all the
implementations. This scenario may be more desirable than Q2 depending on what
is more important between power consumption and detector performance measure in
MCC. The X-NN (3/4) produces the best performance for the implementations in Q4.
For the area consumption in Figure 5.13 (b), there is an almost linear increase in area
with an increase in MCC. Figure 5.13 (b), divides the quadrants in a similar way to
Figure 5.13 (a). However, the average area of the implementations is used to divide the
y-axis. None of the implementations fall into Q1. In Q2, the 5-NN(5), 7-NN(5) and
X-NN(4/5) fall into Q2 with the X-NN(4/5) presenting a better area trade-off than
the other two since it utilises relatively less power. Q3 also represents the undesirable
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Figure 5.13: On-chip area and power. (a) Dynamic power vs MCC. (b) Area vs MCC.
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quadrant, with large area consumption and an average MCC below 0.5. In Q4, the
best implementation in terms of MCC is the X-NN(3/4). Thus, this demonstrates that
the complementary configuration offers a good trade-off for complexity and accuracy
measures.
5.4.3 Comparison with other Neurological Event Detectors
Table 5.6 summarises the characteristics of state of the art neurological event detec-
tion processors implemented between 2013 to date. The implementation with the best
efficacy, area and dynamic power trade-offs in this work, which uses the X-NN (4/5)
classifier is adopted and compared with other neurological event detection processors.
It performs on a comparable level in terms of area and power to other neurological event
processors as can be seen in Table 5.6. The detection processor developed in this work
is the first processor for PD detection. So far, neurological event detection processors
have focussed on epileptic seizure detection. For seizure detection, the major signals
of interest are EEG and ECoG (mostly < 30 Hz), which are obtained from the scalp
and cortex respectively. In seizure detection, most studies use phase synchronisation
between signals recorded from different channels as the biomarker of interest. Seizures
are detected when phase synchronisation increases above a specified threshold. An
increase in EEG or ECoG synchronisation between channels can be indicative of an
epileptic episode. The main challenge of using the phase synchronisation approach for
detecting epileptic seizures is that the baseband synchronisation varies across subjects
and between channels. Nevertheless, neurological signals for epilepsy (EEG and ECoG)
are more distinguishable than those of PD (LFP signals). This is why a closed-loop
system for epileptic seizure suppression has already gained FDA approval [142]. On the
other hand, the unpredictable nature of LFP signals for PD and their higher frequency
content compared to EEG and ECoG makes their processing more computationally
intensive. LFP signals are used as biomarkers in PD detection and monitoring due
to their stability and rich spatiotemporal content [16], which is necessary to overcome
the unpredictable nature of PD. Besides, their ability to be obtained from the stimula-
tion electrodes also makes them minimally invasive. However, EEG signals are usually
obtained from electrodes attached to the scalp. This makes them impractical for am-
bulatory disease monitoring as they are not implanted, which means they could limit
patients’ quality of life. Another issue is that correlation between PD and EEG signals
are yet to be established or reported. This made the use of LFP signals necessary.
Fundamentally, the trade-offs are mainly between efficacy and complexity measures.
And from Table 5.6 it is clear that in terms of complexity (i.e. on-chip area and
power), some neurological events detectors present a better result than the PD detec-
tion processor. In terms of on-chip area, the works in [254–256], have a lower area per
channel. In terms of power, [254] and [255] present a lower power per channel. Re-
garding efficacy, most studies in epileptic seizure detection have focussed on sensitivity,
which only measures the true-positive rate. This means a randomly guessing processor
that always returns a positive can achieve a 100% sensitivity, since it will get all the
actual positives (but will achieve a specificity of 0%). This is why more balanced and
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comprehensive efficacy measures are required for an objective assessment of processor
performance. This is particularly necessary for situations where event detection in-
forms therapy. Administering therapy when it may not be needed can result in side
effects [36]. This was the reason more comprehensive measures like the MCC and F1-
score are adopted in this work. In addition, the PD detection processor monitors a
wider range of frequencies (i.e. < 50 Hz compared to the < 30 Hz in epileptic seizure)
which could contribute to its complexity. Nevertheless, it presents superior efficacy
than other neurological event detectors. Its complexity is also comparable to those of







































Table 5.6: Performance comparison with state of the art neurological event detection processors.
Ref. This work [254] [204] [257] [258] [255] [256] [208] [195] [259]
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a Gives the total area of the chip not area per channel. b total for 24 channels and extra stages. c total for 8 channels and extra stages. d not in %.
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5.5 Discussion
5.5.1 Personalised Health Monitoring in PD
In PD, proper health monitoring can lead to better PD mitigation as well as reduce
the number of face-to-face visits by patients. Further understanding on how disease
progresses in patient population can be achieved through remote health monitoring.
This can involve the analysis of data from multiple patients such that aDBS strategies
that incorporate more universal features or biomarkers could be incorporated in tack-
ling varying PD disorders. This will make therapy more proactive and less retroactive.
As more and more data is collected a better understanding of disease progression can
be obtained, which could be used in refining therapy. Moreover, since diverse popula-
tion of PD patients are aﬄicted with various dominant symptoms, implementations of
personalised health monitoring systems can be tailored to cater for individual patient
needs. Early detection of patient deterioration could help caregivers to immediately
take action in modifying stimulation parameters or therapeutic paradigms [260]. This
can be achieved by remote and continuous monitoring of the disease states. The infor-
mation obtained from health monitoring systems are intended to be logged to monitor
disease progression or relayed to caregivers in the event of an emergency. This can
make therapeutic interventions more sustainable, by early recognition of unresponsive
symptoms so that alternative therapeutic regimes are provided [112].
5.5.2 Supporting Technology
Advancements in bio-sensing, signal processing, data communication and nanotechnol-
ogy are providing the possibility of fully implantable systems for disease monitoring.
The major requirement is to devise systems that detect patient-specific physiological
states in real-time using minimally invasive and low power devices. This is however
made easy because of the development in machine-learning algorithms that are capa-
ble of exploiting statistical properties in the data to model specific correlations; which
facilitate decision making by healthcare experts and devices [65]. For disease mon-
itoring using machine learning models, prior pre-processing is as important, or even
more important than the use of the machine learning models themselves [261]. As the
models are only as good as the input signals that are fed to them. This makes the use
of high-performance low noise amplifiers (LNA) and analog-to-digital converter (ADC)
essential to achieving high-performance detection. In this work, already pre-processed
neural signals were used. The PD detection processor was prototyped on an FPGA
platform to demonstrate the feasibility of on-site and real-time PD detection without
compromising flexibility. Also, translating the RTL implementation to lay-out for on-
chip implementation is fairly straightforward. This was why power and area estimates
for various implementations of the PD detection processor were obtained for 45 nm
CMOS process.
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5.5.3 Challenges
Healthcare monitoring systems are required to be operational for long periods of time.
Monitoring systems like the LiveNet system [262], which uses an accelerometer, ECG,
EMG and skin conductance to obtain information on PD and epileptic seizure, among
others, by transmitting raw samples of data to external devices. Adopting this approach
imposes high power and throughput requirements. This motivated the adoption of an
implementation that can be deployed for on-site real-time processing. Due to the need
for detection algorithms to be made implantable, there might be insufficient storage
and computing capability to handle large and dynamically changing training data.
Large training data is required as classification accuracy improves as more knowledge
on the disorder is incorporated into the processor. Other challenges confronted by
personalised health monitoring systems are security and privacy issues [263]. So far,
the major limitation of disease monitoring is the issue of security and privacy of patient
data. Security and privacy is mainly dependent on the adopted communication method
used for transmitting PD events. A serious effort is already invested in research on
encryption to protect from data interception and tampering [264].
5.6 Chapter Summary
In this chapter, we presented complementary PD detection as a hardware-efficient
method for PD detection. Based on the work presented, the following conclusions
can be drawn:
a) Complementary detection uses a combination of weak classifiers to produce a clas-
sifier with a higher consistency and confidence level than the individual classifiers
in the configuration. The complementary configuration was tested against various
implementations of the PD detection processor in terms of detection performance,
dynamic power and area consumption. The PD detection processor is the first
known implementation of a PD detection processor.
b) The design leveraged on the flexibility of FPGA to test the various implementa-
tions of the PD detection processor. FPGA implementation offers the opportunity
to incorporate additional functionality into the implemented design. In addition,
estimates for power and area were obtained for 45 nm CMOS technology.
c) In terms of detection accuracy and optimal power and area trade-off, the comple-
mentary detection schemes presented the best trade-offs. Nevertheless, the most
optimal classifier configuration is dependent on the emphasis an application gives
to power and area in relation to detection performance.
d) The PD detection processor monitors a wider range of frequencies than other neu-
rological event detectors. It presents more comprehensive efficacy measures than
other neurological event detectors and it has a complexity that is comparable to
state-of-the-art event detectors. This offers a good trade-off in terms of efficacy and
complexity.
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e) Considering how spectral features are useful as biomarkers in other neurological
applications, the proposed approach can find a range of applications and implemen-
tations.
f) For hardware implementations, the challenge remains the realisation of an efficient
processor that can handle the complexity in physiological signals and still meets the




A Framework for Adapting Deep Brain
Stimulation Based on Parkinsonian
State Estimates
6.1 Introduction
Continous DBS for PD uses high frequency stimulation to ameliorate patient condi-
tion. However, this induces side effects in patients and shortens pacemaker battery
life [24]. Both can be resolved using aDBS. aDBS driven by feedback signals provides
an approach that optimizes clinical benefits while minimizing side effects and battery
depletion [24,38]. A commonly adopted feedback signal for aDBS is LFP. LFP are used
due to their correlation to patient clinical states and the ease with which they can be
acquired [78, 163]. In conventional DBS, programming of stimulation parameters are
done by trained clinicians [265]. Thus, aDBS techniques that imitate human reasoning
into decision making could be adopted – an example of which is fuzzy control. Fuzzy
control is found in numerous applications for closed loop therapy [266–268]. It has
the potential to achieve a level of expertise close to (and possibly better than) human
expertise in therapy modulation [269]. However, the capabilities of fuzzy control are
dependent on the level of sophistication of its rules and input signal. In this chapter,
state estimates are used as input to a fuzzy controller to achieve a critic-actor control
policy as shown in Figure 6.1. It leverages on a machine learning model as the critic and
a fuzzy controller as the actor. This individualises therapy using patient-specific state
estimates which are obtained through the machine learning models. Machine learning
models were selected because of their ability to create adaptable models for complex
signals using statistical attributes from the signals [270]. The choice of fuzzy control
was driven by their ability to provide computationally efficient and robust decision
making. Consequently, as more knowledge on PD and DBS is gained, the fuzzy rules
could be updated, which provides an adaptable control scheme. The scheme has the
potential to be developed into a fully implantable closed-loop DBS system. The rest
of the chapter is organized as follows. Section 6.2 describes the motivation for using
machine learning in disease tracking. Section 6.3 details the models and metrics used
in evaluating the performance of the scheme. The fuzzy controller design is explained
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Figure 6.1: A typical scheme for adapting DBS using PD state estimates.
in Section 6.4. Performance evaluation is detailed Section 6.5. Section 6.6 outlines the
prospects and limitations of the critic-actor control policy. And, Section 6.7 summarises
the major points addressed in the chapter.
6.2 Machine Learning for Disease Tracking
Disease tracking is important because dynamic changes in PD pathophysiology could
help inform treatment strategies. This can be achieved using machine learning models
as they provide insights on disease progression. In BMI applications, machine learning
provides the ability to notify caregivers of life-threatening events related to chronic
disease diagnosis and management [261]. Using closed-loop control strategies, this use-
ful information can be used to generate actionable outputs – mostly from stimulation
devices – to mitigate patient conditions [271]. Machine learning models for disease
tracking are intended to achieve one of two outcomes: prediction or state estimation.
Prediction requires the isolation of dynamic features preceding critical events. This
can be computationally intensive due to the complex and progressive nature of neural
signals and the hardware requirements for tracking their real-time fluctuations. On the
other hand, state estimation involves identifying critical events that could be sugges-
tive of disease processes. For optimal delivery of bio-electronic therapy, prediction is
the most desirable outcome. Nevertheless, early and accurate state estimation can be
used to adjust therapy to suit patients’ needs. State estimation tracks fluctuations in
PD symptom severity so that stimulation can be modulated correspondingly. As such
PD symptom severity is represented by the probability that a patient signal is a PD
condition. A good understanding of the system dynamics is essential for achieving ade-
quate control. The state estimator measures the PD dynamics to enable the controller
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to update stimulation appropriately. The complex nature of the underlying processes
in physiological signals has led to the development of various machine learning frame-
works for modelling data. These frameworks give an insight into the evolution of the
pathophysiological processes in patients and they help to model transitions between
various states in a disease. Machine learning algorithms are classified into supervised
(using labelled data), semi-supervised (using partly labelled data) and unsupervised
(using unlabelled data) learning algorithms. Table 6.1 highlights the working principle
of each of the classes of machine learning algorithms.
Table 6.1: Working principle of the major classes of machine learning algorithms.
Algorithms Operating Principle Remarks
Supervised The provided labels enable
the formation of a robust and
efficient model.
Supervised learning algorithms
are adopted for use in PD
tracking. They are generally the
preferred approach in medical
applications because of the
availability of medical records
with clinical annotations. These
annotations provide clinicians
(or trained operators) proper
monitoring of disease processes,
which could help inform
treatment strategies.
Semi-supervised Uses a mixed approach of
supervised and unsupervised
learning where some of the
training data are labelled and
others are not.
Unsupervised Builds representations from
unlabeled data by finding
hidden structure (e.g. clus-
tering and dimensionality re-
duction).
6.2.1 Supervised Learning Algorithms
These algorithms are not only concerned with detecting patient states but can also
be used in understanding the evolution of the pathophysiological processes in patients;
thus modelling transitions between various states in a disease. Supervised learning
algorithms are divided into discriminative and generative machine learning models.
6.2.1.1 Discriminative Algorithms
Discriminative models focus on detecting disease or non-disease states, in this case, PD
and non-PD states. In BMI applications, various discriminative frameworks have been
proposed, notable among are the logistic regression, support vector machine (SVM)
and k-nearest neighbour (k-NN) techniques – all of which were discussed in Chapter 4.
Logistic regression and SVM are parametric models while the k-NN is a non-parametric
model. Generally, non-parametric models like k-NN do not require the normal iterative
learning phase necessary to fit the training data to a classification model. Nevertheless,
their major setback is their storage requirements.
6.2.1.2 Generative Algorithms
Generative algorithms are particularly useful in applications were the sequence of tran-
sition between states is essential in determining future states, like in sleep-stage moni-
149
6. A Framework for Adapting Deep Brain Stimulation Based on Parkinsonian State
Estimates
toring applications [272]. In aDBS, they can be principally useful in applications were
stimulation parameters are defined by the evolution of the sensed neural potentials.
The most common generative frameworks are the Gaussian mixture model (GMM)
and the hidden Markov model (HMM). HMM uses hidden (non-observable) states that
can be inferred from a series of observable states to model the underlying processes.
Figure 6.2 shows a graphic representation of how the hidden states are modelled in a
typical generative model. In the example generative model in Figure 6.2, each state
is defined using three parameters: state transition probability (T), output observation
probability (O) and initial state probability (I). Figure 6.2 has two hidden states and
four output observations. Each node represents a state or output observation, with the
arrows representing state transition probability (tij) between the current state Si and
the next state Sj . The output probability Oij depicted by the dashed arrows, represents
the probability that the observation in Oj is from state Si. The initial state probability
(Ii), represents the probability that the sequence of observations start from state Si. In
Figure 6.2, state estimates are obtained using information on the output observation
and the previously recorded state. This can be used to obtain the probable sequence
of state of a process. Compared to discriminative algorithms, generative algorithms
present a more detailed analysis of the underlying processes involved. This study will
investigate the efficiency of a state estimator from each of the classes to validate the
proposed framework for adapting DBS.
6.2.2 Representative State Estimators
Generative algorithms model the data based on the joint probability distributions be-
tween its classes (PD and non-PD) while discriminative algorithm models data based
on their conditional probability distribution. One example in each of the two models
was used to test the soundness of the proposed framework for aDBS. A linear kernel
SVM was selected as the representative algorithm for the discriminative models while
the Gaussian mixture model (GMM) was selected for the generative algorithms. SVM
and GMM were selected because of their computational efficiency compared to other
similar algorithms. Figure 6.3 shows the gradation on a features space using the con-
ditional probability from the SVM as state estimate and the joint probability from the
GMM as state estimate.
The SVM discriminating function Equation 4.30 used in classifying test cases into either
PD or non-PD classes. The score in Equation 4.30 could range from negative infinity
to positive infinity depending on how large the features are, with the decision boundary
(demarcating point between PD and non-PD examples) represented by a score of 0.
The score provides a measure of how far a test case is from the decision boundary. Due
to the unbounded range of the scores, the scores are normalised to a range between 0
and 1 depending on their magnitude, with the decision boundary represented by the
region having a probability of 0.5. For the feature space in Figure 6.3 (a), the obtained
probabilities using the SVM discriminating function is illustrated in Figure 6.3 (c). The
GMM function in Equation 6.1 provides the level of similarity between a test case and
the training examples (with PD training examples as the reference point). If a test
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Figure 6.2: Graphical representation of a typical generative model. (a) Depicting the various
output observations on the feature space and the various parameters of the model
with: I as the vector of the initial probability of the states, T is a matrix of the
transition probability between states and O is a matrix of the output probabilities.
(b) A generative model having two hidden states (PD and non-PD) with four
output observations (O1, O2, O3, and O4).
151
6. A Framework for Adapting Deep Brain Stimulation Based on Parkinsonian State
Estimates
Figure 6.3: Contour plot for state estimates over a feature space for the machine learning
models. (a) Feature space for dataset C. (b) Probability density function (PDF)
for PD and non-PD training examples. (c) Contour plot for state estimates using
SVM, with a range form 0 - 1 representing levels of severity from non-PD to
PD. (c) Contour plot for state estimates using GMM, with a range form 0 - 1
representing levels of severity from non-PD to PD. The two features are, Feature
1 (21-26 Hz band) and Feature 2 (18-23 Hz band).
case presents a very good similarity to PD training examples it will have a probability
approaching 1, and if it has a good similarity to non-PD training examples it will have
a probability approaching 0 as can be seen in Figure 6.3 (d). Like the case for LR (in
Section 4.4.3.2 of Chapter 4) probabilities greater than or equal to 0.5 are classified
as PD and those less than 0.5 are classified as non-PD cases. This is why PD regions
are points on the feature space where the probability is greater than 0.5, while non-PD
regions are those in which the probability is less than 0.5. Thus, from non-PD to severe
PD is a transition in probability from 0 to 1.
The SVM uses the widest margin between differing states to discriminate. The discrim-
inating function for the SVM is given in Equation 4.30 as adapted from [238]. Figure
6.3 (c) depicts the state estimates obtained using SVM on the feature space in Figure
6.3 (a), whose probability density function (PDF) is shown in Figure 6.3 (b).
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The GMM estimates joint probability using a weighted sum of a number of PDFs.
These PDFs are used to form the Gaussian models. The weighted Gaussian functions





−→x − µi)TΛi(−→x − µi)) (6.1)
where wi is the weight assigned to a particular Gaussian model i, ~x is the input feature
vector for test case, µi is the mean vector for Gaussian model i and Λi is the covariance
vector. The major assumption employed in GMM is that the population of feature
vectors can be represented by N Gaussian models. For this application, two Gaussian
models are fitted in the training data, in order to represent each of the patient states
(PD and non-PD). Figure 6.3 (c) shows the state estimates obtained using SVM on the
feature space in Figure 6.3 (a), whose PDF is shown in Figure 6.3 (b).
6.3 Models and Metrics
The proposed model in Figure 6.1 consists of a physiological basal ganglia network,
a feature extraction stage, a state estimation stage for diagnosing PD severity and
an adaptive stimulator for delivering therapy. The basal ganglia network uses LFP
recordings to mimic the underlying mechanism of PD. LFP signals from the basal
ganglia model are applied to a feature processing stage, and the output from this stage
is applied to a regression model (state estimation stage) which estimates the patient
state. Stimulation parameters are adjusted based on patient state estimates. The model
was implemented using custom SIMULINK blocks (level-2 MATLAB S-function). The
S-function implementation operated at 128 Hz, which is the sampling frequency of
the original LFP signals. Thus, mimicking real-time operation. This was used to
validate the adaptive brain stimulation scheme that restored LFP characteristics with
PD condition to non-PD conditions by applying stimulation based on parkinsonian
state (symptom severity).
6.3.1 Basal-Ganglia Network Model
To validate these methods, a basal ganglia model using LFP recordings obtained from
measurements made on patients exhibiting a combination of bradykinesia and/or rigid-
ity during the onset of PD, with less noticeable tremor was employed. The network
which is shown in Figure 6.4, it consists of: patient LFP signals, modulating network
and the modulated LFP signal.
Patient LFP Signals
These are LFP signals consisting of PD and non-PD periods synthesized from real LFP
recordings. The LFP synthesis, involved fitting ARMA models to the real-life recordings
to produce semi-synthetic LFP signals. Fitting an ARMA model provides the flexibility
to manipulate the signal characteristics such that all underlying conditions can be
represented. Also, it offers the opportunity to generate LFP signals consisting of PD
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Figure 6.4: Basal-ganglia network model.
and non-PD episodes of variable duration. The complete LFP data synthesis process
and a detailed description of the LFP recordings are provided in Chapter 4 and in [90].
For the aDBS framework, on detecting PD-like LFP, the applied stimulus regulates the
input LFP signal such that the modulated LFP characteristics are restored to those
resembling non-PD LFP. For input LFP with non-PD characteristics, the modulated
LFP signal is the same as the patient LFP signal.
Modulating Network
The therapeutic mechanisms of DBS on neuronal activities are still not clear. Various
studies suggest that it reduces neuronal activities [273], while others claim that it
increases neuronal activities [33]. Later studies provide other alternative explanations
[32]. From the studies, what is clear is that DBS has a modulating effect on neuronal
activities at the stimulation site. Chapter 1 discussed a number of theories posited for
DBS mechanism. In this model, a black box approach was used to model the effect of
stimulation on patient LFP signals. In response to an applied stimulus, the modulating
network adjusts LFP signals such that they can be restored to their PD-free state. The
correlation between the changes in PD and the changes in the coefficient of variation
(CV) of neuronal signals supports the hypothesis that modulating LFP signals during
DBS is one of the mechanisms that can lead to PD suppression [274,275]. This prompted
the two-degrees-of-freedom (2-DOF) modulation applied by the modulating network as
shown in Figure 6.5. For 2-DOF modulation, the modulating network varies the patient
LFP signals in the two bands with the most pronounced variation between non-PD and
PD bands as shown in Figure 6.5 (b). In both bands, the headroom of variation for the
magnitude of the filter response is between 1 and the ratio of CV for non-PD to PD
(CVNPDCVPD ), as is shown in Figure 6.5 (c). This makes the modulating network unique for
each patient since the frequency response of the modulating network is dependent on
the relationship between PD and PD-free periods of individual patients.
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Modulated LFP Signals
These are extracellular LFP signals resulting from the modification of patient LFP sig-
nals by the modulating network. The modulated LFP signals are the signals monitored
by aDBS to adjust the stimulation.
Figure 6.5: 2-DOF modulating network used to simulate the effect of DBS on neuronal signals.
(a) Frequency response for configuration with non-PD having higher amplitude
in both bands. (b) Frequency response for configuration with PD having higher
amplitude in both bands. (c) Frequency response for configuration with non-PD
having higher amplitude in band 1, and PD having higher amplitudes in band 2.
CVNPD is the coefficient of variation for non-PD LFP signal and CVPD is the
coefficient of variation for PD LFP signal.
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6.3.2 Feature Extraction and Selection
6.3.2.1 Time-Frequency Analysis
It uses the FFT to obtain time-frequency data. This is achieved by dividing the signal
into windows and applying FFT to each window. This was discussed in Chapter 4 and
presented in Equation 4.14. For this application, the time-stamped measurements are
split into 2 seconds (consisting of 256 samples) overlapping epochs, with 50% overlap
between epochs. Also, the power bands (features) are divided into 5 Hz bands, with 3
Hz overlap between bands; 0 to 5 Hz, 3 to 8 Hz, . . . , 45 to 50 Hz. This provides a total
of 16 features. The window is chosen such that a balance between time and frequency
resolution is obtained.
6.3.2.2 Feature Selection
Feature selection involves reducing the number of features that will be used for state
estimation. This is achieved using the MRM. The process of MRM starts by identifying
the channel having the two bands with the most pronounced variation in activity.
The goal is to obtain the bands that make state estimation easier. The MRM is a
computationally simple method. It is discussed and investigated in more detail in
Chapter 4.
6.3.3 Stimulation Adaptation
It is used to respond to fluctuations in the dynamics of patient LFP data. The estimated
patient state is applied to the fuzzy controller and the fuzzy controller determines the
appropriate stimulation parameters. The fuzzy controller is designed in Section 6.4.
The limited understanding of DBS mechanisms makes the selection of stimulation pa-
rameters (i.e. amplitude, frequency and pulse duration) difficult [276]. Experimental
studies have been undertaken regarding the most beneficial stimulation parameter for
the reduction in motor symptoms. Some studies suggest that there are more notice-
able improvements when stimulation frequency is adjusted [277–279]. However, other
studies maintain that stimulation amplitude is more critical [280–282]. More research
has focused on stimulation frequency alone [109, 274, 283]. Nevertheless, the major
considerations in selecting stimulation parameters are patient responses to stimulation
patterns and power consumption to conserve battery life [276]. The consensus is that
the most beneficial stimulation frequency occurs at 130 Hz [274,277,284]. Based on the
therapeutic benefits of varying the stimulation frequency, the fuzzy rules are designed
to adjust the stimulation frequency. Adjusting the stimulation frequency modifies the
modulating effect in a quasi-linear fashion as is depicted in Figure 6.6. The headroom
for the frequency response of the modulating network in Figure 6.5 corresponds to a
stimulation frequency ranging from 0 − 90 Hz (i.e. a magnitude response of between
1 to CVNPDCVPD ). This is shown in Figure 6.6, where increasing the stimulation frequency
by 45 Hz moves the test case marked X to the centre of the non-PD cluster, while a
decrease of 45 Hz moves it to the centre of the PD cluster. In theory, a 90 Hz change in
stimulation frequency can move a test case from the centre of one cluster to the other
(PD to non-PD cluster or vice versa). To accommodate for outliers, the stimulation
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Figure 6.6: A contour plot depicting the effect of increasing stimulation frequency on the
transition path of a test case (in the XY-location marked “X”) over the feature
space. Feature space is that of dataset B.
frequency is capped at 180 Hz, which is normally the limit for conventional DBS.
6.3.4 Evaluation Metrics
In assessing the performance of the different state estimator based approaches, three
measures that are indicative of accuracy, latency and computational complexity have
been used.
6.3.4.1 Accuarcy
The state estimators are evaluated using MCC and WCE, both of which were discussed
in Chapter 3. MCC and WCE are balanced measures used in assessing state estimator
quality that can be used even for cases with skewed classes. MCC measures the cor-
relation coefficient between the observed and predicted binary classifications. It has a
range between −1 (total disagreement) and +1 (total agreement); with 0 representing
a random prediction. WCE is a weighted representation of type I and type II error











where TP are the true positives, FP the false positives, FN the false negatives and
TN the true negatives. The major shortcoming of MCC is that it can only be used
when one of the denominators TP +FN , TP +FP , TN +FP and TN +FN is not a
zero. The first part of Equation 6.2 represents type I error (false-positive rate), while
the second part represents type II error (false-negative rate). In Equation 6.2, WCE
uses equal weights to compute the average of type I and type II error.
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6.3.4.2 Latency
Detection latency in this work measures the total time required by the system (or
controller) to settle to the modal class interval for non-PD state defined by the fuzzy
controller. For SVM driven control policy, it is a state between 0.15 and 0.35, while for
GMM, it is a state between 1× 10−8 and 0.1.
6.3.4.3 Computational Complexity
A critical consideration in assessing complexity cost in BMI processors is determining
the arithmetic operations required to decode information from neural activity. This
is particularly important for resource efficient hardware implementation. Arithmetic
manipulations are performed on recorded signals to transform them into useful, man-
ageable or computationally efficient forms. In this work, the primary concern is the
computational cost of the critic-actor control algorithm consisting of the state estima-
tor and the fuzzy controller. Computational cost consists of two components, NOP and
memory requirements. NOP is measured using the number of additions and number of
multiplications. It can be represented mathematically as [91],
NOP = Nadd(sub) +Res ·Nmult(div) (6.3)
where Nadd(sub) is the number of 1-bit additions or subtractions; Nmult(div) is the num-
ber of 1-bit multiplications and divisions required in each algorithm; and Res is the
resolution of the data converter used. For memory estimates, the number of 1-bit
registers required are obtained.
6.4 Fuzzy Controller Design
Based on the severity of parkinsonian state, fuzzy rules are defined to regulate stimula-
tion based on parkinsonian state estimates. The fuzzy controller modifies the frequency
of the stimulation applied to the modulating network to suppress PD-related oscilla-
tions. A fuzzy controller was chosen because it uses a reasoning which is similar to
human reasoning and decision making. This makes it superior in handling non-linearity
and uncertainty compared to schemes like proportional-integral-derivative controllers,
lead-lag and state feedback control [147, 285]. Fuzzy controller design essentially in-
volves the following:
• Choosing the fuzzy controller inputs and outputs.
• Choosing the pre-processing that is required for the controller inputs and the
post-processing for the controller outputs.
• Designing the four components of the fuzzy controller (rule-table, inference mech-
anism, fuzzification and defuzzification as shown in Figure 6.7).
Figure 6.7 depicts the block diagram of a fuzzy controller for adapting DBS. To facilitate
the design of the fuzzy controller, Figure 6.8 (a) and (b) shows the desired average profile
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Figure 6.7: Block diagram of a fuzzy controller for adapting DBS.
for the effect of incremental stimulation frequency for all possible input combinations
for the SVM and GMM driven approaches respectively.
Figure 6.8 represents the average 3-D profile that maps state estimates and change in
state to stimulation frequency. To obtain the profile or each patient dataset, training
examples at discrete points on the feature space representing states estimates ranging
0 to 1 in steps of 0.1 are identified. For training examples at each discrete point on
the feature space, stimulation frequency is increased in steps from −45 to +45 Hz (in
steps of 5 Hz). The corresponding rate of change in patient state is obtained for each
discrete pair consisting of patient state estimate and applied stimulation frequency.
This produces a mapping of three variables (patient state estimates, change in state
and applied stimulation frequency). This means, for every patient state, there is an
applied stimulation frequency that results in a specific rate of change in patient state.
The process is repeated for all nine patient datasets and the average for the various
profiles obtained as Figure 6.8 (a) and (b). For the SVM based approach, Figure 6.8
(a) represents the average 3-D profile that maps state estimates and change in state
to stimulation frequency. This is represented by Figure 6.8 (b) for the GMM based
approach. The average profiles in Figure 6.8 are used to guide the rule-tables used to
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Figure 6.8: Surface plot for input-output relationship for: (a) SVM based controller, (b) GMM
based controller.
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control PD suppression. The profile for the change in state (measured in s−1) targets
a settling time of between 1 to 1.5 seconds from the centre of the modal class of the
PD state (with a probability 0.75 for SVM, and 0.9999 for GMM) to the centre of
the modal class of the non-PD state (with a probability 0.25 for SVM and 1 × 10−4
for GMM). From Figure 6.8 it is obvious that from a PD state of 1, the SVM-driven
approach has a more gradual descent, while the GMM has a sharper descent at the
edges, plateaus for a range of input values in which change in input only causes a slight
change in stimulation frequency before it finally descends steeply. This surface plot
guided the choice of membership function and rule table for the fuzzy controller, which
are normally chosen heuristically. The input-output relationship was obtained using
the average profile for state estimate and incremental stimulation frequency which are
depicted in Figure 6.3 and Figure 6.6 respectively.
6.4.1 Fuzzification
This is the encoding step. It modifies the inputs so that they can be interpreted
and compared to the rules in the rule-table. The controller inputs are converted to
information usable by the inference mechanism. Obtaining a value for an input variable
and finding the numeric values of the membership functions that are defined for that
variable. It can also be seen as an encoding of the fuzzy controller inputs. The encoded
information is used in the fuzzy inference process that begins with matching.
6.4.2 Fuzzy Rules and Membership Functions
Fuzzy rules and membership functions are obtained by studying the plant dynamics
(using modelling and simulation), based on these, a set of control rules that make
sense are adopted. This makes fuzzy controller design subjective and dependent on the
expert designer. Also, the adaptable nature of a fuzzy controller makes it a suitable
candidate, since the mechanisms of DBS are still under debate. The control scheme
uses a two-input one-output fuzzy controller. The inputs are PD state estimate and
the rate of change in state. The state estimates and rate of change in state quantify
the dynamics of the underlying process to enable control. State estimates are obtained
using SVM and GMM. The output is the incremental stimulation frequency. Based on
the gradation of the state estimates in Figure 6.3 (c) and Figure 6.3 (d), and the contour
plot depicting the effect of stimulation frequency in Figure 6.6, triangular membership
functions were used for the inputs and output of the SVM driven approach. While for
the GMM based approach, Gaussian functions were adopted. The rule table for the
SVM-driven control approach is shown in Table 6.2. It is obtained using the 3-D profile
in Figure 6.8 (a) representing the mapping between state estimates and change in state
to stimulation frequency. By representing each triangular membership function of the
state estimates by the equation,
161
6. A Framework for Adapting Deep Brain Stimulation Based on Parkinsonian State
Estimates
µA(a;xi, yi, zi) =

0, a ≤ xi
a−xi
yi−xi , xi ≤ a ≤ yi
zi−a
zi−yi , yi ≤ a ≤ zi
0, a ≥ zi
 (6.4)
where µA is the certainty of membership in a fuzzy set, a is the universe of discourse [0,
1] for state estimates (b is used for the change in state for SVM, and c is used for the
output for SVM), xi,yi and zi are scalar parameter representing points on the triangle.
The left feet of the triangle is represented by xi, the peak of the triangle is represented
by yi and the right feet is represented zi. The input membership function for the
rules in Table 6.2 are summarised in Table 6.3 and Table 6.4. While the membership
functions for the output (incremental stimulation frequency) is summarised in Table
6.5.
For the GMM based-control approach, its rule table is shown in Table 6.6. It uses
Gaussian membership functions, some of which are symmetrical about the mean, while
others are unsymmetric about the mean. Equation 6.5 represents the membership for
the state estimates that are symmetrical about the mean,




B−4 B−3 B−2 B−1 B0 B1 B2 B3 B4
State
A0 C−3 C−3 C−2 C−2 C−1 C−1 C0 C0 C1
A1 C−2 C−2 C−1 C−1 C−1 C0 C0 C1 C1
A2 C−2 C−1 C−1 C0 C0 C0 C1 C1 C1
A3 C−1 C−1 C0 C0 C0 C1 C1 C2 C2
A4 C0 C0 C0 C0 C1 C1 C2 C2 C2
A5 C0 C0 C0 C1 C1 C2 C2 C3 C3
A6 C0 C1 C1 C1 C2 C2 C3 C3 C3
A7 C1 C1 C1 C1 C2 C2 C3 C3 C3
A8 C1 C1 C1 C2 C2 C2 C3 C3 C3
A9 C1 C1 C2 C2 C2 C3 C3 C3 C3
A10 C1 C2 C2 C2 C2 C3 C3 C3 C3
Table 6.3: Membership function for state estimates using SVM based approach.
Fuzzy Set Membership Function (µA)
A0 = [x0 = 0, y0 = 0, z0 = 0.10] µA(a;x0, y0, z0)
A1 = [x1 = 0, y1 = 0.10, z1 = 0.15] µA(a;x1, y1, z1)
A2 = [x2 = 0.15, y2 = 0.25, z2 = 0.35] µA(a;x2, y2, z2)
A3 = [x3 = 0.35, y3 = 0.40, z3 = 0.45] µA(a;x3, y3, z3)
A4 = [x4 = 0.40, y4 = 0.45, z4 = 0.50] µA(a;x4, y4, z4)
A5 = [x5 = 0.45, y5 = 0.50, z5 = 0.60] µA(a;x5, y5, z5)
A6 = [x6 = 0.50, y6 = 0.60, z6 = 0.70] µA(a;x6, y6, z6)
A7 = [x7 = 0.60, y7 = 0.70, z7 = 0.80] µA(a;x7, y7, z7)
A8 = [x8 = 0.70, y8 = 0.80, z8 = 0.90] µA(a;x8, y8, z8)
A9 = [x9 = 0.80, y9 = 0.90, z9 = 1] µA(a;x9, y9, z9)
A10 = [x10 = 0.90, y10 = 1, z10 = 1] µA(a;x10, y10, z10)
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Table 6.4: Membership function for change in state (s−1) using SVM based approach.
Fuzzy Set Membership Function (µB)
B−4 = [x−4 = −0.31, y−4 = −0.31, z−4 = −0.24] µB(b;x−4, y−4, z−4)
B−3 = [x−3 = −0.31, y−3 = −0.24, z−3 = −0.17] µB(b;x−3, y−3, z−3)
B−2 = [x−2 = −0.24, y−2 = −0.17, z−2 = −0.10] µB(b;x−2, y−2, z−2)
B−1 = [x−1 = −0.17, y−1 = −0.10, z−1 = 0] µB(b;x−1, y−1, z−1)
B0 = [x0 = −0.10, y0 = 0, z0 = 0.10] µB(b;x0, y0, z0)
B1 = [x1 = 0, y1 = 0.10, z1 = 0.17] µB(b;x1, y1, z1)
B2 = [x2 = 0.10, y2 = 0.17, z2 = 0.24] µB(b;x2, y2, z2)
B3 = [x3 = 0.17, y3 = 0.24, z3 = 0.31] µB(b;x3, y3, z3)
B4 = [x4 = 0.24, y4 = 0.31, z4 = 0.31] µB(b;x4, y4, z4)
Table 6.5: Membership function for Incremental stimulation frequency (Hz) using SVM based
approach.
Fuzzy Set Membership Function (µC)
C−3 = [x−3 = −60, y−3 = −45, z−3 = −30] µC(c;x−3, y−3, z3)
C−2 = [x−2 = −45, y−2 = −30, z−2 = −15] µC(c;x−2, y−2, z2)
C−1 = [x−1 = −30, y−1 = −15, z−1 = 0] µC(c;x−1, y1, z1)
C0 = [x0 = −15, y0 = 0, z0 = 15] µC(c;x0, y0, z0)
C1 = [x1 = 0, y1 = 15, z1 = 30] µC(c;x1, y1, z1)
C2 = [x2 = 15, y2 = 30, z2 = 45] µC(c;x2, y2, z2)
C3 = [x3 = 30, y3 = 45, z3 = 60] µC(c;x3, y3, z3)
µD(d;σi, di) = e
−(d−di)2
2σ2
i , di − 3.7σi ≤ d ≤ di + 3.7σi (6.5)
where µD is the certainty of membership in a fuzzy set, d is the universe of discourse [0,
1] for state estimates (e is used for the change in state for GMM, and f is used for the
output for GMM), σi and di are scalar parameters representing the standard deviation
and mean respectively of the symmetric Gaussian function. On the other hand, the
unsymmetric Gaussian functions can be represented by Equation 6.6,








ib , di ≤ d ≤ di + 3.7σib
 (6.6)
where µD is the certainty of membership in a fuzzy set, d is the universe of discourse [0,
1] for state estimates (e is used for the change in state for GMM), σia is the standard
deviation of the left tail of the Gaussian membership function, σib is the standard
deviation of the right tail of the Gaussian membership function, and di represents the
mean of the Gaussian function. Its input membership functions for the rules in Table
6.6 are summarised in Table 6.7 and Table 6.8. While the membership functions for
the output (incremental stimulation frequency) is summarised in Table 6.9.
The universe of discourse for the state estimates for both SVM and GMM driven
approaches is [0, 1] as can be seen in Figure 6.9 (a) and Figure 6.10 (a) for the SVM and
GMM respectively. The input fuzzy sets for the SVM are represented by alphanumeric
163
6. A Framework for Adapting Deep Brain Stimulation Based on Parkinsonian State
Estimates
variables A0, A1 . . . , A10, and that of the GMM is D0, D1, . . . , D7. This means that for
state estimates, the SVM driven approach has eleven fuzzy sets and the GMM driven
approach has eight fuzzy sets.
For the second input which is the change in state, the fuzzy sets of the SVM driven




E−4 E−3 E−2 E−1 E0 E1 E2 E3 E4
State
D0 F−3 F−3 F−2 F−1 F−1 F−1 F0 F0 F1
D1 F−2 F−2 F−1 F−1 F−1 F0 F0 F1 F1
D2 F−2 F−1 F−1 F0 F0 F0 F1 F1 F2
D3 F−1 F−1 F0 F0 F0 F1 F1 F2 F2
D4 F0 F0 F0 F1 F1 F1 F2 F2 F2
D5 F0 F0 F1 F1 F2 F2 F2 F2 F3
D6 F1 F1 F1 F2 F2 F2 F3 F3 F3
D7 F1 F1 F2 F2 F2 F3 F3 F3 F3
Table 6.7: Membership function for state estimates using GMM based approach.
State Estimates Membership Function (µD)




2σ20 , 0 ≤ d ≤ 3.7σ0
}
D1 = [σ1a = 1×10−10, σ1b = 3.23×10−9, d1 =
1× 10−10]
µD(d;σ1a, σ1b, d1)
D2 = [σ2a = 3.33 × 10−5, σ2b = 3.33 ×
10−2, d2 = 1× 10−4]
µD(d;σ2a, σ2b, d2)
D3 = [σ3 = 0.1, d3 = 0.4] µD(d;σ3, d3)
D4 = [σ4 = 0.1, d4 = 0.6999] µD(d;σ4, d4)
D5 = [σ5a = 0.1, σ5b = 3.33 × 10−5, d5 =
0.9999]
µD(d;σ5a, σ5b, d5)
D6 = [σ6a = 3.33 × 10−5, σ6b = 3.33 ×
10−10, d6 = 0.999999999]
µD(d;σ6a, σ6b, d6)




2σ27 , 1− 3.7σ7 ≤ d ≤ 1
}
Table 6.8: Membership function for change in state(s−1) using GMM based approach.
Change in state (s−1) Membership Function (µE)
E−4 = [σ−4a = 1.5, σ−4b = 0.165, e−4 = −0.5] µE(e;σ−4a, σ−4b, e−4)
E−3 = [σ−3a = 0.165, σ−3b = 0.00167, e−3 =
−0.005]
µE(e;σ−3a, σ−3b, e−3)
E−2 = [σ−2a = 0.00167, σ−2b = 1.67 ×
10−8, e−2 = −5× 10−8]
µE(e;σ−2a, σ−2b, e−2)
E−1 = [σ−1a = 1.67 × 10−8, σ−1b = 1.67 ×
10−14, e−1 = −5× 10−14]
µE(e;σ−1a, σ−1b, e−1)
E0 = [σ0 = 1.67× 10−14, e0 = 0] µE(e;σ0, e0)
E1 = [σ1a = 1.67 × 10−14, σ1b = 1.67 ×
10−8, e1 = 5× 10−14]
µE(e;σ1a, σ1b, e1)
E2 = [σ2a = 1.67 × 10−8, σ2b = 0.00167, e2 =
5× 10−8]
µE(e;σ2a, σ2b, e2)
E3 = [σ3a = 0.00167, σ3b = 0.165, e3 = 0.005] µE(e;σ3a, σ3b, e3)
E3 = [σ3a = 0.165, σ3b = 1.5, e3 = 0.5] µE(e;σ4a, σ4b, e4)
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Figure 6.9: Input-output membership functions for the fuzzy controller driven by SVM state
estimates. (a) Membership functions for the state estimates. (b) Membership
functions for the rate of change in state. (c) Membership function for the incre-
mental stimulation frequency.
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Figure 6.10: Input-output membership functions for the fuzzy controller driven by GMM
state estimates. (a) Membership functions for the state estimates. (b) Member-
ship functions for the rate of change in state. (c) Membership function for the
incremental stimulation frequency.
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Table 6.9: Membership function for incremental stimulation frequency (Hz) using GMM based
approach.
Incremental Stimulation Frequency (Hz) Membership Function (µF )
F−3 = [σ−3 = 4.95, f−3 = −45] µF (f ;σ−3, f−3)
F−2 = [σ−2 = 4.95, f−2 = −30] µF (f ;σ−2, f−2)
F1 = [σ−1 = 4.95, f−1 = −15] µF (f ;σ−1, f−1)
F0 = [σ0 = 4.95, f0 = 0] µF (f ;σ0, f0)
F1 = [σ1 = 4.95, f1 = 15] µF (f ;σ1, f−1)
F2 = [σ2 = 4.95, f2 = 30] µF (f ;σ2, f−2)
F3 = [σ3 = 4.95, f3 = 45] µF (f ;σ3, f3)
approach are represented by alphanumeric variables B−4, . . . , B0 . . . , B4, making a total
of nine fuzzy sets. Their membership functions are summarised in Table 6.4. From
Table 6.4, it can be seen that negative subscripts represent a change in PD probability
from one towards zero (PD to non-PD) and positive subscripts represent a change
from zero towards one (non-PD to PD). This is the same for the change in state
of the GMM-driven approach with fuzzy sets represented by alphanumeric variables
E−4, . . . , E0, . . . , E4, and their respective membership functions summarised in Table
6.7. As summarised in Table 6.4 and Table 6.7 respectively, the universe of discourse for
the SVM-driven approach is [−0.31, 0.31]s−1 and that of the GMM-driven approach is
[−5, 5]s−1. The fuzzy sets representing the output (incremental stimulation frequency)
are labelled C−3 . . . , C3, for the SVM approach and that of the GMM are labelled
F−3, . . . , F3. Like in the fuzzy sets for the change in state, the negative subscripts
represent an output representing a reduction in stimulation frequency, while a positive
subscript represents an output resulting in an increase in stimulation frequency. Both
have a universe of discourse of [-60, 60] Hz. Based on heuristics, the SVM rule-table
has an 11× 9 array making a total of 99 possible rules, which are summarized in Table
6.2. For the GMM rule-table in Table 6.6, it is made up of an 8 × 9 array making a
total of 72 possible rules.
The desired fuzzy set for the SVM driven approach is shaded in Figure 6.9 (a). The
desired fuzzy set for state is between the intervals 0.15 - 0.35 [represented by fuzzy set
A2 in Figure 6.9 (a)]. This represents the modal class for non-PD cases. In terms of the
change in state, the desired interval is between −0.1s−1 to 0.1s−1 [represented by B0 in
Figure 6.9 (b)]. The modal class interval for the state estimate (A2) was made not to
overlap with other classes to avoid ambiguity in fuzzy quantification. The outermost
membership functions for the inputs can be seen to saturate and values outside the range
are grouped to their closest fuzzy set. However, this is not the case for the output, due
to the requirement for a defined output value at any instant in time. For the GMM
driven approach, the desired input values are a probability of: 1× 10−8 to 0.1 for state
estimates [represented by D2 in Figure 6.10 (a)] and −5 × 10−14/s to 5 × 10−14/s for
change in state [represented by E0 in Figure 6.10 (b)]. Fuzzy rules and definition of
membership function are subjective and are dependent on the expert designer. That is
why a wide desired range was selected in both approaches to ensure convergence. Also,
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the selected range represents the modal state for stable and non-disease conditions
when projected to the patient feature space, which could be demonstrative of symptom
severity. The membership functions and fuzzy rules were defined carefully based on
the gradation of the state estimates on the patients feature space. This was to enable
a gradual and deliberate PD suppression as against abrupt and jerky response.
6.4.3 Inferenece Mechanism
The inference mechanism generally involves two steps. Comparing the premise of all
rules to the controller inputs to determine which rules apply to the current situation. It
involves determining the certainty with which rules apply. The recommendations from
rules that we are more certain with are adopted. Conclusions (control actions to take)
are drawn using the rules that have been determined to apply at the current time. The
conclusions are characterised by a fuzzy set that represents the certainty with which
the input should take various values.
Premise Quantification: It involves quantifying the certainty with which our inputs be-
long to a fuzzy set. Then using the rules for combining premise based on Boolean logic,
the certainty of the premise is obtained. There are two methods for quantifying an op-
eration: minimum and product operation. In this work, premise is quantified using the
minimum operation. Before that, the first step is to determine the applicability of each
rule which is called matching. A rule is activated if its premise membership function
µpremise (i) > 0. As an example, assuming the current state is 0.05 and the change in
state is −0.15 s−1, then using the SVM rules in Table 6.2, premise quantification can
be obtained as shown in Figure 6.11. Based on this, the applicable rules are,
1. if A0 and B−2 then C−2 : µpremise(1) = min{0.5, 0.7143} = 0.5
2. if A0 and B−1 then C−2 : µpremise(2) = min{0.5, 0.2857} = 0.2857
3. if A1 and B−2 then C−1 : µpremise(3) = min{0.5, 0.7143} = 0.5
4. if A1 and B−1 then C−1 : µpremise(4) = min{0.5, 0.2857} = 0.2857.
Rules 2 and 4 are masked by rules 1 and 3 respectively. As a result, only µpremise(1)
and µpremise(3) will be applicable for use.
Determining Conclusions: The first step is to consider the recommendations of each
rule independently. Then later the recommendations from all the rules are combined
to determine the output. The minimum premise quantification is used for ANDing in
above. Based on the premise quantification, the ‘output fuzzy set’ is determined which
are C−1 and C−2. The justification for using the minimum operator for quantification
is that we can be no more certain about our consequent than the minimum of all our
premise. While the input to the inference process is a set of rules that are on, its output
is the set of implied fuzzy sets that represent the conclusions reached by all rules that
are on. At any given time since we are using two inputs and one output we can have
three possible scenarios for applicable rules: one, two or four rules can be active.
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Figure 6.11: Premise quantification and defuzzification.
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6.4.4 Defuzzification
This is the final operation of the fuzzy controller. It operates on implied fuzzy sets
(output fuzzy sets) produced by the inference mechanism. It combines the effects of
the various fuzzy sets to produce the ‘most certain’ controller output (plant output).
Defuzzification can be considered as decoding. As the fuzzy sets produced by the
inferencing process (implied fuzzy sets) is converted to numerical controller outputs.
The centre of gravity (COG) method for combining recommendations represented by
the implied fuzzy sets of all the rules is adopted for defuzzification. It is worth noting
that:
• To avoid having an infinite area such that the COG is infinite, saturated member-
ship functions are not allowed for the output membership functions. The COG is
made not to extend beyond certain limits such that outputs above certain ranges
are not applied.
• Fuzzy rules must be defined such that the sum of the denominator (in Equation
6.7) for computing COG is not equal to zero. A denominator of zero means that
an undefined output will be obtained.
• Computations needed to obtain the COG of a triangle are not too significant.
If ci denotes the centre of the membership function of implied fuzzy sets Ci, from Figure
6.11, C−2 = −30 and C−1 = 15. To obtain the additional stimulation frequency Cstim
required to move the test case from its current position to the modal class for PD using








where Ai denotes the area under the membership function Ci. Cstim for the case in
Figure 6.11, incremental stimulation frequency is obtained to be -22.5 Hz. As such
stimulation will need to be increased by -22.5 Hz since the current state is 0.05 and
the state is changing at a rate of −0.15s−1. A change in state of −0.15s−1 represents a
movement away from the non-PD modal class (0.15 - 0.35 for SVM based approach).
From both rule tables for the SVM and GMM driven approaches, the pattern of rule
consequents show a certain symmetry. For states estimates approaching a state of 1
and having a positive rate of change in state (positive subscript, i.e. moving from non-
PD to PD), there is a positive increase in stimulation frequency (positive subscript).
Similarly, for state estimates approaching 0 and having a negative rate of change in
state (negative subscript, i.e. moving from PD to non-PD), the incremental stimulation
frequency is negative (negative subscript).
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PD suppression is depicted in Figure 6.12 using the GMM and SVM driven approaches.
From Figure 6.12 (a) which depicts SVM state estimation, it can be seen that the test
case travels from the PD region and converges at the non-PD region as desired. It is
also the case for the GMM approach in Figure 6.12 (c), but with a smoother trajectory.
Figure 6.12 (a) and (c) show the XY-profile and Figure 6.12 (b) and (d) display the
time profile.
For the time profile, it can bee seen that both cases cross the desired interval exactly
Figure 6.12: State transition of PD suppression on feature space. (a) Showing PD state
transition on a feature space using SVM for state estimation, with “X” markers
showing start (from PD) and settling (non-PD) positions. The XY-trajectory is
indicated in grey. (b) PD state profile for PD suppression using SVM to obtain
state estimates. It depicts the modal interval for the non-PD state when SVM
is used for state estimation. (c) Showing PD state transition on a feature space
using GMM for state estimation, with “X” markers showing start (from PD)
and settling (non-PD) positions. The XY-trajectory is indicated in grey. (d)
PD state profile for PD suppression using GMM to obtain state estimates. It
depicts the modal interval for the non-PD state when GMM is used for state
estimation. The feature space was that of dataset E.
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after 2 seconds and both present the same settling profile. After settling, the SVM based
approach has a mean PD state of 0.3137 and GMM-driven approach has a PD state of
1.3×10−2, both of which fall within the desired range. The stimulation profile for both
cases is shown in Figure 6.13. Both cases present almost the same stepwise pattern,
with the SVM having a more gradual ascent to the required stimulation frequency
compared to the GMM which overshoots before finally settling. The settling frequency
for both cases are not far apart. The XY-profile on the feature space and the time
profile (both in Figure 6.12) display a stable PD suppression profile. In addition, the
stimulation profile in Figure 6.13 also displays a stable stimulation profile. Both of
these are indicative of a stable PD suppression.
For the rest of the datasets, Figure 6.14 and Table 6.10 summarises their mean PD
state and settling time. For the mean PD state in Figure 6.14 (a), the SVM has a
lower quartile of 0.2514 and an upper quartile of 0.3162, which both fall within the
desired range (0.15 - 0.35). For the GMM, it has an upper quartile of 0.0851 and a
lower quartile of 2.5× 10−4, which are both within the desired range (1× 10−8 − 0.1).
For the average settling times in Figure 6.14 (b), the SVM-driven approach has a lower
quartile of 1.25 secs and an upper quartile of 1.875 secs. The design targeted 1 − 1.5
seconds settling time, this is not far off the desired mark.
While for the GMM, it has a lower quartile of 0.25 and an upper quartile of 1.75 sec. The
GMM based approach is a bit off the desired 1 – 1.5 seconds settling time. Nevertheless,
it has a median settling time of 1.25 seconds which falls within the desired range of
values (between 1 - 1.5 second settling time). The behaviour of the GMM based-
approach can be attributed to the gradation of the GMM based state estimates, which
makes smooth control of its trajectory more difficult than the SVM based approach.
This shows that on average, the GMM based approach has more fluctuations in settling
times compared to the SVM based approach as shown in Table 6.10.
Figure 6.13: Stimulation profile for the state transition shown in Figure 6.12.
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Figure 6.14: Summarizing the mean settling state and settling time for the various dataset
using SVM and GMM driven approaches. (a) Mean settling state for SVM
(median = 0.2584) and GMM (median = 4× 10−3). (b) Settling time for SVM
(median = 1.5 secs) and GMM (median = 1.25 secs).
Table 6.10: Average settling time and settling state for various patient datasets.
Datasets
Average settling time (secs) Average settling state
SVM GMM SVM GMM
A 1.25 0.50 0.3237 0.0034
B 1.50 1.75 0.2584 0.1640
C 1.50 1.25 0.2802 3.5 ×10−4
D 1.25 0.25 0.2547 4.5 ×10−9
E 1.75 1.75 0.3137 0.0130
F 1.75 1.75 0.2542 0.0720
G 2.25 2.25 0.4950 0.1245
H 2.25 0.25 0.1735 4.4 ×10−20
I 0.5 0.25 0.2431 0.0042
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6.5.2 Performance of State Estimators
To assess the quality of the SVM and GMM state estimators, the MCC and WCE which
are skew insensitive measures were used. The MCC measured the correlation coefficient
between the original dataset and the models fitted using each of the state estimators.
On the other hand, the WCE consisted of weightings of type I and type II error. This
was because in aDBS, high false positive-rate will result in administering stimulation
when it is not required, and this may lead to stimulation induced side effects [217].
High false-negative rate will result in the non-administering of stimulation when it
may be required, which could worsen patient condition [37]. The real-time detection
performance of the state estimator was investigated. Both models used 128 training
examples and PD events were detected from two-second overlapping epochs (with 50%
overlap). Table 6.11 summarises the average result obtained for each dataset for 100
Monte Carlo runs using 256 test cases (256 LFP epochs).
For MCC in Table 6.11, both state estimators present a positive correlation for all
datasets, with the SVM having a median of 1 and the GMM with a median of 0.9433.
Of the 9 cases, both SVM and GMM have 7 cases with strong positive correlation
(MCC ≥ 0.5). Only the state estimates of dataset G have a weak positive correlation
in both cases. This is due to the high overlap between its PD and non-PD clusters
which makes it difficult to fit the classifier to the data. From the MCC results, it can
be seen that SVM fits the data better than the GMM. Similarly, the WCE results
present a superior performance of the SVM over the GMM. The SVM presents a mean
and median WCE of 9.03% and 0% respectively. While the GMM presents a mean and
median of 11% and 1.98% respectively. This further confirms the superiority of the
SVM over the GMM in fitting the data.
6.5.3 Relative Complexity
To obtain complexity estimates for both approaches, 128 training examples were as-
sumed to be used with 8-bit quantisation (GMM inputs to fuzzy controller were assumed
to have 32-bit quantization due to their resolution requirements) and 10% of the train-
ing examples were assumed to be support vectors of the SVM. The relative complexity
between the SVM-driven and GMM-driven approach for each of the two stages of the
Table 6.11: State estimation performance of SVM and GMM on various patient data.
Datasets
MCC WCE
SVM GMM SVM GMM
A 0.3534 0.5273 0.3447 0.2204
B 1 0.8863 0 0.0771
C 1 1 0 0
D 1 0.9976 0 0.0016
E 1 1 0 0
F 0.9433 0.9433 0.0198 0.0198
G 0.4479 0.2347 0.3273 0.3757
H 1 0.9963 0 0.0012
I 0.7371 0.4343 0.1210 0.2943
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critic-actor control policy are shown in Figure 6.15 . From Figure 6.15 (a), it can be
seen that at the state estimation stage the SVM-driven approach requires more NOP
(about 1.43 million 1-bit additions), with the GMM approach requiring only about 5%
SVM NOP. At the state estimation stage, computation in the GMM is dominated by
memory while for the SVM it is dominated by NOP. The GMM based approach will re-
quire about 42,352 1-bit registers to enable state estimation. This is because the GMM
is a population dependent algorithm, while the SVM only uses the footprint from the
population to infer properties.
In Figure 6.15 (b), the GMM requires a higher NOP for fuzzy inferencing due to its
adoption of Gaussian functions as against the triangular function used by the SVM –
where triangular COG is simpler to calculate. The GMM requires at least 784 1-bit
additions for fuzzy inferencing as against the 208 required by the SVM based approach
due to its triangular membership functions which makes COG computation easier. In
terms of memory, the GMM requires fewer rules compared to the SVM. The SVM based
Figure 6.15: Relative complexity of the critic-actor control driven by GMM and SVM. (a)
Normalized complexity for the state estimation stage. (b) Normalized complexity
for the fuzzy control stage. Normalized to the maximum for all cases (maximum
= 1).
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approach requires at least 952 1-bit registers to store its fuzzy rules, while the GMM
requires 904 1-bit registers. It is clear that in the state estimation stage the GMM has
less computation and more memory, while at the fuzzy control stage the reverse is the
case.
6.6 Discussion
6.6.1 Critic-Actor Control Policy
The critic-actor approach models the relationship between the physician and the au-
tomated neuromodulation system. The critic like the ‘trained clinician’ assesses the
state of the system based on a cost function (in this case state estimates) and provides
the information to the actor. The actor provides control signal based on evaluation
from the ‘informed critic’. In this configuration the state estimator is the critic, while
the fuzzy controller is the actor. The main motivation for adopting the critic-actor
control policy is because PD suppression can be extremely difficult to achieve due to
the limited understanding of the mechanisms underlying PD. This makes it difficult
to produce an accurate model that could be used for controller development. It is for
this reason that more heuristic methods are proposed. The adaptive scheme exhibited
the ability to restore patient LFP characteristics to PD-free conditions for different pa-
tients without a change in controller parameters. Changing conditions were monitored
through the state estimates, which was the feedback signal. The feedback-loop consists
of parkinsonian state (representing symptom severity) determination and stimulation
facilitated by the fuzzy controller. The control signal modulates the spectral features
to match PD free conditions of each individual patient. The resulting spectral features
show that the adaptive scheme has the capacity to restore PD signals to their primary
oscillations present under PD-free conditions. More so, using fuzzy inference mecha-
nisms to quantify the dynamics of PD can be very intuitive for modulating therapy.
Since it uses rule-based decision making that combines human heuristics into decision
making; these rules could be updated into the controller as more knowledge regarding
PD is acquired. Effective fuzzy control can only be achieved by adopting the right
input preprocessing, in this case state estimates and their rate of change over time
were chosen (as this determined the speed of PD suppression). In the future, external
signals e.g. accelerometer activity can be incorporated to produce comprehensive rules
that cover an increased number of possible situations. As things stand, optimal control
can only be achieved by having a deeper understanding of the underlying mechanisms
of DBS and PD – which is more of a clinical challenge. Ultimately, this tool could
provide a paradigm on which stimulation can be adapted. The study provides a frame-
work in which DBS can be adapted using heuristics. To validate the efficacy of the
approach, state estimates were obtained using both generative and discriminative ma-
chine learning models. Both showed promising results, which are attributable to their
self-calibrating nature resulting from their standard gradation on the patient feature
space.
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6.6.2 Model Limitations
At present, a model representing all possible dynamics is far from being realised because
there is insufficient knowledge to produce models which closely represent the expected
behaviour of the system. This is why PD symptom severity is represented by the prob-
ability that a patient LFP signal is a PD condition (ranging form 0 to 1). Apart from
clinically sound PD state estimates, several other issues are necessary to achieve efficient
PD onset control, such as optimal stimulation parameters and how they vary across
patients and time. More specifically, the study focused on modulating DBS frequency;
it is still under debate which of the parameters (stimulation intensity, pulse width and
frequency) is the most beneficial. Nevertheless, controlling one of the parameters could
shed more light on how best to control therapy. Currently, some assumptions regarding
the effect of stimulation on neuronal signals are used to create a stimulation model that
draws on the common denominator in all of the theories in [32,33,273]; which suggest a
modulating effect on neuronal signals. This model could be improved if more detailed
information on experimental LFP data consisting of stimulation parameters and PD
symptom severity are obtained. Achieving significant progress in aDBS will depend on
the correlation between patient state and LFP signal, as well as how stimulation mod-
ulates patient LFP. This would require a large LFP dataset representing the effect of
stimulation on the progression in PD symptoms for a wide range of patients. Presently,
the major challenge in adaptive DBS is the difficulty in establishing a direct relationship
between patient state and stimulation parameters. This is mainly due to the complex-
ity of post-surgery programming of stimulation parameters by trained clinicians, which
can take up to six months or more [287]. Because of the limited availability of PD
data incorporating the effects of stimulation, stimulation was modelled only by varying
stimulation frequencies. This was chosen because stimulation frequency has proven to
be more beneficial and reliable than other stimulation parameters [109,274,283].
Finally, the control policy proposed tends to work better on cases with separable classes
and more granular states. For non-binary clusters (like the XOR classification problem)
or binary clusters with large overlap (like the case shown in Figure 6.16), additional
input information may be required to enable convergence. In Figure 6.16 the interquar-
tile range (which is the modal class) of the PD and non-PD clusters have near complete
overlap. This will make fitting a machine learning model very difficult. Convergence of
the state estimates to the modal interval of the non-PD state can only be guaranteed
for feature spaces with binary clusters and machine learning models that produce an
MCC greater than 0.5.
6.7 Chapter Summary
The major hypothesis advanced by this chapter is that since obtaining realistic models
to design controllers for the brain may be difficult, heuristic methods could be adopted
to elucidate the mechanisms of DBS in patients. The following conclusions can be
drawn:
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Figure 6.16: 2-D representation of feature space with a very high similarity between PD and
non-PD clusters. It has a near complete overlap in the training examples that
fall within the interquartile ranges of both clusters. The interquartile range of
the non-PD cluster is represented by the light-red circle inscribed in the non-PD
cluster, and also indicated is the PDF for the non-PD cluster. While that of PD
is the light-blue circle inscribed in the PD cluster, and also indicated is the PDF
for the PD cluster.
a) The dynamic progression of neural signals in PD patients necessitated the adoption
of machine learning models for tracking PD. The machine learning models were
used to represent the probability that an epoch of LFP signal is a PD event. These
estimates were indicative of symptom severity
b) The fuzzy control approach was adopted for computational efficiency and robustness
to nonlinearity. This was done with hardware implementation in mind so that the
architecture can be deployed in fully implantable aDBS systems that automatically
adjust stimulation parameters in real-time in response to neurophysiological signals.
c) Fuzzy rules and membership functions are obtained by studying the plant dynamics
using modelling and simulation, based on these, and other requirements set by the
expert designer, a set of control rules that make sense are adopted. This makes
fuzzy controller design highly dependent on its designer.
d) The SVM and GMM-driven approaches used different fuzzy rules and membership
functions because of their differences in grading PD and non-PD severity.
e) Both control configurations (using either SVM or GMM machine learning models)
achieve PD suppression to the desired state in seven out of nine cases. This presents
evidence on the possibility of mitigating intractable Parkinsonism by adaptively
regulating stimulation using heuristic methods. However, it puts to question the
use of universal controllers for controlling DBS as different patient datasets resulted
in different settling times, settling states and state estimate profile.
f) Finally, this study presents a framework in which a control approach representing
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the relationship between the trained clinician and the neuro-modulation system
could be introduced into DBS adaptation. With better refinement and access to
more clinical recordings, the feasibility of this approach could be explored further
to ascertain if it could be deployed for clinical applications.
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Chapter 7
Output Stage of a Dynamic Current
Steering Stimulator for Adaptive Deep
Brain Stimulation
Clinical DBS uses 4 cylindrical electrodes driven in monopolar or bipolar configura-
tions. This yields a spherical stimulation field around the electrode modulating both
targeted and untargeted areas. This chapter presents an approach in which activation
field spread beyond targeted areas can be mitigated using dynamic current steering.
Dynamic current steering uses segmented electrodes as in [8] together with dynamic
current sources in order to accurately stimulate intended neural tissue. This chapter
will focus on the output stage of the dynamic current steering system. The chapter
is organised as follows: Section 7.1 gives a brief motivation for implementing the dy-
namic current steering system, Section 7.2 describes the high level architecture of the
proposed output stage, Section 7.3 presents the simulated performance of the output
stage, Section 7.4 gives a brief discussion and Section 7.5concludes the chapter.
7.1 Introduction
Cylindrical electrodes provide poor control over the stimulation field, since the re-
sulting potential distributes symmetrically around the contact electrode and not to
specific targets. This stimulates unintended neural structures and thus results in side
effects [130]. As a remedy, techniques that enable accurate targeting of the electric field
to the intended neural structures have been proposed [288]. These have been achieved
using novel current steering techniques and novel lead designs. In terms of lead design,
segmented electrodes were used in [8]. This produces radially distributed field around
the electrodes and enables better targeting of neural structures compared to cylindrical
DBS leads. More so, alternative methods using novel multipolar current steering stim-
ulators were presented in [127], with [128] using both multipolar and multisite current
steering. Additionally, precise neural targeting has been reported to improve the thera-
peutic window of DBS by reducing the threshold for beneficial effect and increasing the
threshold for side effects [125]. This reduces the need for high amplitude stimulation.
Current steering can also improve the long term adaptation of the system by tack-
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ling lead migration in chronic deep brain stimulation. In order to achieve this, novel
lead designs were proposed in [8]. In addition, the prospects of current steering led to
the commercial development various current steering stimulators, notable among is the
Vercise current steering system marketed by Boston Scientific. Most of the commercial
developments use multiple independent current sources. This approach is uneconomi-
cal in terms of area and power consumption. In order to reduce power consumption,
area and mismatch; dynamic current steering is proposed. Particular focus is placed on
the output stage which uses dynamic current sources (DCS) in achieving multichannel
current steering. Mismatch as well as power consumption are reduced by using a single
bias voltage for both anodic and cathodic stimulation. Dynamic current sources are
used in implementing 8 push-pull current sources which are interfaced to 16 electrodes
through a multiplexing stage. This ensures that the output stage lends itself well to
high neural selectivity and stimulation focus.
7.2 Output Stage Architecture
The architecture of the output stage is shown in Figure 7.1. It consists of a current
DAC, a PMOS and NMOS DCS as in [289], binary-weighted current sources and a
multiplexing stage. The output stage operates in two phases; programming (φ1) and
stimulation (φ2). During the programming phase, the current DAC (IDAC) is used in
setting the bias voltage (gate-source voltage) of the DCS in Figure 7.1.
Each DCS consists of a storage capacitor and a transistor in a voltage controlled resistor
(VCR) configuration as in [290]. The current DAC determines the amount of bias
voltage to be stored in the gate to source capacitors of each DCS transistor, this stored
voltage biases the DCS during the stimulation phase. During stimulation, the DCS
Figure 7.1: Architecture of the stimulator output stage.
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routes the stimulation current through the anodic and cathodic current sources, which
use binary weighted transistors in order to produce binary weighted currents, thereby
creating independently weighted current sources. These binary weighted currents are
steered to individual electrodes via a multiplexing stage, which provides flexibility by
enabling the use of each electrode as either an anode or a cathode. The electrode
configuration determines if an electrode sources or sinks current. For a proof of concept
of the approach, the design parameters used are summarised in Table 7.1. Programming
of the current sources adopted in this work enables the use of a single bias voltage during
both anodic and cathodic stimulation phases. Moreover, it ensures that only a single
branch is used for biasing and stimulation. This together reduces mismatch and power
consumption. Finally, the stimulator is driven in an idle mode – with the output stage
isolated from supply - during periods outside programming or stimulation.
7.2.1 Dynamic Current Sources
The DCS in Figure 7.2 is implemented using a VCR topology [289]. This was chosen
in order to boost the output impedance and lower the headroom voltage. A PMOS
configuration is used for the high voltage (HV) side, and an NMOS configuration is
used for the low voltage (LV) side. The drain to source voltage of M4 is set by the
PAMP amplifier, and that of M1 is set by the NAMP amplifier. Both amplifiers are
two stage amplifiers, with the NAMP having an NMOS input stage and the PAMP
having a PMOS input stage. They use a bias current of 1 µA each. The amplifiers are
used in a configuration such that a single amplifier is shared between programming and
stimulation phases.
In order to operate the M1 and M4 transistors in a VCR configuration, control is
required over the gate to source voltage (VGS) of each transistor. This serves as
the bias voltage, and is achieved during the programming phase, by activating the
programming switches in Table 7.2. The clock signals are shown in Figure 7.3. Figure
7.3 (a) shows the programming phase and Figure 7.3 (b) shows the stimulation phase.
This creates a path for the bias current to the PMOS and NMOS DCS. This current
flow through the DCS enables the storage of corresponding bias voltages in the gate
to source capacitance of each DCS (CGSP and CGSN ). During this process, the binary
weighted push-pull current sources are isolated from the DCS using switches SIs1 and
SIs2. Afterwards, the HV and LV DCSs source and sink stimulation current through
the binary weighted push-pull current sources by activating all the stimulation phase
Table 7.1: Output stage parameters.
PARAMETER VALUE
VDDH , VREFP , VREFN 3.3V, 3.25 V, 50mV
(W/L)P ofHV DCS M1 =185 µm/1µm at 0.5 mA
(W/L)N ofLV DCS M4 =56 µm/1µm at 0.5 mA
CGSP /CGSN 1 pF
Current amplitude 10 µA − 0.5mA












































Figure 7.2: Architecture of the DCS interfaced to the binary-weighted anodic and cathodic current sources.
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Table 7.2: Timing summary biphasic stimulus.
Phase Active switches Clock signals
Programming (ϕ1) S1, S2, S3, S4, S5, S6 Programming phase clocks
Stimulation (ϕ2) SN1 . . . SN8, SP1 . . . SP8, SIS1, SIS2
Anodic and cathodic
stimulation phase clocks
Figure 7.3: (a) Programming phase clock. (b) Stimulation phase clock.
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switches in Table 7.2 and deactivating all programming phase switches. In terms of
bias voltage, this uses a straightforward approach, unlike the current steering system
in [128] which needs a linearization circuit for its VCR bias voltage.
7.2.2 Binary Weighted Current Sources
These are activated only during stimulation. From Figure 7.2, transistors MP1 to MP8
are binary weighted transistors, with the last two, MP7 andMP8 having the same width.
These transistors share the NAMP amplifier and serve as the anodic current sources.
While transistors MN1 to MN8 share the PAMP amplifier and serve as the cathodic
current sinks. Both the anodic and cathodic current sources are operated such that
all transistors are in saturation with a VDSAT of 100 mV during stimulation. These
weighted transistors together with the DCS create 8 dynamic VCR current sources in
a push-pull configuration, and are interfaced to the electrodes via a multiplexing stage.
The currents through the transistors have a relative weight of I2 for IP1 and IN1,
I
4 for
IP2 and IN2, and reduces by a factor of 2 up to
I
128 for IP7, IP8, IN7 and IN8, so that
the total current sourced or sinked sums up to I, where I is the programming current.
This approach has an advantage of increasing the resolution without an increase in
current source area, by further splitting the least weighted current source depending
on the adopted radix.
7.2.3 Multiplexing Stage
The 8 push-pull current sources are interfaced to the electrodes via a multiplexing stage,
as shown in the schematic of Figure 7.4.This stage enables the routing of current to
specific electrodes. In order to ensure that each electrode can be individually driven
in an anodic or cathodic configuration, the electrodes have independent anode and
cathode connections as can be seen in Figure 7.4 labelled Ai and Ci respectively, where
i is between 1 and 16. For the 16-electrodes in this design, there are 16 different anodes
connected to each of the 8 anodic current sources and 16 different cathodes connected
to each of the 8 cathodic current sinks. These connections between the anodes or
cathodes to individual current sources is enabled using complementary switching. The
complementary switches select which of the weighted current sources to connect to the
anodes and cathodes based on control signals. The configuration in which the electrodes
operate is determined by the state of the Ai and Ci switches.
7.3 Simulated Results
The output stage was designed in a 0.18µm CMOS technology and simulated in Cadence
Spectre. The clock signals in Table 7.2 and Figure 7.3 were used to simulate the
transient analysis of Figure 7.5.
In Figure 7.5, the output stage delivers 503.2 µA and −503.2 µA (programmed for
500 µA) through electrode E8 during both anodic and cathodic phases to a 5kΩ load
for periods of 100µs. This current is steered to two different electrodes for similar
period, to E1 delivering −193.7 : µA and 189.6 µA (programmed for 187.5 µA) during
anodic and cathodic phases and E16 delivering −309.5 µA and 313.6 µA (programmed
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Figure 7.4: Schematic of the proposed multiplexing stage showing how the current sources
are interfaced to the stimulating electrodes.
for 312.5µA) respectively. This is a matching accuracy of within 2%. The DC analysis
in Figure 7.6 shows that a headroom voltage of less than 300 mV is needed for the output
stage under variable load conditions. In terms of matching, Figure 7.7 compares the
input-output characteristics of the output current from the LV and HV DCS.
Figure 7.5: Transient operation of current driver (configuration as depicted in Figure 7.4)
using E1 and E16 as cathodes, with E8 as anode during initial stimulation phase.
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Figure 7.6: Output characteristic depicting the headroom voltage requirements for different
levels of output current under load conditions.
Figure 7.7: Transfer characteristics of the current driver for 5 kΩ load, IP (Anodic current)
and IN (Cathodic current).
The mismatch between IN and IP is shown to be below 4% throughout the operating
range, and can be attributed to a slight difference in bias voltage during programming,
which can be improved using larger storage capacitors. However, using larger capacitors
increases the area of the circuit which is not desired. Finally, Figure 7.8 depicts the
effects of process variations and mismatches by performing 200 runs of Monte Carlo
analysis of the output stage for IDAC of 500 µA and 100 µA. The analysis was run
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Figure 7.8: Monte Carlo Analysis of effects of process variations and mismatches on the output
current IOUT depicted using 10 bins. The analysis was done on 200 runs for 3−σ
models.
using a 3−σ model with Gaussian distribution on typical corners. For IDAC = 100µA,
77% fall within a 10% tolerance limit, and for IDAC = 500 µA, 100% fall within a 10%
tolerance limit.
7.4 Discussion
State-of the-art DBS stimulators use a supply voltage greater than 10V. A typical
example is the Activa family of stimulators produced by Medtronic which has the
ability to administer up to 10.5V, voltage mode stimulation. However, the application
of high voltage stimulation is still unused in clinical DBS, as clinical DBS still adopts
a maximum stimulation of within 3 - 4 V. Nevertheless, incorporating high voltage
capability is the current trend for DBS stimulators marketed by major companies like
Boston Scientific, Medtronic and St Jude. A possible explanation for maintaining
clinical DBS within low voltages for even the high voltage systems can be attributed to
the possibility of brain tissue damage with high voltage stimulations. As an example,
consider the conventional Medtronic DBS lead model 3389, which has a diameter of
1.27 mm. And is placed in the STN for stimulation. The STN is a grey matter, having a
conductivity of about 0.255 S/m along the height of the cylindrical DBS electrode (with
length 1.5mm) [291]. Furthermore, it is also known that the minimum power density
that causes brain tissue damage is 800µW/mm2 [39]. By neglecting the impedance as a
result of electrode-tissue interface, an approximate value for the maximum voltage the
brain tissue around the electrode can withstand is 3.54 V. This is why state-of-the-art
DBS systems having high voltage supply, still use a maximum voltage less than 4 V. It is
for this reason that the proposed stimulation technique uses a 3.3 V supply as a proof of
concept. The aim of the design was to demonstrate the possibility of using a single bias
voltage for stimulation during both anodic and cathodic phases of stimulation. This
was in order to conserve power and reduce mismatch. Also, the design demonstrated
the use of a single current source in producing several weighted current sources that
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can be interfaced to a multiplexing stage in order to facilitate current steering. This
was in contrast to other directional steering systems like the Vercise current steering
system which uses multiple independent current sources [292]. Multiple independent
current sources introduce redundancy in the circuit, as not all current sources may be
utilised at a given time, this approach promotes inefficiency since it uses an excessive
amount of high voltage sources. For the dynamic current steering system in this work,
a high voltage alternative will require very large storage capacitors in order to store the
bias voltage for use during both stimulation phases. This is the major bottleneck of the
design, as this will increase the area of the system. The major factor that will determine
the implementation of the high voltage design of the dynamic current steering system
is if the increased area as a result of the storage capacitor will serve as a good trade-off
for reduced power consumption and mismatch.
7.5 Chapter Summary
a) The aim of the design is to implement an output stage for dynamic current steering
which can overcome the common inefficacies associated with DBS, which involve
output current mismatch and power consumption.
b) The output stage uses a 3.3 V supply, however it can be scaled for use with higher
supply voltages. The output stage lends itself well to increasing current source
resolution without a corresponding increase in area or power consumption.
c) The adopted multichannel configuration offers control over current delivered at the
stimulation site, which has the potential of improving neural selectivity. Also the
use of current controlled stimulation enables constant excitation. And the dynamic
current sources assist in reducing power usage and mismatch.
d) With clearer insights into the effects of DBS at the stimulation site, control algo-
rithms can be designed to provide effective stimulation paradigms that can be used
in implementing dynamic current steering. Future developments will incorporate
novel charge balancing techniques.
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Conclusion and Future Directions
8.1 Summary
Clinical DBS is a tool used to mitigate pharmacologically intractable neurological disor-
ders such as PD, ET and dystonia. It currently uses continuous, high frequency voltage
or current pulses to mitigate PD. This results in a number of limitations, notable among
are stimulation induced side effects and shortening of pacemaker battery life. These
limitations can be tackled using aDBS, which delivers stimulation precisely only when
needed. This thesis presents work undertaken to investigate, propose and develop novel
algorithms and implementations for adapting DBS. The major focus of the work was
to identify implementation strategies that could lead to fully implantable systems for
aDBS, vis-a-vis biomarker processing and stimulator implementation. Biomarker pro-
cessing involves strategies to detect PD such that PD detection informs therapy. Thus,
enabling the use of demand-driven DBS to overcome the shortcomings of continuous
DBS. For stimulator implementation, a directional steering stimulator with capabilities
for spatially adaptating DBS was proposed. Spatial adaptation offers a new dimension
to DBS therapy by directional control over stimulation focus. These two forms of DBS
adaptation motivated the major contributions of the work.
To enable hardware-efficient PD diagnosis and management, the first part of the work
involved establishing a processing chain for PD detection and evaluating a combination
of algorithms across the processing chain based on customised performance metrics.
Selection of appropriate performance metrics are the cornerstone for a thorough assess-
ment of PD detection algorithms. This motivated the use of custom as well as standard
measures for evaluating the algorithms in terms of area, NOP and efficacy. Establishing
a detection scheme consisting of dynamic FE and dynamic pattern classification was
the first novelty of the work. This was tagged dynamic detection. The PD detection
algorithms were designed to incorporate dynamic detection schemes such that feature
extraction and classification were made dynamic so as to track the unpredictable nature
of Parkinsonian LFP. The need for dynamic detection was essential due to the non-
linear progression of PD in patients. Furthermore, a novel DR technique, the MRM
(inspired by Fisher’s separability criterion) was proposed as part of the algorithms to
be evaluated. It provided the most efficient DR performance; based on customised
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complexity and accuracy metrics. The PD detection algorithms were validated using
semi-synthetic LFP data generated from representative PD and non-PD LFP record-
ings. The statistical methods used in LFP data synthesis was another novelty of the
work.
For hardware demonstration, a processor consisting of the combination with the best
accuracy and complexity trade-offs was implemented and prototyped on an FPGA
platform. This was the first known hardware implementation of a neurological event
detector for PD. To establish the most optimal implementation of the detector, various
implementations of its classification stage were analysed for efficacy, power and area
trade-offs. More emphasis was placed on optimising the classifier as it is the most
computationally intensive processing stage. The implementation was proposed for use
in personalised PD monitoring. Personalised health monitoring can serve as a precursor
to fully implantable aDBS systems. The major novelty in the PD processor was the
choice of application, as it is the first known hardware implementation intended for on-
site PD detection and monitoring. Another novelty involved the detection approach,
which uses complementary detection. This involved using a number of weak classifiers
to produce a classifier with improved consistency and confidence level. Since more
knowledge regarding PD and DBS is still gained by the day, a microchip implementation
of the design may not be cost effective at this point. This prompted prototyping it
on an FPGA platform because RTL implementations could be seamlessly translated
for use on microcontrollers or implemented as a microchip. Nevertheless, microchip
performance analysis for power and area were obtained to guide future implementations.
This analysis can serve as a guide for anyone embarking on ASIC implementation of
PD detection processors. The PD detection processor was aimed for use in monitoring
PD onset such that the information is communicated for external use by caregivers or
as a trigger for stimulation devices; both of which could be used to mitigate patients
conditions.
The thesis also proposes a smart control strategy for adapting DBS that is designed
to overcome the high efficiency demands of aDBS without compromising on hardware
resources. It proposes a critic-actor control approach that uses a LUT based controller
implemented using a fuzzy logic controller. The critic-actor approach was adopted
because it models the relationship between the physician and the automated neuro-
modulation system. Like the trained clinician, the critic evaluates the patient based on
a defined criteria. The actor “acts” based on information from the critic. The motiva-
tion for adopting this approach was inspired by the need to incorporate more heuristics
in PD suppression due to the extreme difficulty in taming PD as well as the limited
understanding of its internal mechanisms. Besides, the requirement that hardware im-
plementations of aDBS should be designed to take into consideration implantability
also motivated the critic-actor approach. Nevertheless, further analysis may be needed
to assess the effect of external body signals as well as an increased number of input
signals on the performance of the controller.
With the first three parts focused on PD detection and tracking for aDBS, the fourth
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and final part presents preliminary design on a dynamic current steering stimulator
output stage that lends itself to spatial adaptation. A full implementation of the design
could be used for controlling activation field spread beyond targeted areas, which is a
major source of stimulation induced side effects.
8.2 Original Contributions
The work in this thesis provides the following significant contributions:
1. Chapter 4 proposed dynamic PD detection as a way to overcome the inconsis-
tencies associated with neural signals during PD detection. This led to the de-
velopment of an algorithm for feature selection, inspired by Fisher’s separability
criterion: the MRM. The MRM implemented a hardware-efficient feature and
channel selection of LFP power features.
2. Chapter 4 also embarked on the development of the first known methodology
for a balanced, objective and fair evaluation of trade-offs between accuracy and
computational complexity for PD detection algorithms using customised perfor-
mance metrics. A subset of algorithms consisting of FE, DR and dynamic pattern
classification stages were analysed and investigated for hardware-efficiency.
3. Section 4.2 in Chapter 4 presented the first known statistical method for semi-
synthetic LFP generation that can be used for unbiased and accurate evaluation
of PD detection algorithms.
4. Chapter 5 was involved with the development of the first known hardware imple-
mentation of a processor for PD detection and monitoring. Based on power, area
and efficacy trade-offs, complementary detection was presented as a consistent
and hardware-efficient method of PD detection and monitoring.
5. Chapter 6 proposed a framework for adapting DBS using a critic-actor control
strategy. The approach models the relationship between the physician and the au-
tomated neuromodulation system. The critic like the “trained clinician” assesses
the state of the system based on a cost function (in this case state estimates) and
provides the information to the actor.
6. Chapter 7 introduces the design of an output stage for dynamic current steering
which is aimed towards the development of a power-efficient multi-polar multi-site
stimulator for spatially adapting DBS.
8.3 Suggestions for Future Work
This section discusses some ways the work presented in this thesis can be developed
further.
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8.3.1 Implementation of a Power-Efficient Output Stage for Multisite
and Multipolar DBS
Therapeutic benefits of DBS are often affected by poor stimulation focus [99]. This
is one of the major motivations for multisite and multipolar DBS. In addition, precise
targeting during stimulation has been reported to reduce the threshold for beneficial
effect [125]. This makes the design of power efficient stimulator output stages essential.
Boston Scientific, Medtronic and Aleva Neuroprosthetics are currently marketing direc-
tional steering stimulators. However, their designs use multiple current sources, which
is an inefficient approach. The need for a power-efficient approach motivated the work
in Chapter 7 which introduced a possible implementation of a dynamic current steering
stimulator. The design is a preliminary implementation. For future implementations,
the design can be extended to use a large number of electrodes. Also, the design speci-
fication can be further improved by increasing the output current to 20 mA. Above all,
the output stage could be developed into a full ASIC.
8.3.2 Development of a Hardware Efficient PD Prediction Processor
Machine learning provides techniques for analysing complex physiological signals, which
was why it was used for PD tracking in this work. PD tracking presented in this work
and in other aDBS applications have mainly focussed on early detection and state
estimation. However, for optimal therapy, prediction of critical events may be more
beneficial than early detection. The major challenge of prediction is that critical events
preceding PD may be difficult to discern due to the unpredictable nature of PD dy-
namics. Nevertheless, it will be important in the future to explore the possibility of
predicting PD events in advance. A starting point in PD prediction could be the adop-
tion of strategies that combine short-term (like electrical activity measurements) and
long-term (like metabolic activity measurements) sensing such that repetitive patterns
from the long term sensors can be used to assist in PD prediction. A major issue in
achieving this will be the need to design novel DBS recording electrodes that can con-
currently obtain electrical and metabolic activity measurements from the brain. For
implantability, it is imperative that the prediction processor or system is designed with
hardware implementation in mind.
8.3.3 Investigation into the Efficacy and Hardware Efficiency of Closed-
loop Control Strategies
For closed-loop DBS, clever control strategies are required to generate actionable out-
puts. However, for fully implantable systems, there are certain hardware resource con-
straints imposed. It will thus be important to embark on a study that works towards
answering the following questions:
• Which control strategies are most effective for modulating therapy?
• Which control strategies are most robust to noise and other electrical or metabolic
disturbance sources in patients?
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• Which control strategies are the most feasible for implantable hardware imple-
mentation?
• How sophisticated do the control techniques need to be and how much can they
adapt to effects like disease progression, environmental factors, mechanical fac-
tors, and behaviourally induced changes in brain or network activity?
Due to the complexity and limited understanding of the brain, efficacious and hardware
efficient controller design for aDBS could be the next frontier of DBS research.
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Meaning of Mathematical Symbols and
Notations
The symbols and notations have been defined in the main text of the thesis. However,
they are defined again in a tabular form in this appendix for more clarity – related
equations are grouped together. The symbols and notations are presented in the order
they appear in each Chapter.
A.1 Symbols and Notations Used in Chapter 2
A.1.1 Equations 2.1 & 2.2
E(t) Proportion of excitatory cells active per unit time.
I(t) Proportion of inhibitory cells active per unit time.
hE(t) External input to the excitatory population.
hI(t) External input to the inhibitory population.
fE Firing rate functions for the excitatory population.
fI Firing rate functions for the inhibitory population.
WEI Connection weights between excitatory and inhibitory.
WIE Connection weights between inhibitory and excitatory.
WEE Self-excitation weights.
WII Self-inhibition weights.
r Absolute refractory period.







VK , VNa and VL Ionic channel potentials.
RK , RNa and RL Channel resistance.
Vm Membrane potential.
ISTIM Applied stimulation current.
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Qtot Total charge injected.
T Pulse width for a mono-polar stimulation.
A.2 Symbols and Notations Used in Chapter 3











MCC Mathews Correlation Coefficient.
A.3 Symbols and Notations Used in Chapter 4
A.3.1 Equation 4.1
sj j-th independent source signals.
xi i-th discrete point in the original signal.
aij Mixing matrix.
A.3.2 Equations 4.2, 4.3, 4.4, 4.5, 4.6 & 4.7
Xt Stochastic process.
Zt Independent white noise error terms.
q Order of MA Process.
βi Parameters of MA Process.
p Order of AR process.
αi Parameters of AR process.
c Constant term.
µ Mean (average) of a series.
σ2Z Variance of a white noise process.
τ Translation parameter.
t Time.
E[X(t)] Expectation of the joint distribution X(t).
Cov[X(t), X(t+ τ)] Covariance of X(t).
∆ Differencing operator.
εt Mean zero innovation process.
yt Time series.
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A.3.3 Equations 4.8
γ(k) Partial autocorrelation between yt and yt+k.
Cor(yt+k, yt) Autocorrelation between yt and yt+k.
Pt,k(yt) Parameter adjusting for partial autocorrelation.
A.3.4 Equations 4.10
Corrnormx,y Normalized cross-correlation.
a[n] and b[n] Two data sequences, where n is an integer.
A.3.5 Equation 4.11
r PD rate.
∆t An interval of time.
d Number of PD events over an interval ∆t.
A.3.6 Equation 4.12
L Bit quantisation per sample.
CompCosta Complexity cost of the combination of PD detection algorithm
labelled a.
NOPa NOP of the combination PD detection algorithm labelled a.
areaa Area of the combination PD detection algorithm labelled a.
v Number of combinations of PD algorithms.
A.3.7 Equations 4.13
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Xn[t; f ] STFT for the discrete time index t and discrete frequency index
f .
x[n] Discrete input signal with index n.
W Window length.
A.3.9 Equations 4.15
W (u, 2j) DWT with u as the translational parameter and 2j as the scale
parameter.
Ψ Wavelet function.
A.3.10 Equations 4.16, 4.17 & 4.18
A Reduced feature vector.
B Original feature vector.
U Projection matrix.
PC Square matrix containing the coefficients of all principal com-
ponents.
m Number of training examples.
n Feature vector dimension.
H Projection matrix for NMF.
A.3.11 Equations 4.19, 4.20, 4.21, 4.22, 4.23, 4.24, 4.25 & 4.26
O = [o1, o2, . . . , oD]
T Vector of training examples having a total of D observations.





i , . . . , o
(n)
i ] i-th training example.
C = [C0, C1, . . . , Ck] Vector of k + 1 classes, with each class having a total number
observations D0, D1, . . . , Dk respectively.
µi and σ
2







i , . . . , µ
(n)





i , . . . , σ
(n)
i ] Standard deviation for class i having n-dimensional features.
J(SD, SD) Fisher’s criterion of separability.
A.3.12 Equation 4.27
fkNN (λ) k-NN discriminating function.
λ Test case.
Υn Labels for the training datasets.
Nk(λ) The index of k-nearest neighbours of test case, λ.
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A.3.13 Equations 4.28 & 4.29
fLR(λ) LR discriminating function.
Υ Class labels for LR (0 for non-PD or 1 for PD).
λ(i) Extracted features for test case i, with a label Υ(i).
θ Vector of threshold and weight parameters.
A.3.14 Equations 4.30
fSVM (λ) SVM discriminating function.
K(λi, λ) Kernel transformation function.
λi Support vectors with their labels Υi and weights ρi.
ω Classification threshold.
A.3.15 Equations 4.31
Training NOP Total NOP during training.
Operating NOP Total NOP during normal operation.
A.4 Symbols and Notations Used in Chapter 5
A.4.1 Equation 5.1
Pi Average power for level i coefficients.
Ni Number of coefficients in sample i.
xi[n] DWT coefficients at level i.
A.4.2 Equations 5.2 & 5.3
h0 Half-band low pass filter.
g0 Half-band high-pass filter.
di Detail coefficients at level i of DWT.
ai Approximation coefficients at level i of DWT.
ai(k) k is the index of the input signal (approximation coefficients,
ai).
h0(n) n represents the index of the filter coefficients of h0.
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A.5 Symbols and Notations Used in Chapter 6
A.5.1 Equation 6.1
fGMM (x) State Estimation function for GMM.
wi Weight assigned to a particular Gaussian model i.
~x Input feature vector for test case.
µi and Λi Mean and covariance vectors for Gaussian model i.
N Number of Gaussian models.
A.5.2 Equation 6.2






NOP Average number of operations.
Nadd(sub) Number of 1-bit additions or subtractions.
Nmult(div) Number of 1-bit multiplications or divisions.
Res Resolution of the data converter.
A.5.4 Equation 6.4
µA(a;xi, yi, zi) µA is the certainty of membership in a fuzzy set.
a is the universe of discourse.
xi,yi and zi are scalar parameters representing points on the
triangle.
A.5.5 Equation 6.5
µD(d;σi, di) µD is the certainty of membership in a fuzzy set.
d is the universe of discourse.
σi and di are scalar parameters representing the standard de-
viation and mean respectively.
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A.5.6 Equation 6.6
µD(d;σia, σib, di) µD is the certainty of membership in a fuzzy set.
d is the universe of discourse.
σia is the standard deviation of the left tail of the Gaussian
membership function.
σib is the standard deviation of the right tail of the Gaussian
membership function.
A.5.7 Equation 6.7
Cstim Incremental stimulation frequency.
Ai The area under the membership function Ci.
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